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ABSTRACT 
Protein turnover is the balance between protein biosynthesis and protein degradation in living cells. Protein 
degradation is thereby not only a final destiny but also an essential and carefully regulated mechanism to 
maintain cell fitness. Even though the key players for protein degradation are known for long, only few 
aspects of protein recognition, unfolding and degradation have been characterised mechanistically in 
bacteria. 
 
A dynamic regulation of protein stability is a key interest in applications in synthetic biology, biotechnology, 
metabolic engineering and fundamental research. However, only a few tools for conditional protein 
degradation have been developed in bacteria so far. This thesis presents two attempts to improve the 
available tool box for conditional degradation of soluble proteins as well as membrane proteins in E. coli. 
 
 
DANSK SAMMENFATNING 
Proteinomsætning er balancen mellem proteinsyntese og proteinnedbrydning i levende celler. 
Proteinnedbrydning er dermed ikke kun en endelig skæbne men også en essentiel og omhyggeligt reguleret 
mekanisme til at opretholde celle fitness. Selvom nøglemekanismerne for proteinnedbrydning har været 
kendt længe er kun få aspekter af protein genkendelse, denaturering og nedbrydning blevet karakteriseret 
mekanistisk i bakterier. 
 
En dynamisk regulering af proteinstabilitet er en hovedinteresse i implementeringen af syntetisk biologi, 
bioteknologi, teknisk metabolisme og grundvidenskab. Men for nuværende er der kun blevet udviklet få 
værktøjer til konditionel proteinnedbrydning i bakterier. Denne afhandling præsenterer to forsøg på at 
forbedre den tilgængelige værktøjskasse til konditionel nedbrydning af både cytoplasmiske og membran 
associerede proteiner i E. coli. 
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ABBREVIATIONS AND GLOSSARY 
aa amino acid(s) 
AAA+ proteins ATPases associated with diverse cellular activities; protein superfamily 
araBp  promotor sequence for the araBAD operon; DNA level 
AvGFP native green fluorescent protein (GFP) from Aequorea victoria 
bp base pair(s) 
cAMP 3',5'-cyclic adenosine monophosphate 
CreiLOV engineered fluorescence reporter (FR) protein domain of the Light-Oxygen-Voltage (LOV) 
protein family, derived from Chlamydomonas reinhardtii 
C-terminal carboxy-terminal 
ClpA caseinolytic protease A; ATP-binding unfoldase subunit of ClpAP proteasome 
ClpP caseinolytic protease P; proteolytic subunit of proteasomes ClpAP and ClpXP 
degradation motif a degradation motif on a protein usually consists of two degrons: a tether-degron, that 
regulates protein substrate recognition; and an initiation site-degron, where 
unfolding/degradation begins (details in text). Both degron moieties are essential to initiate 
proteasome-dependent protein degradation. 
degron a degron is degradation signal: a specific sequence, conformational fold or amino acid in a 
polypeptide chain that contributes unmodified (primary degron) to a degradation motif (see 
details in the text); when a degron is either N- or C-terminally located on a peptide chain, it 
would be termed either N-degron or C-degron, respectively. Definition modified from 
VARSHAVSKY (2011) 1. 
dg degradation sequence motif 
dgFtsH native N-terminal degradation sequence motif recognised by the FtsH proteasome 2 
dgClpAP synthetic N-terminal degradation sequence motif recognised by the ClpAP/ClpS proteasome 3 
EcFbFP engineered fluorescence reporter (FR) protein domain of the Light-Oxygen-Voltage (LOV) 
protein family, derived from Bacillus subtillis 
EnvZ protein product encoded by the envZ gene; env is a mnemonic for envelope; EnvZ is described 
as an osmosensor protein situated in the bacterial inner membrane (IM) 
FR fluorescent reporter, fluorescence reporter 
frGFP GFP folding reporter; a variant of the A. victoria green fluorescent protein (AvGFP) 4 
FtsH filament temperature-sensitive protein H; ATP-dependent;  
membrane-bound proteasome in E. coli 
DG free energy of unfolding (DG = Gfinal – Ginitial); DG is the energy difference in between the 
unfolded and folded state of a protein 
g unit for relative centrifugal force (RCF) 
GFP green fluorescent protein from the GFP family derived from A. victoria 
GST glutathione S-transferase 
IM inner membrane 
IMP inner membrane protein; membrane protein (MP) of the inner membrane 
IPTG isopropyl-β-D-thiogalactoside 
lacIo operator sequence recognised and bound by the LacI repressor; DNA level 
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LOV protein photoactivatable protein of the Light-Oxygen-Voltage protein family 
LPS lipopolysaccharide 
µL microgram 
µL microliter 
mM millimolar 
MP membrane protein 
MQ water Milli-QTM water; ultrapure water 
n count of independent experiment(s) 
NarX protein product encoded by the narX gene; nar is a mnemonic for nitrate reductase or nitrate 
regulation; NarX is described as a nitrate sensor-transmitter protein situated in the inner 
membrane protein 
NavZ1 inactive membrane protein chimera consisting of the N-terminal and C-terminal moieties of 
osmolarity sensor histidine kinases NarX and EnvZ from E. coli, respectively 5 
N-terminal amino-terminal 
OM outer membrane 
OMP outer membrane protein; membrane protein of the outer membrane 
ORF open reading frame 
phiLOV2.1 engineered fluorescence reporter (FR) protein domain of the Light-Oxygen-Voltage (LOV) 
protein family, derived from Arabidopsis thaliana 
PL phospholipid 
POI protein of interest 
PpiD peptidyl-prolyl cis-trans isomerase D, inner membrane protein (IMP) of E. coli 
PQC protein quality control 
pro-degron precursor of a degron; generally, a pro-degron is a specific sequence, conformational fold or 
amino acid in a polypeptide chain that can be cleaved or otherwise modified to produce a 
secondary or primary degron (see details in the text); if upon modification a N-terminal or C-
terminal degron is released, it would be termed either pro-N-degron or pro-C-degron, 
respectively. Definition modified from VARSHAVSKY (2011) 1. 
PROTi protein interference 
rB count of biological replicate(s) 
rT count of technical replicate(s) 
rpm revolutions per minute; unit for the frequency of rotation 
rsTEVP(X) restriction site of the tobacco etch virus protease (TEVP) with amino acid X in amino acids 
position seven of rsTEVP; X becomes N-terminally released upon TEVP cleavage; peptide 
sequence 
SD sequence Shine-Dalgarno sequence; mRNA level 
SecYEG translocon protein translocation complex in the bacterial inner membrane (IM) 
sfGFP superfolder GFP; variant of the A. victoria green fluorescent protein (AvGFP) 6 
SRP signal recognition particle 
T temperature 
TEV tobacco etch virus 
TEVP tobacco etch virus (TEV) protease 
TIR translation initiation region; mRNA level 
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TM transmembrane 
TMH transmembrane helix 
ts temperature-sensitive 
Ub refers to free ubiquitin as well as to a ubiquityl moiety bound/fused to a protein 
UPS Ubiquitin (Ub)-proteasome system 
U-SM uracil-excision based site-directed mutagenesis 7 
YFP yellow fluorescent protein; variant of the A. victoria green fluorescent protein (AvGFP) 
YfgM protein product encoded by the yfgM gene; inner membrane protein (IMP) of E. coli 
YhaI protein product encoded by the yhaI gene; inner membrane protein (IMP) of E. coli 
 
All amino acids and their respective three- or one-letter symbol as suggested by the IUPAC-IUB COMMISSION 
ON BIOCHEMICAL NOMENCLATURE (1968) 8 are not part of this list. 
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NOMENCLATURE 
The strain nomenclature as well as genetic nomenclature used in this thesis are as described in Instructions 
to Authors of the Journal of Bacteriology 9 and Linkage map of E. coli K-12, Edition 10:  
The traditional map by Berlyn 10 with following additional specifications inspired by Help: Genetic 
nomenclature of EcoliWiki 11. 
 
Molecular Genetic Constructs 
Coding sequences or open reading frames (ORFs) are separated from their respective promoters by a slash 
symbol (/). Example: T5p/malE-gfp, the malE-gfp gene fusion is under the transcriptional control of the T5 
promoter. 
 
Proteins products of modified genes 
As suggested for genes 9, superscript “ + ” and “ ‘ “ post-fix’ are also used for protein products to demonstrate 
a complete or truncated protein product, respectively. In case for a terminal truncation, the modified 
terminus is indicated by using superscript “N” or “C”. Example: XN’ or XC’ exemplify an  
N- or C-terminally truncated protein X. 
 
Plasmids 
Derivatives of natural plasmids or plasmid vectors are indicated with a lowercase “p” pre-fix (e.g. pACYC). 
For genes on a plasmid and any other gene that are introduced into a strain by experiment (see below), the 
same nomenclature as for chromosomal genes is used (see ASM (2018) 9), but placed within square brackets 
([]). Example: pACYCW[T5p/malE-gfp] indicates that the malE-gfp coding sequence is fused to the T5 
promoter which has been inserted into plasmid pACYC. 
 
Oligonucleotides or primers 
Oligonucleotides, often shortened as oligos or also termed primers, are indicated here below with a 
lowercase “o” pre-fix. Example: oMSB1234 stands for oligo with number 1234 from the collection of author 
with the initials MSB. 
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THESIS OUTLINE  
Errors happen constantly at any time in nature. This also refers to misfolded proteins in vivo du to genomic 
mutations, to errors during transcription or translation, or to various stress conditions 12. Misfolded proteins 
represent a dosage-dependent fitness cost for the cell, sometimes leading to its death 13. Proteins’ fate and 
therefore also a cell’s fitness is determined by the repetitive trial-and-error chaperone-assisted refolding 
attempts. If misfolded proteins are unable to refold or to be refolded correctly, they are targeted for 
processive proteolysis 12. Processive proteolysis is not only a fate but can also be an essential regulatory 
mechanism for the levels of fully functional proteins. Under certain conditions, a cell favours the dynamic 
regulation of specific protein levels by proteolysis rather than their transcriptional control 14. Processive 
proteolysis usually occurs in two ways: constitutively or conditionally 15. In either way, it is a carefully 
regulated mechanism in vivo that affects many cellular functions 16,17.  
 
The dynamic regulation of protein abundances is equally a central interest in synthetic biology 18. Synthetic 
biology aims to create robust, orthogonal molecular systems with new, valuable functions for industrial and 
medical applications 19. Those systems need to be subject to unconditional control for protein biosynthesis 
as well as for protein stability. Regulated processive proteolysis is especially advantageous in case of long-
living proteins which would otherwise persist for many generations 20. Practically, most native globular 
proteins are relatively stable in vivo 17,21,22 which might represent an adaptation to secure their  
functionality 21. 
 
For bacterial cells, there are many tools to modulate specific protein levels by altering the rate of protein 
biosynthesis. However, a versatile tool box for bacteria that is able to tune the stability of specific proteins 
by their destabilisation (or re-stabilisation) is only just about to be developed 18. Tools for intracellular 
proteolysis are of general value for a wide variety of biotechnological applications, metabolic engineering 
and synthetic biological circuits but also for fundamental studies of essential proteins and biological 
networks 18,23. Here, the additional presence of an engineered, conditional element which can trigger or 
disable targeted intracellular proteolysis has been proven to be an essential part for tool regulation. The 
nature of this conditional element needs to be adapted on the need of each study. 
 
As for all Gram-negative bacteria, processive proteolysis in E. coli is mediated by five ATP-dependent 
proteasomes which are all located in the cytoplasm: ClpAP, ClpXP, HslUV (alias ClpYQ), Lon and FtsH 24. Only 
proteins that reveal the right combination of specific degradation signals, or degrons, are (1) recognized by 
the proteasome, (2) processively unfolded and (3) subsequently degraded 25. To any synthetic biologist’s 
distress, an overwhelming number of factors affect how proteins are targeted to a proteasome and how 
they are subsequently degraded 25. Only few aspects of the bacterial proteasomes’ multistep mechanisms 
encompassing protein recognition, mediation, unfolding and degradation have been characterised 
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mechanistically, though most of it is still unknown. Additionally, the vast variety of protein substrate classes, 
conformations, architectures, topologies and their individual intracellular localisation adds up to the 
complexity of understanding proteolysis. 
Nevertheless, with the given knowledge, a few tools for conditional protein destabilisation have been 
developed in bacteria until now 18,20,23,26. Each of them is able to target a particular fraction of the cells 
proteome, which is defined by the protein terminus (i.e. N- or C-terminus) where degradation is initiated 
by those tools. For some proteins, both termini may be used for degradation. However, all the available 
conditional tools have been shown suitable for cytoplasmic globular proteins. Their applicability on 
membrane proteins (MPs) was only tested in rare cases until now. In brief, there is much room for 
improvement in general and a particular need to expand the available tool box for conditional degradation 
of MPs. 
 
The practical work conducted during this thesis aimed at expanding the range of proteins that are 
targetable for proteolysis in a conditional manner. To achieve this, known synthetic, heterologous and 
endogenous proteic building blocks were rearranged to design a synthetic platform for targeted proteolysis 
de novo. This thesis is structured into three interdependent main parts. The first past (INTRODUCTION) 
represents an introductory preface which is important for a general understanding of the thesis. The second 
part (STUDY I) details the development of a bipartite synthetic tool for the conditional control of probably 
predominantly cytosolic globular proteins in form of a published article. And finally, the third part (STUDY II) 
describes an unfinished attempt to transplant the synthetic set-up from STUDY I into the context of 
conditional MP degradation. 
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INTRODUCTION 
For a general understanding of this thesis, the following sections intend to provide insights into the 
complexity of native processive proteolysis in eukaryotes as well as prokaryotes since there are many 
parallels between those two domains; however, focus will be kept on prokaryotes. Additionally, an 
overview is given about synthetic strategies already available to manipulate protein stability. Finally, details 
about the proteic and molecular building blocks relevant for this thesis are provided. 
 
1 NATIVE PROTEOLYSIS IN BACTERIA 
The genome of E. coli is predicted to harbour approximately 4,300 protein-coding genes but only about 
one-fourth of the protein products seem to be abundant at various growth conditions 27,28. Differences in 
protein abundance were found to correlate with the proteins’ function(s) in the cell 28. The ability to control 
protein availability is essential for cell homeostasis, that itself is critical for cell viability 22. Besides an often 
complex regulation of protein biosynthesis, the availability of a given protein is also controlled upon the 
regulation of its stability 14,22.  
In bacteria, intracellular protein degradation or processive proteolysis, plays a role, on one hand, in the 
elimination of misfolded, damaged as well as incompletely synthesised proteins; on the other hand, it also 
regulates levels of key proteins responsible for intracellular signalling as well as gene transcription  
control 17. Therefore, processive proteolysis can affect a variety of diverse functions 17: it plays a major role 
in the general protein quality control (PQC) 17, can affect many stress response pathways 17,22, has an impact 
in the regulation of pathogenesis 29 or can trigger transitions between different physiological stages in 
certain bacteria 30.  
General proteolysis is usually catalysed by different proteases available in the cell. In contrast to most 
regulatory mechanisms, processive proteolysis is inherently irreversible and may seem wasteful 31 since the 
restoration of a degraded protein requires its re-synthesis 22. In order to avoid random, uncontrolled 
degradation, some intracellular proteases developed into ATP-dependent unfoldase-protease complexes, 
called proteasomes (discussed for E. coli in INTRODUCTION section 1.1), and evolved processive proteolysis 
into a carefully regulated process 24. Generally, proteasomes ensure unfolding of their target proteins with 
subsequent cleavage of the unfolded polypeptide at multiple sites by releasing oligopeptides that can be 
further degraded into single amino acids for recycling 32. Proteasome-mediated proteolysis as such is 
usually regulated by a two-part degradation motif on the protein substrate. It consist of two inter-
dependent specific degradation signals, termed degrons, that are responsible for the substrate recognition 
(recognised by the proteasome directly or by specific adaptor proteins 33) and the provision of an initiation 
site for unfolding 25. 
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Alternatively, other but ATP-independent proteases abundant in cytosol 34 and periplasm 35 are responsible 
for another form of regulated proteolysis: the limited proteolysis or proteolytic processing 22 (not to be 
confused with the processive proteolysis performed by proteasomes 14). It involves cleavage at a limited 
number of specific sites in the protein resulting in its activation or maturation 22. Alike processive 
proteolysis, proteolytic processing underlies highly specific mechanisms 14 (not discussed in this thesis). 
Originally the degron term referred to proteasome-specific degradation motifs 36 but is recently also used 
for degradation signals from ATP-independent proteases due to an apparent similar complexity 37–39. 
Interestingly, proteolytic processing activities from ATP-independent proteases involved in periplasmic PQC 
(e.g. DegP) seems to be regulated not only by degradation signals abundant on their target proteins but 
also by the apparent availability of adaptor proteins 37–39. It seems that proteolytic processing is a similar 
regulated process as processive proteolysis by proteasomes. Finally, proteolytic processing and processive 
proteolysis can also cooperate: a site-specific cleavage in a protein might increase its susceptibility for 
processive proteolysis 14,22.  
 
1.1 Proteasomes in E. coli 
As for all Gram-negative bacteria, processive proteolysis in E. coli is carried out by five ATP-dependent 
proteasomes which are all located in the cytoplasm: ClpAP, ClpXP, HslUV (alias ClpYQ), Lon and FtsH 24 
(Figure 1). In general, those proteasomes are composed of two functional moieties, an unfoldase and a 
protease 40. The unfoldase and protease moieties are either located on separate polypeptides (ClpAP, ClpXP 
and HslUV) or both moieties are folded from a single polypeptide chain (Lon and FtsH) 40.  
Without exception, all unfoldases belong to the AAA+ (ATPase associated with diverse cellular activities) 
superfamily and form an hexameric ring 33,40. Unfoldase rings can interact as mono- (ClpX, HslU) or double 
layer (ClpA) with the protease moieties 41 and thereby activate the latter 34. Biochemical experiments 
suggested that a double layer of unfoldase rings increase the unfolding capacity to process targeted 
proteins with high intrinsic thermodynamic stability 42. Furthermore, unfoldase rings can also bind to both 
sides of the protease moiety to form a doubly capped protease complex 43.  
 
Generally, the unfoldase unfolds target proteins and translocates them through a central axial pore in an 
ATP-dependent manner into the protease moiety 33. Unfolded polypeptides entering the protease moiety 
are bound by substrate-binding domains of the protease and are subsequently cleaved into oligopeptides 
in an ATP-independent fashion 24,43. For ClpP and HslV, two oligomeric protease rings form a 
compartmentalised proteolytic chamber 24. General access of protein substrates to this proteolytic chamber 
is severely limited; this blockage is only relieved upon binding with the unfoldase 33. Non-specific 
degradation in the proteolytic chamber is limited to small oligopeptides when the unfoldase moiety is not 
bound 43. Interestingly for the two-peptide proteasomes, the mono-ring structure for HslV is a 
homohexamer whereas the ClpP ring is formed as homoheptamer 43. Consequently, the ClpP ring interacts 
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with its unfoldase partners, ClpA or ClpX (both homohexamer rings), in a mismatched docking fashion 43. 
The mechanistic basis behind this asymmetric mismatch for ClpAP and ClpXP activities are still debated in 
literature 33,43. In contrast, HslUV works without mismatch, as do the unfoldase and proteolytic 
homohexamer-rings of Lon and FtsH which are fused in one polypeptide anyway 33. 
 
 
Figure 1: Overall composition and structure of proteasomes in E. coli. ClpAP, ClpXP, HslUV (alias ClpYQ) and Lon 
are all soluble in the cytoplasm whereas FtsH is bound to the IM. The AAA+ unfoldase moieties and auxiliary 
domains are depicted here in green and the protease moieties are in blue. The auxiliary domains for each AAA+ 
unfoldase moiety are family-specific and often serve as substrate recognition sites directly, or as docking sites for 
adaptor proteins. In FtsH, auxiliary domains anchor the proteasome to the IM 33. Mono- and double layer 
arrangements of the unfoldase rings and protease rings are indicated and their distinct oligomeric mono-ring 
structures are given for each complex; the graph also describes whether the unfoldase or protease rings are 
formed from a single or from two polypeptide chains. The possible binding of two independent unfoldase rings on 
either side of a given proteolytic chamber is not shown. Figure modified from KIRSTEIN et al. (2009) 44. 
 
Although the mechanistic steps for protein substrate entry are well established, the pathway for product 
release from proteasomes seems to be widely unknown 45. Two possibilities are discussed in literature: (1) 
the unfoldase rings (e.g. ClpX) function as gatekeeper not only for substrate entry but also for product 
release 43; (2) peptide products are released through dynamic side pores in the proteolytic chamber at the 
interface between the two protease rings, as discussed for ClpP for instance 17,45. Once released by the 
proteasome, oligopeptides have a very brief half-life: within seconds they are rapidly digested into amino 
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acids by the cytosolic endopeptidases and aminopeptidases involved in protein re-synthesis or energy 
metabolism 31. 
 
1.2 Degrons – A general overview 
Most protein substrates are recognised by direct interaction with the unfoldase moiety of a proteasome. 
Other proteins require specific substrate recruiting factors, known as adaptor proteins, to direct them to a 
proteasome for conditional processive proteolysis 40. To date, four adaptor proteins have been identified 
in E. coli, three of which, SspB, UmuD and RssB, modulate ClpXP specificity, whereas a single adaptor 
protein, ClpS, alters the specificity of ClpAP 44. There are proteins that have recognition sites for numerous 
proteasomes, adaptor proteins as well as ATP-independent proteases 20. In case for processive proteolysis, 
the proteasomes themselves or the adaptor proteins contain specific domains for substrate recognition 
which bind selectively to degradation signals on their protein substrates (Figure 2) 46.  
 
 
 
Figure 2: Minimal models for protein substrate recognition for processive proteolysis. Protein substrate 
recognition is regulated by the tether-degron (x). An exposed tether-degron, terminally (A) or intrinsically (B, C) 
on a protein, is bound either directly by the auxiliary domains of the AAA+ unfoldase moiety (green; A, B) or through 
adaptor proteins (yellow; C) or regulatory subunits (not shown). ATP-dependent unfolding of the protein substrate 
by the unfoldase moiety, translocation to the proteolytic chamber and subsequent degradation are initiated upon 
interaction of the initiation site-degron (x) with the axial pore of the AAA+ unfoldase moiety (green; A, B, C). 
Proteolytic active sites in the proteolytic chamber are depicted as red dots. Details in the text. Figure modified 
from OLIVARES et al. (2016) 43. 
 
Those degradation signals have been originally coined degrons 47. Since their discovery in 1986, degrons, 
by definition, represent protein features that confer metabolic instability 15,48. The present knowledge 
postulates that an active degradation motif that finally leads to processive proteolysis is, however, an 
interplay of minimum two degrons. One degron is responsible for tethering the substrate protein efficiently 
A B C
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to the proteasome, coined the tether-degron, and the other one represents the initiation site where 
unfolding/degradation begins 25 (initiation site-degron). This binary structure has been shown for the 
prokaryotic SsrA-tag recognised by a variety of proteasomes 49 and the N-terminal degradation sequence 
motif processed by the prokaryotic N-end rule pathway 50 (Figure 4). The eukaryotic Ub-proteasome system 
(UPS) is even regulated by three inter-dependent degradation signals 51 that lead to an active UPS 
degradation motif: (1) a tether-degron I which consist of an amino acid residue (terminal or internal) that, 
once recognised, initiates substrate ubiquitination at (2) one or more internal Lys’ residues. Each Lys residue 
can be characterised, functionally spoken, as pro-degron (see Table 1) of a tether degron II which is 
represented by the attached poly-Ub-chain 51; and finally, (3) an initiation site-degron that is located on a 
structurally disordered segment of a target protein 51. Thus, the actual tether-degron responsible for 
proteasome recognition is the Ub-chain (tether degron II) which is dependent on the availability of (1)  
and (2). Interestingly, it was shown that the Ub-chain and the initiation site are spatially separated and can 
be either located in-cis on one single protein or in-trans on different proteins in a protein complex 52  
(Figure 3c). In either case, the initiation site-degron is always acting in-cis on a protein, thus, only the 
initiation site-bearing proteins get degraded (cis-acting degron) 1. The tether-degron can be described as 
cis- or trans-acting depending on its localisation 1,25,53–55.  
 
Since it was proposed the first time by VARSHAVSKY (1991) 47, the degron term has been used very 
inconsistently in the literature 51 due to the discovery of apparent increasing structural complexity. A term 
re-definition for standardised use seems imperative. In this thesis, the term degron will refer to any 
degradation signal that contributes to an active degradation motif which is able to initiate processive 
proteolysis. Thereby, a single degron is assumed to be essential but not sufficient to embody an active 
degradation motif. Instead, an interplay of minimum two degrons is needed to regulated proteasome 
recognition as well as unfolding initiation. Those will be termed tether- and initiation site-degron, 
respectively. Furthermore, the degron term will be only used in context with processive proteolysis (not for 
proteolytic processing). In case there is a higher level of regulation prior to proteasome recognition and 
unfolding, as in the case for an active UPS degradation motif, the respective degrons or its precursors (pro-
degrons) will be characterised accordingly, including their hierarchical order, if known. 
Speaking of hierarchy, degrons have been functionally organised into hierarchical levels: primary, 
secondary and tertiary degrons (Table 1) 17,36,56. A primary degron can contribute directly to the completion 
of an active degradation motif that initiates proteolysis (constitutive degron 15). Alternatively, it can be 
generated from secondary or tertiary degrons (conditional degrons 15). Following the logic of VARSHAVSKY’s 
definition of a pro-degron 1, secondary or tertiary degrons are precursors of a primary degron and therefore 
pro-degrons. Structurally, a pro-degron is a specific sequence, conformational fold or amino acid residue in 
a polypeptide chain or protein that can be cleaved or otherwise modified to produce a primary degron or 
primary pro-degron (equivalent to a secondary degron). Accordingly, secondary and tertiary degrons (or 
primary and secondary pro-degrons, respectively) need one or two modification steps, respectively, to be 
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turned into a primary degron. In case a (pro-)degron is located directly at the N- or C-terminus, it would be 
termed (pro-)N-degron or (pro-)C-degron, respectively. However, the recognition and modification of 
known tertiary degrons, which are exclusively tertiary N-degrons (secondary pro-N-degrons), and their 
conversion into secondary degrons (primary pro-N-degrons) have been only described in eukaryotes until 
now 1,17. 
 
Table 1: Hierarchy of degrons and pro-degrons.  
DEGRON  PRO-DEGRON FUNCTIONALITY AFFILIATION 
     
Primary degron   constitutive Eukaryotes, prokaryotes  
Secondary degron = Primary pro-degron conditional Eukaryotes, prokaryotes  
Tertiary degron = Secondary pro-degron conditional Eukaryotes  
 
1.2.1 Nature and location of (pro-)degrons  
The nature of (pro-)degrons can be manifold:  
§ intrinsically unstructured sequence motifs (e.g. the eukaryotic PEST motif 57,58;  
the initiation site-degron of an UPS degradation motif 51),  
§ conformational folds (e.g. the eukaryotic IκBα-degron 59) and  
§ terminal/intrinsic exposed amino acids (e.g. the primary tether-degron or Lys residues of an active 
UPS degradation motif 51; the N-terminal tether-degron recognised by the prokaryotic N-end rule 
pathway 50) 52,60. 
Some proteins even contain (1) multiple (pro-)degrons which contribute to the proteolysis by the same 
degradation pathway(s) (e.g. multiple eukaryotic PEST motifs 57,58; multiple Lys residues as part of an active 
UPS degradation motif 51), (2) overlapping degrons attracting different degradation pathways upon 
exposure (e.g. the prokaryotic SsrA-tag 49) or (3) inactive cis-/trans-acting tether-(pro-)degrons that are 
missing their partnering initiation site-degrons on the same protein in order to form an active degradation 
motif but which turn active upon complex formation with an initiation site-bearing protein (see Figure 3c; 
e.g. intrinsic Lys residues, as primary pro-degrons of the Ub-chain tether-degrons, which can contribute in-
cis or in-trans to an active eukaryotic UPS degradation motif 1,25,53–55). 
 
(Pro-)degrons seem to be located anywhere along the peptide chain, such as at internal sites 58 yet often 
nearby the N- or C-termini 61. In folded proteins, (pro-)degrons can be either exposed or buried within the 
protein structure itself (cryptic degrons); they can also be buried upon complex formation with other 
protein(s) which is described as cooperative stability (Figure 3b) 14,22,62. In contrast, buried degrons within 
a fully folded protein can only become accessible to proteolytic recognition systems upon conformational 
change (Figure 3e and f), (partial) unfolding of protein substrates (Figure 3g) or specific proteolytic cleavage 
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(Figure 3i) 22. Thus, besides the appearance of degrons or pro-degrons and their function as well as given 
proteasome-specificity, the turnover of a protein is also regulated by its correct folding and/or complex 
formation with other proteins. Exposed degrons on folded proteins might result in the constitutive and 
rapid degradation of the latter (Figure 3a). However, rapid degradation combined with stringently regulated 
protein production can result in very defined protein levels at specific time points 14.  
 
1.2.2 Conditional protein modifications for generating (pro-)degrons or active degradation 
motifs in vivo  
There is a whole variety of intracellular or extracellular events which induces the formation or the exposure 
of (pro-)degrons. On one hand, their release might be the result of conformational changes, unfolding or 
misfolding of the respective protein. On the other hand, they can be generated by modifications of exposed 
pro-degrons, proteolytic processing events or direct covalent attachment of a degron. In special cases, even 
a whole active degradation motif can be attached. An exhaustive overview of (pro-)degron-generating 
events as well as attachments of active degradations signals in prokaryotes and eukaryotes is provided in 
Figure 3. A detailed insight on proteolytic processing (Figure 3i) and on intracellular protein modification 
events including amino acid modifications, direct covalent attachment of a primary degron and attachment 
of a whole active degradation motif (Figure 3l) is also given. 
(Pro-)degron formation by amino acid modification 
As reported in the literature there is a whole variety of amino acid modifications that generate degrons 
with different hierarchies and significance. An overview – differentiating eukaryotic and prokaryotic 
modifications – is given here below. 
 
Active degradation motifs for the eukaryotic UPS can come in multiple flavours which, in turn, trigger one 
of the individual degradation pathways within UPS. An active UPS degradation motif is tripartite 51. It consist 
of (1) the tether-degron I (specific terminal or intrinsic amino acids) that initiates ubiquitination at (2) one 
or more internal Lys residues which are pro-degrons of the tether-degron II’s, the poly-Ub-chains, and (3) 
the initiation site-degron that is located on a structurally disordered segment of the protein substrate 51. 
Thus, the (pro-)degron nature for (1) and (2) can be summarised as single amino acids. Their appearance 
can be modulated in vivo to turn them into functional primary degrons. 
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A tether-degron I can initially be a secondary pro-degron (tertiary degron). Locally it seems to be restricted 
to the N-terminus. Two modification steps are needed in order to convert it into a primary degron. The first 
step is its transfer into a primary pro-degron (secondary degron) which might be derived by 
§ post-translational enzymatic deamidation of an N-terminal Asn or Gln or  
§ post-translational chemical oxidation of an N-terminal Cys 1,63. 
A tether-degron I, that is a primary pro-degron (secondary degron) needs a single modification step before 
it can initiate ubiquitination. This can be accomplished by 
§ post-translational phosphorylation of specific intrinsic Ser or Thr,  
§ post-translational hydroxylation of a specific intrinsic Pro, 
§ post-translational mono-methylation of a specific intrinsic Lys and  
§ co-translational acetylation of specific N-terminal amino acids (Ac/N-end rule pathway) 52,64–66.  
Another strategy is the  
§ post-translational aminoacylation of N-terminal Asp (alias deaminated Asn), Glu (alias deaminated 
Gln) or oxidised Cys. The aminoacyl-tRNA-protein transferase Ate1 recognises those N-terminal 
amino acids and conjugate them directly with Arg, a primary degron 52,63.  
The internal Lys residue(s) are functionally spoken primary pro-degrons. Upon post-translational poly-
ubiquitination 15, they become ubiquitinated. During ubiquitination, the small regulatory Ub protein (76 aa) 
is covalently conjugated to the exposed Lys residue(s) which finally results in a multi Ub-chain with ³2 Ub 
moieties 15. Finally, the poly-Ub-chain act as tether-degron II of the active UPS degradation motif 
responsible for its direct proteasomal recognition.  
 
In prokaryotes, the only mechanism described to create a primary degron based on an amino acid 
modification is the post-translational aminoacylation of N-terminal Lys, Arg, Asp, Glu and Meta, similar to 
eukaryotes 52,63,67. Depending on the species, one or two of the aminoacyl-tRNA-protein transferases Aat, 
Bpt and ATEL1b recognise those N-terminal amino acids and conjugate them directly with the primary 
degrons Lys or Phe 52,63. The N-terminal Lys or Phe functions directly as tether-degrons for the prokaryotic 
Leu/N-end rule pathway 1. In an individual case, Met was recently identified as novel N-terminal residue 
that is prone to aminoacylation 67. As a side note, N-terminal Met in bacteria is usually formylated  
(fMet) 68,69. However, the study does not discuss if there is a deformylating reaction prior to the 
aminoacylation of Met.  
 
                                                             
a Only Lys, Arg and Met in E. coli. 
b Aat is the only aminoacyl-tRNA-protein transferase in E. coli. 
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Proteolytic processing of pro-degrons 
The cooperation between ATP-independent proteases and ATP-dependent proteasomes has been long 
speculated 14,17,22,48,70. In essence, a protease with endoproteolytic or exoproteolytic activity was 
hypothesised to reveal a terminal (pro-)degron upon cleavage and thereby contributing to the generation 
of substrate recognitions sites for processive proteolysis. Demonstrating the genuineness of this 
phenomenon took however a long time 71. Until today, only individual cases in eukaryotes and prokaryotes 
are described in the literature.  
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Figure 3: Regulatory principles of processive proteolysis as part of the general protein quality control. Proteolysis 
can either be (a) constitutive or (b-l) conditionally regulated by a whole variety of stimuli or mechanisms. Major 
scenarios are presented although variations and combinations are possible in vivo. (a) Efficient constitutive 
proteolysis due to an exposed primary degron is usually combined with conditional protein biosynthesis resulting 
in very defined windows of protein levels 14. (b) A primary degron buried upon complex formation with other 
protein(s) (cryptic degron) can be released upon spatial resolution of the protein complex. (c) In-trans proteolysis 
occasionally occurs when the tether- and the initiation site-degron are physically separated on two different 
proteins. Upon complex formation only the initiation site-bearing protein gets degraded 17. (d) fMet can act 
directly as tether-degron of the active prokaryotic formyl-N-degradation motif prior to folding, if the co-
translational de-formylation of the N-terminal fMet fails 68,69. Changes in protein conformation are releasing 
cryptic degrons due to (e) intracellular stimuli or (f) the loss of a stabilising factor (e.g. AAIc molecule stabilises the 
conformation of TraR in Agrobacterium tumefaciens 72). Alternatively, (g) environmental stresses cause partial 
protein unfolding and hence the release of a cryptic degron. (Partially) unfolded proteins get either proteolysed 
directly, undergo chaperone-mediated refolding or (h) reversely form insoluble aggregates. Re-solubilisation of 
the aggregated proteins occur with the help of chaperones 24. In contrast, (i) a conditional proteolytic cleavage 
event of a pro-degron by ATP-independent proteases can make the protein susceptible for proteolysis by releasing 
a degron. Furthermore, (j) protein misfolding due to genetic mutations, errors during transcription or translation, 
and stress can cause the disclosure of primary degrons that would otherwise be cryptic. Events that covalently 
add primary degrons or even active degradation motifs directly to a protein encompass: (k) the co-translationally 
attachment of the SsrA-tag, an active degradation motifs, to the C-terminus of incompletely synthesised proteins 
33; (l) post-translational amino acid modifications which include, firstly, the attachment/removal of functional 
groups to/from primary or secondary pro-degrons as well as the oxidation of already existing functional groups 
52,63,65,66; secondly, the terminal addition of a primary degron directly to a primary pro-degron (e.g. the amino acids 
Phe or Lys, as tether-degron of the prokaryotic N-degron, attached to the prokaryotic secondary degron residues 
Lys, Arg 33 or Met 67); and finally, post-translational attachments of small regulatory proteins (e.g. the poly-Ub-
chain as tether-degron of the eukaryotic N-degron 15,48,60,73; the Pup protein as primary degron in mycobacteria 
74,75; poly-SAMP-chain as putative primary degron in archaea 76–78). Legend: Primary degron, ¢; cryptic degron, 
¢; pro-degron, £; tether-degron, x; initiation site-degron, x. See text for details. Figure inspired by JENAL AND 
HENGGE-ARONIS (2003) 14, GOTTESMAN AND MAURIZI (1992) 22, SAUER AND BAKER (2011) 33. 
 
Direct N-terminal (pro-)degron exposure due to endoproteolytic cleavage events 
In yeast, the SCC1 protein was shown to be cleaved at an internal site resulting in the release of the C-
terminal fragment. This fragment bears a primary tether-degron on its released N-terminus which can be 
recognised and degraded by the UPS 71.  
The discussion whether endoproteolytic cleavage events exist also in prokaryotes might be supported by 
recent findings of SEKAR et al. (2016) 18. By using a synthetic 113 aa N-terminal degradation tag (Ntag 18), 
the authors demonstrated the release of an as-yet unspecified N-terminal (pro-)degron due to a 
spontaneous cleavage event within the tag-sequence. The specificity of this spontaneous endoproteolytic 
activity was equally unknown 18. Pending the clarification regarding the involved protease(s) and their 
physiological relevance, the aforementioned concept might have found its first evidence in bacteria. 
  
                                                             
c TraI-synthesized autoinducer N-3-oxooctanoyl-l-homoserine lactone is an effector molecule in A. tumefaciens. 
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Direct or indirect N-terminal (pro-)degron exposure due to exoproteolytic cleavage events 
The conditional exoproteolytic removal of the N-terminal Met (1Met ) to reveal an N-terminal tether-degron 
has been recently suggested for playing both a direct as well as an indirect role for the fate of a protein 17. 
Generally, the first amino acid which initiates protein translation is always a Met 79,80 (more specifically, an 
ordinary Met in eukaryotes 69 and a formyl-Met (fMet) in prokaryotes as well as eukaryotic mitochondria 
and chloroplasts 68,69). Yet, despite being the first amino acid during translation, 1Met predominance is not 
implicit at all N-termini of functional proteins. In E. coli, co-translational removal of 1Met by Met-
aminopeptidases was demonstrated in cases where Ala, Gly, Ser, Cys, or Pro were encoded as second amino 
acid - occasionally also the bulky Val or Thr 68,81. However, the resulting N-terminally exposed amino acids 
are widely inconsistent with the known destabilising N-terminal residues of the N-end rule which are 
predominantly bulky and hydrophobic 52. Based on aforementioned general observations and individual 
case studies, three hypothesis are discussed in literature of 1Met-cleavage playing a role in protein 
destabilisation 17. 
 
The first hypothesis is based on the exceptional yet proven cases where 1Met was cleaved despite the 
presence of a bulky amino acid in second position in E. coli  68,81. Consequently, the removal of Met followed 
by an bulky N-end-degron residue is considered as highly speculative but not impossible 17. In this context, 
the possible abundance of endopeptidases other than Met-aminopeptidases has been speculated 68. 
The second hypothesis describes an indirect role of 1Met-removal in processive proteolysis since 1Met has 
been identified as secondary destabilising residue 67. In the unique case – so far – of the prokaryotic 
cytoplasmic PATase, Met-aminopeptidases were shown unable to remove 1Met. Instead, an aminoacyl-
tRNA-protein transferase was discovered to attach directly a primary degron residue to 1Met in vitro and in 
vivo 67 (see prokaryotic amino acylation of amino acids here above). It remains to be determined whether 
this is a general mechanism to regulate proteolysis 24. 
The third, more recently formulated hypothesis discusses fMet (alias 1Met) as primary degron in bacteria, 
similarly to N-terminal acetylated amino acids of the eukaryotic Ac/N-end rule 69 (see eukaryotic acetylation 
of amino acids here above). Generally, the removal of fMet encompasses two steps: (1) co-translationally 
to the growth of the nascent peptide chain during translation, the formyl-group of fMet is removed by a 
ribosome-associated deformylase; (2) the resulting deformylated Met can be then conditionally removed 
by the Met-aminopeptidase 17,69. Since de-formylation is expected to fail frequently in vivo in bacteria, it 
has been suggested that (non-deformylated) fMet in bacteria can act as N-terminal degron, termed fMet/N-
degron, thereby contributing to co-translational quality control of nascent proteins 68,69. Furthermore, 
growing polypeptide chains with this (non-deformylated) fMet occur to be largely co-translationally 
destructed by a novel branch of the bacterial N-end rule pathway, termed the fMet/N-end rule pathway 69. 
FtsH is suggested to act as putative processive proteolytic protease in this pathway 68,69. 
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Attachment of an active degradation motif  
According to the literature, there are three special cases where an active degradation motif gets directly 
attached to a protein or a nascent polypeptide chain (Figure 3k and l). All those cases have been discovered 
in prokaryotes. They encompass a co-translational attachment of a unique oligopeptide on one hand (SsrA-
tag), and on the other hand, two post-translational attachments of small regulatory proteins which have 
been described as ubiquitination-analogues (pupylation and SAMPylation). All attachments seem to 
harbour both, the tether-degron as well as the initiation site-degron. These three cases will be described 
here in more detail. 
 
The SsrA-tag represents a special case for an active degradation motif attachment 61 due to its unique 
mechanism and key role in intracellular PQC in bacteria 82. The 11-residue peptide (-AANDENYALAA) is  
co-translationally attached to the C-termini of nascent polypeptide chains whose biosynthesis has stalled 
or has been interrupted 82. The last ten residues of the tag are encoded by the ssrA gene that is highly 
conserved throughout bacteria 82,83. Its transcript is a stable 362-nucleotide tmRNA 83 with both tRNA-like 
(charged with Ala) and mRNA-like properties to modify incomplete polypeptides and to mark them for 
degradation 82. SsrA-tagged cytoplasmic polypeptides are recognised and degraded in vivo by C-terminal-
specific proteases which are active in the cytoplasm (ClpAP, ClpXP, Lon 84,85 and FtsH 86; discussed in 
INTRODUCTION section 1.1) or the periplasm (Tsp 82,83, DegP and DegQ 38). Interestingly, recombinant  
C-terminal SsrA-tagging of specific proteins with subsequent proteolysis has been proven to be a powerful 
tool 82,84,87,88. SsrA-mediated proteolysis has been shown essentially for soluble proteins 49,82,84,89,90, but 
recently also for MPs with an Nx-Cin topology. In detail, a solubilised multidomain MP (featuring 12 TMHs) 
was shown to be degraded in vitro by ClpXP 87 and another MP (featuring 3 TMH) was degraded by both 
FtsH and ClpXP in vitro but only by FtsH in vivo 88.  
The pupylation in mycobacteria has been recently described as a mechanism for the attachment of an active 
degradation motif in form of a protein 74,75. Thereby, a single moiety of the modifier protein Pub is  
C-terminally conjugated to an intrinsic Lys residue of a protein substrate prior to degradation 74. 
SAMPylation is a similar process found in archaea whereby the Ub-like proteins SAMP1/2 form polymeric 
chains on substrate proteins 76–78. The poly-SAMP-chain is suggested acting as active degradation  
motif 76–78 even though the whole degradation mechanism needs fundamental clarification. 
 
1.3 Native ClpAP-dependent proteolysis in E. coli 
In the ClpAP proteasome (Figure 1), the protease moiety ClpP partners with the AAA+ unfoldase moiety 
ClpA 43; ClpA is responsible for unfolding and translocating protein substrates through an axial pore into 
ClpP 45. The protease moiety ClpP is a barrel-shaped cylinder composed of two homoheptameric symmetric 
rings stacked back-to-back forming the catalytic chamber 91. Protein substrates usually only access the 
proteolytic chamber upon binding with ClpA, otherwise the two axial pores on both ends of ClpP are  
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blocked 33. Among the AAA+ unfoldase moieties in E. coli, ClpA is unique as it consist of two homohexameric 
rings, D1 and D2, which form two distinct stacked layers on top of ClpP 33,41,43. Obviously, the hexamer-
heptamer interaction in ClpAP complexes creates a symmetry mismatch 33. The mechanistic basis for this 
interaction still remains to be determined 33,43. 
Nevertheless, ClpA is a powerful unfoldase that can efficiently and rapidly process protein substrates of 
high thermodynamic stability 42. A tighter grip on the substrate, due to a larger interaction surface, is 
hypothesised being responsible for the superior and faster unfolding ability in comparison to the unfoldase 
moiety ClpX that has only a single ring architecture 41. In comparison to other bacteria, the wide range of 
proteasome complexes found in E. coli suggests distinct biological roles for each of them 41. While ClpXP is 
considered being the primary recipient of SsrA-tagged proteins with unstable folding 49,92, ClpAP is 
associated with the efficient degradation of intact key proteins 41,93. 
 
1.3.1 Regulation of ClpA specificity  
While ClpA can recognise substrate proteins itself (e.g. SsrA-tagged proteins 49), it also interacts with the 
ClpA-specific adaptor protein ClpS that can alter the proteasome’s specificity depending on its  
availability 44: upon binding to ClpA, ClpS prevents degradation of SsrA-tagged protein substrates 93 and 
simultaneously inhibits ClpA susceptibility towards auto-degradation 92. At the same time, ClpS delivers  
N-end rule substrates to ClpAP for proteolysis (INTRODUCTION section 1.3.2) 3,93. However, ClpS is not only 
crucial for tethering N-end rule substrates to ClpA 94, it also seems to mediate ClpA-substrate binding  
(Figure 2C). ClpS is thus essential for substrate unfolding/degradation and thereby ClpAP function  
in general 44.  
 
1.3.2 N-end rule substrates recognised by ClpS 
All bacterial N-end rule substrates are characterised by a short N-terminal sequence whereby the most 
decisive element is represented in the outermost N-terminal residue. Generally, the identity of this  
N-terminal amino acid dictates the stability of a bacterial N-end rule substrate protein 36.  
However, there are three important components which are essential for efficient ClpS recognition as well 
as ClpA binding (Figure 4). Firstly, the aforementioned first N-terminal amino acid as well as the nature of 
its a-amino group are crucial for recognition by ClpS (tether-degron; Figure 4) 50. Typically, the bulky 
hydrophobic amino acids Phe, Leu, Trp and Tyr have been identified as primary N-degrons 33,52,56. Secondly, 
a hydrophobic element, located downstream of the N-degron, is responsible for ClpA binding (initiation 
site-degron, Figure 4). Finally, an unstructured linker region of at least four amino acids (aa) between the 
tether- and the initiation site-degron facilitates ClpA binding 17. The functional steps are roughly described 
as follows: after tether-degron-dependent substrate recognition and binding by ClpS, ClpS binds 
subsequently at the auxiliary domains of ClpA. A second, yet unknown, ClpS-ClpA binding step is suggested 
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to be necessary for the interaction between the initiation site degron and ClpA, which finally results in the 
translocation of the substrate 17. The linker region seems to be necessary to bridge the distance between 
the ClpS-ClpA binding site and the substrate-ClpA interaction 3,17,50. Additionally, residues adjacent to the 
N-terminal tether-degron influence the efficiency of ClpS/ClpAP interactions 50. 
 
Although, the recognition of all N-end rule protein substrates by ClpS has been determined to be essential 
for proteolysis via the bacterial N-end rule pathway 3,94 only two proteins have been identified as true N-
end rule substrates to date (PATase and DpsN’, discussed in DOUGAN et al. (2010) 17). Nevertheless, a small 
list of other proteins have been recently identified as ClpS-interacting proteins in two independent studies 
67,95 but without having associated any as substrates for ClpAP. If so, their individual degradation 
mechanisms remain to be addressed 17.  
 
 
Figure 4: Components of a prokaryotic N-terminal active degradation motif. (a) ClpS recognition depends on the 
identity of the first N-terminal residue (x, tether-degron) of a protein substrate (blue) and the nature of its a-
amino group (not shown). Primary destabilising residues are Phe, Leu, Trp and Tyr. (c) A hydrophobic element is 
responsible for ClpA interaction (x,initiation site-degron). (b) An unstructured linker region of minimal 4 aa is 
crucial to sterically bridge (a) and (c). Furthermore, neighbouring amino acids () of (a) modulate ClpS recognition 
with decreasing strength the further they are distant to (a). Details in the main text. Figure modified from WANG 
et al. (2008) 50 and DOUGAN et al. (2010) 17. 
 
Considering the metabolic functions of the two confirmed N-end rule substrates and the ones of the 
remaining ClpS-interacting proteins identified to date 67,95, the N-end rule pathway does not seem to be 
linked to a specific metabolic pathway or stress response system 17. Instead, it is speculated to modulate 
the levels for specific proteins with distinct metabolic functions 17. In essence, there is not much known 
about the physiological function of the N-end rule pathway in bacteria 56. However, the mechanistic 
understanding of the functional steps of substrate recognition, ClpS-mediated delivery and degradation has 
increased dramatically lately (for details, the reader is referred to recent reviews and research articles 
3,17,33,41,43,45,94).  
 
…
(a) (c)(b)
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1.4 Native FtsH-dependent proteolysis in E. coli 
In contrast to other proteasomes in E. coli, at the exception of Lon, the unfoldase and protease moieties in 
FtsH reside on a single polypeptide. Once folded, the FtsH monomers complex into a barrel-shaped 
homohexamer (Figure 1) 96,97. Like all proteasomes, a protein substrate is unfolded in the unfoldase moiety 
in an ATP-dependent fashion and reaches the protease moiety for degradation through the axial pore of 
the barrel. Substrate access to the IM-adjacent unfoldase moiety might be sterically facilitated by 
associated, membrane-bound regulatory factors or complexes such as HflKC 98. 
There are additional features that make FtsH unique among the other proteasomes in E. coli (recently 
reviewed 99–102). Firstly, the N-terminal auxiliary domains of the unfoldase moiety are anchoring FtsH in the 
IM while the two large active moieties are facing the cytoplasm 103 (2 TMHs, Nin-Cin topology). This makes 
FtsH the only membrane-bound proteasome. Secondly, FtsH requires catalytic Zn2+ ions for functionality of 
its protease moiety which makes it the only metalloproteasome. Finally, FtsH affects the outer membrane 
structure which is composed of lipopolysaccharides (LPS) and phospholipids (PL) by regulating the 
abundance of key enzymes in lipopolysaccharide biosynthesis 104,105. The balance of LPS’ and PL’s decides 
whether a cell should live or die. Thus, FtsH’s impact therein makes it the only essential proteasome. 
In short, FtsH is suspected to be involved in PQC of assembled and unassembled IMPs 2,88,99,101,106–110 as well 
as cytosolic proteins 86, in the regulation of lipopolysaccharides biosynthesis 104,105, in the control of 
lysogeny/lysis cycle of an abundant l prophage 111 and in the regulation of heat shock response 112. 
 
1.4.1 Substrates recognised by FtsH  
At present, twenty-one FtsH substrates have been discovered ranging from cytoplasmic proteins to integral 
inner membrane proteins (IMPs) 100. Those substrates – as determined yet – seem to exhibit a wide 
spectrum of active degradation motifs: they encompass unstructured sequence motifs as well as 
conformational folds that are located randomly either internally or at the N-/C-termini 2,100. Until now, a 
common degradation motif or degradation pathway has not been uncovered since most substrate-
dependent mechanisms for recognition and degradation are still unknown 100. Instead, it seems that most 
FtsH substrates have unique recognition and degradation mechanisms 2.  
Nevertheless, there are few unique transferable terminal degradation motifs (tags) that can be recognised 
and degraded by FtsH in vivo:  
§ the native, non-polar, C-terminal SsrA-tag effective for soluble 86,103 and IMPs 88,103  
(INTRODUCTION section 1.2.2),  
§ the synthetic, FtsH-specific, non-polar, C-terminal pentapeptide cI108 (-SLLWS 113) effective for 
soluble proteins 86,103 as well as one IMP 103 and  
§ the native, FtsH-specific, N-terminal degradation motif from YfgM (MEIYENENDQVEAVKRFF-; 
INTRODUCTION section 3.2.2) with a putative specificity for IMPs 2.  
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Interestingly, for protein substrates tagged with SsrA or cI108, FtsH was shown to have a weak unfoldase 
activity 103. This suggests that it would only degrade intact proteins with low intrinsic thermodynamic 
stability and/or unfolded proteins - independent of their protein class 103. Generally, FtsH seems to have a 
high substrate selectivity itself 109 and/or substrate specificity is highly regulated by adaptor proteins 2,101. 
Nevertheless, regarding the few deciphered degradation motifs and the function of known protein 
substrates mentioned above, FtsH seems to degrade aberrant proteins as well as intact key regulatory 
proteins 100,103.  
 
1.4.2 FtsH-dependent quality control of inner membrane proteins and putative 
mechanisms of their degradation 
As mentioned here above, FtsH is the first enzyme that has been associated with PQC of IMPs.  
On one hand, it can degrade unassembled IMP moieties of functional IMP complexes, e.g. F0a subunit of 
the H+-ATPase 108 (5 TMHs, Nin-Cout topology 114), SecY of the SecYEG translocon 109 (10 TMHs, Nin-Cin 
topology 115) and PspC of the phage-shock-protein (Psp) response system 110 (1 TMH, Nin-Cout topology 116). 
On the other hand, one IMP substrates has been shown to be assembled in a protein complex but physically 
blocked e.g. the jammed SecY of SecYEG translocon 107. Furthermore, FtsH does also regulate IMPs 
associated with itself that carry a FtsH-modulating function e.g. YccA 107 (7 TMHs, Nin-Cout topology). 
FtsH-mediated degradation is described as processive with subsequent release of short oligopeptides into 
the cytoplasm 99. However, the specific mechanisms of FtsH-dependent MP substrate recognition, 
degradation and its regulation are still unknown. Nevertheless, there seem to be two plausible options for 
the degradation mechanism. On one hand, FtsH is thought to degrade MPs following the pulling model 117 
(Figure 5A). FtsH thereby recognises preferably cytoplasmic N- or C-termini with a minimal length of  
20 aa 118 and extracts the MP substrates from the IM by dislocating their TMHs and periplasmic domains 
towards the proteolytic moiety at the cytoplasmic side of the IM 99. Extended cytosolic loops have also been 
shown to serve as direct initiation sites for degradation 2,100,118. Considering the poor unfoldase activity of 
FtsH 103, FtsH is also thought to participate in proteolytic processing. A domain of high intrinsic 
thermodynamic stability would be able to abort FtsH-dependent processive proteolysis 103. As result, 
undigested yet stable hydrophobic MP fragments would accumulate in the IM 99,118,119. Alternatively, the 
release of remaining hydrophilic stable domains in the cytoplasm is equally conceivable. On the other hand, 
a cooperative interaction of FtsH with ATP-independent IM-bound proteases (e.g. YheL and HtpX with their 
active site located on the cytoplasmic side of the IM) was proposed 99,120 (cooperative shedding-pulling 
model, Figure 5B). Protease(s) might cleave cytoplasmic loops of MP substrates and generate thereby new 
cytoplasmic N- or C-termini that could be recognised and finally dislocated by FtsH 98. 
 
Another conceivable way for MP degradation, however, mainly discussed in eukaryotes but to my 
knowledge not considered yet for FtsH in bacteria, is an additional cooperative interaction with 
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intramembrane proteases 121,122. Intramembrane proteases of the IM 123, could cut cleavage sites within 
TMHs resulting in the destabilisation of the cleaved TMH fragments and their subsequent secretion into 
either of the hydrophilic compartment adjacent to the IM 121,122.  
Additionally, an cooperative outsourcing mechanism for the dislocation of MPs is also discussed in 
eukaryotes. MP substrates are hereby recognised and dislocated over the membrane by a membrane-
bound protein complex that directs the dislocated MP to a cytoplasmic adjacent proteasome 122. In 
reference to the poor unfoldase activity of FtsH 103 the likelihood of similar interaction partners in bacteria 
is reasonable. Considering the above, one can then suspect that FtsH-mediated MP degradation at the 
bacterial IM must be far more complex than the existing models proposed in literature in order to maintain 
the integrity of the diverse IM proteome and thereby securing cell viability under any condition. 
 
 
Figure 5: Proposed models for FtsH-dependent proteolysis of IMPs. (A) Pulling model. FtsH itself (green-blue; 
depicted as monomer for simplification) recognises, dislocates and degrades a MP substrate (brown) from a 
cytoplasmic N- and/or C-terminus. (B) Cooperative shedding-pulling model. A membrane-bound proteases 
(yellow) [or FtsH itself] cleaves cytoplasmic loops of MP substrates and reveals a FtsH-recognisable cryptic degron. 
Primary degron, ¢; cryptic degron, ¢; Proteolytic active site of FtsH, . Details in the main text. Figure modified 
from LANGER (2000) 117. 
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2 SYNTHETIC STRATEGIES TO MANIPULATE PROTEIN STABILITY 
Manipulating intracellular protein levels by engineering protein stability has many applications ranging 
from studying individual protein functions or whole biological networks, controlling protein levels for 
metabolic engineering or those in synthetic biological circuits, improving recombinant protein production 
for purification and enhancing biological therapy for medical use. The purpose dictates the desired 
intracellular turnover rates of the proteins of interest (POIs) – from high to low or vice versa – which itself 
needs to be engineered but also engineerable. The latter relies on several factors including the tool(s) 
applied, the type of biological host and its characteristics, the growth conditions and, last but not least, the 
POI itself (protein class, folding characteristics, location of the active site, protein production pattern and 
regulation). Until now, many of the tools effecting protein destabilisation have been engineered in 
eukaryotic systems whereas tool development in prokaryotes has just started 18 (INTRODUCTION section 2.2). 
A special feature for protein destabilising set-ups is the conditional re-stabilisation of destabilised proteins 
as a rescue of protein function technology (INTRODUCTION section 2.3). Such tools have been developed only 
in eukaryotes until now. Furthermore, despite very few exceptions 2,88,103, most of the available tools for 
protein destabilisation have been shown suitable for soluble proteins more than for MPs. In addition, 
besides one recently developed exception 18, all destabilising tools in bacteria were focused on C-terminal 
degradation 20,23,26.  
To summarise, there is much room to increase the variability of protein destabilising tools particularly in 
bacteria, on one hand. On the other hand, there is a general need to expand or improve the already 
available tools for conditional MP degradation. 
 
2.1 Degradation motifs suitable for synthetic biology 
In most studies for engineered protein destabilisation, a known degradation motif is fused to the N- or  
C-terminus of a protein of interest (POI). Usually the tagged POI is stable until degradation is induced 
resulting in the rapid decrease in POI concentration 18. Accordingly, a degradation motif is suitable for 
engineering set-ups when it can efficiently initiate processive proteolysis without the requirement of 
additional protein substrate information 61. In all degradation motifs used for engineered protein 
destabilisation so far, the minimum requirement for a degradation motif, the tether-degron and initiation 
site-degron, seemed to be situated closely together on a small, intrinsically unstructured terminal 
sequence. This contributes to its transferability to a large number of different POIs which is an equal 
important factor for its application in synthetic biology set-ups 61,65. 
 
However, besides the abundance of a whole degradation motif, success and efficiency of engineered POI 
degradation rely on several factors: (1) amino acids and/or folds in the neighbourhood of degrons 
modulating the degron’s strength (e.g. prokaryotic N-terminal degradation sequence motif 50; Figure 4); 
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and (2) the steric accessibility of degrons to the binding sites of adaptor proteins or proteasomes 18. There 
are also (3) overlapping tether-degrons on a single degradation motif whose degradation efficiency is 
regulated by a competing recognition by proteasomes or adaptor proteins (e.g. SsrA-tag) 20. Furthermore, 
it is essential that (4) the engineered degradation motif exhibits no POI-destabilising character on folding 
and that (5) it does not significantly effect POI activity or function 18. Additional roles play (6) the 
concentration ratio between the POI and the recognising proteasome or adaptor protein 19, (7) the intrinsic 
thermodynamic stability, class as well as topology of the POI and (8) the efficiency as well as robustness of 
the recognising proteasome(s) 18,20. 
Owing to genetic engineering and synthetic biology, many of the mentioned factors affecting strength, 
specificity and efficiency of a degradation system can be tuned to attain a robust and predictable tool to 
modulate protein stability 19. 
 
2.1.1 Finding a transferable degradation motif 
The identification of a native or synthetic, transferable degradation motif usually includes a minimum of 
two inter-dependent screening steps. First, a putative degradation motif candidate can act stabilising by 
turning it into a neutral sequence/fold 2,20 or by removing it from the native protein/POI to prove its 
destabilising character and/or decipher its relation to specific adaptor proteins or proteasomes. Second, it 
can be fused or grafted to a known stable POI 2,3,124 to prove its independence and transferability. In all 
cases levels of targeted proteins are observed over time and compared to those of the unaltered proteins. 
If the chosen destabilising motif is indeed a degradation motif, the degradation rate of the protein substrate 
is expected to be decreased during the first screening step and increased during the second. 
 
2.1.2 Tuning the strength of degradation motifs 
Degradation motifs may also be modified to create libraries with different degradation rates. This had been 
especially done by randomisation of whole native/synthetic degradation motifs or degron moieties which 
consisted of an intrinsically unstructured sequence or amino acid. A good examples are here: the 
randomisation of the N-terminal tether-degrons belonging either to the prokaryotic or eukaryotic N-
terminal degradation motif processed by the respective N-end rule pathways 3,52,56; the C-terminal 
prokaryotic SsrA-tag 20,125; the N-terminal degradation sequence motif from YfgM in E. coli 2 and internal 
eukaryotic PEST sequences 126.  
An extreme example for tuning the degradation rate is the stabilisation of a POI by turning a degradation 
motif or associated degron into a dysfunctional or stabilising motif. Examples from literature are again the 
N-terminal tether-degrons belonging an N-terminal degradation motif processed by either the prokaryotic 
124 or eukaryotic 127 N-end rule pathways and the N-terminal degradation sequence motif from YfgM  
in E. coli 2. 
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2.2 Strategies for conditional destabilising of target proteins 
With the help of a precisely regulated mechanism, an engineered biological set-up catalysing the removal 
of a POI can be turned into a valuable synthetic tool. The nature of the regulation mechanism can be 
manifold depending on the engineered degradation set-up, the degradation pathway, the POIs, the host 
and the final application. A non-exhaustive overview of tools for conditional protein destabilisation in 
eukaryotes and prokaryotes is provided in the following sections. 
 
2.2.1 Tools for conditional regulation of eukaryotic ubiquitin-dependent proteolysis 
The multi-component UPS in eukaryotes has been successfully manipulated on different levels. The 
tethering of a substrate protein either to the 26S proteasome or to enzymes that mediate poly-
ubiquitination have been proven to be sufficient for increased degradation efficiency. Since the early 
1990’s, Ub-conjugating enzymes (E2s) were known to accomplish the Ub-transfer alone to the substrate 
protein whereby other Ub transfer reactions required the help Ub protein ligases (E3s) 128,129. Later, it was 
shown that the former seems to be the exception and the latter the norm 130 since substrate specificity is 
usually conferred by E3s 15,130,131 but may be influenced by E2s 130. Those findings were picked up in a couple 
of studies to engineer UPS with increased specificity for target proteins and therefore their efficient 
degradation. 
 
In one study (demonstrating the exception), E2s were fused C-terminally with various POI-specific 
recognition domains to pre-define POI specificity for targeted Ub transfer. Subsequent ATP-dependent 
proteolysis was observed for one POI out of five in vitro 132. Alternatively, in other studies (supporting the 
rule), POIs were tethered to E3s to increase ubiquitination efficiency by replacing the native substrate 
recognition sites in E3 with a POI binding domain. As a result, successful targeted POI degradation was 
observed in vivo 131,133. The production of the aforementioned E2 or E3 chimeric proteins (with the re-
defined recognition domains) was inducible so that POI-degradation was conditional.  
In contrast, JANSE et al. (2004) used compound-inducible dimerisation domains to tether a POI in direct 
vicinity to the proteasome 134. Finally, another less invasive approach is the Protacs (proteolysis-targeting 
chimeric molecules)-mediated tethering of POIs to an endogenous E3 which was demonstrated being 
successfully applicable in vitro 135 and in vivo 136. 
 
2.2.2 Tools for conditional regulation of the C-terminal SsrA-mediated proteolysis 
Until recently, the few tools available for conditional proteolysis in prokaryotes focused on degradation 
from the C-terminus; all engineered synthetic set-ups were based on a C-terminally attached SsrA-tag as 
active degradation motif 20,23,26. Yet, the conditional elements responsible for inducing proteolysis differed 
from study to study. 
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The native SsrA-tag in E. coli harbours competing recognition motifs for the unfoldases ClpX and ClpA as 
well as SspB (adaptor protein for ClpXP) 49. Moreover, SsrA-tagged proteins are also recognised by other 
proteasomes including Lon 85 and FtsH 86, as well as the proteases Tsp 82,83, DegP and DegQ, 38. Based on 
this, MCGINNESS at al. (2006) designed modified SsrA*-tags with recognition motifs almost inefficient for 
ClpX and ClpA binding but increased for SspB interaction 20. Upon induced production of endogenous SspB 
in an E. coli sspB- strain, the SspB-dependent ClpXP degradation was increased for cytosolic proteins 
carrying the modified SsrA-tag 20.  
In a similar study, DAVIS et al. (2011) used one of the modified SsrA*-tags from MCGINNESS at al. (2006) 20, 
but designed a dual split-SspB protein as the conditional element (in an E. coli sspB- strain). Both SspB 
moieties were constitutively produced and dimerised upon supply of a small compound 23. The set-up 
resulted in a conditional, specific and efficient tethering of the SsrA*-tagged POI to ClpXP. 
By far the most elegant system for conditional protein degradation in bacteria was reported by CAMERON 
AND COLLINS (2014) 26. The authors introduced successfully an orthogonally functional Lon protease from 
Mesoplasma florum (MfLon) with its cognate SsrA-tag (MfSsrA-tag) into E. coli and Lactococcus lactis 26. 
MfSsrA -specific proteolysis was then regulated by induced protein production of MfLon in-trans and 
resulted in highly specific degradation 26. Their system did not require the disruption or modification of the 
hosts proteolysis pathways 26, nor does the conditional element require a physical stress event for 
activation; in contrary, their system was characterised by high specificity, modularity and transferability to 
other bacteria as well as eukaryotes. 
 
2.2.3 Tools for the conditional exposure of a site-specific N-terminal residue 
To date, the synthetic conditional exposure of an N-terminal residue in a site-specific manner has been 
engineered in two different ways for the purpose of inducible proteolysis starting from the N-terminus. An 
endoproteolytic cleavage event (proteolytic processing) is part of both. 
 
The classical way to release spontaneously an N-terminal residue is by using the Ub-fusion-technique, 
discovered in eukaryotes 127,137. In yeast, a Ub-domain fused to the N-terminus of a POI became co-
translationally cleaved by endogenous deubiquitylases after the last 76Gly residue of Ub in a spontaneous 
fashion 52. The cleavage was completely unbiased of the nature of the subsequent amino acid which became 
finally exposed 137. Interestingly, the Ub-fusion-technique was used by BACHMAIR et al. (1986) in yeast for 
their elementary work on the eukaryotic N-end rule pathway in which the stability of a substrate protein 
was shown to be dependent on the identity of the N-terminal amino acid 48. However, as mentioned before, 
the set-up as such is spontaneous in eukaryotes and is not subject to any conditional regulation. Only later, 
DOHMEN et al. (1994) presented a eukaryotic system in which an N-terminal residue was conditionally 
exposed in two phases with the help of the Ub-fusion-technique and a conditional element. Firstly, an  
N-terminally fused Ub provoked a co-translational spontaneous Ub cleavage which in turn released an  
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N-degron of the N-end rule. The latter was the N-terminus of a temperature sensitive (ts)-protein domain 
that masked the N-degron at permissive temperatures (cryptic N-degron). Secondly, upon increased 
temperature and conformational destabilisation of the ts-protein domain, the cryptic N-degron became 
finally susceptible for degradation 138. Until the early 1990s, the Ub-fusion technique had been inapplicable 
in bacteria 56 due to two reasons: (1) bacteria lack Ub and Ub-specific enzymes 56, and (2) the enzyme 
mapping within the family of Ub-specific proteases had just started in eukaryotes 139–141. However, TOBIAS 
AND VARSHAVSKY (1991) isolated the UBP1 protease from Saccharomyces cerevisiae which cleaves off single 
Ub moieties in natural or engineered Ub-POI fusions irrespective of the size of the POI 140. The same authors 
finally successfully applied UBP1 in E. coli in an inducible fashion to decipher the N-end rule criteria in 
bacteria: when produced, UBP1 efficiently deubiquitinated the Ub-X-POI construct and released the varying 
N-terminal residue X attached to the POI 56. Finally, the nature of X regulated the degradation efficiency of 
the POI which finally let to the establishment of half-life values for the POI depending on X in E. coli 56. 
 
The conceptual idea to use the highly specific protease from tobacco etch virus (TEVP) for the exposure of 
site-specific N-terminal residues was first mentioned by KAPUST et al. (2002) 142 and was finally realised by 
TAXIS et al. (2009) 143. The authors developed a technique based on TEVP-induced protein instability (TIPI) 
which is universally applicable 143. TIPI takes advantage of TEVPs high sequence specificity for amino acids 
one to six in its recognition site (rsTEVP) and its seemingly high tolerance towards amino acid seven (any 
amino acid with the exception of Pro) 142. Upon TEVP cleavage, amino acid seven (alias amino acid in P1 
position of rsTEVP 142) becomes exposed as new N-terminal residue 143.  
 
2.3 Strategies for conditional re-stabilising of target proteins 
Only few tools for conditional re-stabilisation of artificially destabilised proteins do exist and all were 
developed in eukaryotic systems. The general goal for those tools is the efficient blocking - sometimes 
cleavage - of an attached degradation motif to a POI that otherwise directs proteolysis.  
 
STANKUNAS et al. (2003), for example, made use of the FRB-FKBP-rapamycind heterodimer formation system 
to stabilise an otherwise destabilised protein product 144. The authors fused an intrinsically unstable variant 
of FRB (FRB*) to a POI. FRB* was able to heterodimerise with FKBP, another yet stable protein, depending 
on the availability of the small molecule rapamycin. Due to the instability of FRB*, the monomeric FRB*-
POI fusion protein was rapidly degraded. However, the FRB*-POI fusion could be stabilised upon inducible 
dimerisation with FKBP in vivo 144. However, this system could be used in both, eukaryotes and prokaryotes. 
                                                             
d Rapamycin, an antifungal antibiotic macrolide, binds simultaneously to the 12-kDa FK506 binding protein (FKBP) and the FKBP-rapamycin 
binding (FRB) domain and mediates their tight heterodimer formation. The FRB-FKBP-rapamycin heterodimer formation system is one of the 
most useful dimerization systems for protein engineering 303. 
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This inducible FRB*/ FKBP heterodimer system was picked up as conditional element by PRATT et al. (2007). 
The authors developed a tool based on split-Ub to expose a stabilising N-terminal residue in eukaryotes. 
Specifically, the authors fused FRB* and the C-terminal moiety of Ub (UbC) in-line to the N-terminus of a 
POI (FRB*-UbC-POI). The N-terminal moiety of Ub was fused to FKBP (UbN-FKBP) and produced 
constitutively. Upon the supply with rapamycin FRB*/FKBP and UbN/UbC could dimerise and complement, 
respectively. Consequently, the whole complementing protein complex FKBP-UbN/FRB*-UbC-POI got 
stabilised and became spontaneously cleaved after the complemented Ub by eukaryotic endogenous 
deubiquitylases (Ub-fusion-technique; INTRODUCTION section 2.2.3). The released N-terminal stabilising 
residue finally led to a stabilised POI. The tool was coined ‘split ubiquitin for rescue of function’ (SURF 145)e.  
  
                                                             
e The conceptional idea of SURF could also be modified, as an idea, to release site-specific destabilising N-terminal residues in a conditional 
manner in eukaryotes, similar to the tools presented in INTRODUCTION section 2.2.3. However, the FRB*, attached to UbC-POI, would need to 
be replaced by a stable variant. Instead of a physical stress event for induction – as in the tool developed by DOHMEN et al. (1994) 138 
(INTRODUCTION section 2.2.3) – this set-up would only require the addition of rapamycin for induction. A methodological advantage over TIPI 
143 might depend on the application. Both systems have, from my point of view, advantages and disadvantages.  
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3 PROTEIC BUILDING BLOCKS FOR CONDITIONAL DESTABILISING OF 
TARGET PROTEINS IN E. COLI IN THE PRESENTED STUDIES 
As discussed in INTRODUCTION section 1.2.2, one strategy nature has found to reduce specific protein levels 
is to generate degrons by revealing a degradation motif via proteolytic processing (alias proteolytic 
cleavage). In essence, a conditional endoproteolytic or exoproteolytic cleavage event releases a  
(pro-)degron which then can contribute to an active degradation motif for subsequent processive 
proteolysis.  
 
In Studies I and II, we aimed to engineer conditional synthetic tools that were able to mimic the biological 
design of combined proteolytic processing and processive proteolysis. The difference between both studies 
were the targeted proteasomes, namely ClpAP (INTRODUCTION section 1.3) and FtsH (INTRODUCTION section 
1.4) for Study I and II, respectively. This specificity was defined by the chosen N-terminal degradation 
motifs. In turn, the pool of targetable protein substrates was defined by the transferability of the respective 
N-terminal degradation motifs as well as the unfoldase capacity of the targeted proteasome. Based on the 
actual understanding about mechanism and efficiency of ClpAP-dependent proteolysis, the targetable 
protein pool for Study I was expected to encompass cytoplasmic globular proteins even with high intrinsic 
thermodynamic stability. Membrane proteins have, to my knowledge, never been published as substrate 
proteins for ClpAP/ClpS-mediated proteolysis. In contrast, the targetable protein pool for Study II was, to 
the greatest extend, unknown due to a very limited understanding about the FtsH-dependent N-terminal 
degradation sequence motif (dgFtsH; INTRODUCTION section 3.2.2) and its degradation pathway. However, 
dgFtsH seemed to exhibit a specificity for IMPs 2; for FtsH accessibility, it appeared albeit imperative that 
the putative IMP targets exhibit a cytosolic N-terminal (Nin) topology. Nevertheless, the substrate specificity 
of FtsH is at the moment poorly defined, although it is expected that IMPs degraded thereby have a low 
intrinsic thermodynamic stability due to FtsH’s poor unfoldase  
activity 103. 
 
The feasibility and applicability of a conditional synthetic tool for targeted protein destabilisation are 
influenced by the following factors: (1) a conditional element that triggers efficiently the proteolytic 
processing and is easy to manipulate, (2) an active degradation motif that confers highest specificity and 
efficient degradation of a POI, (3) a spectrum of POIs with broad structural characteristics and (4) an easy 
and preferably non-invasive read-out.  
The proteic building blocks which contributed to the tool development attempts in Study I and II are 
described in detail in the following sections. Overviews about characteristic details on the proteins touched 
upon and fluorescence properties of the chosen reporter proteins are given in the APPENDIX Table S 3 and 
Table S 2, respectively. 
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3.1 TEV protease and its recognition site 
As described in INTRODUCTION section 2.2.3, the technology for Tobacco etch virus protease (TEVP)-induced 
protein instability (TIPI) 143 is a universal approach to conditionally expose almost any N-terminal residue 
that is part of an N-terminal degradation motif. Study I and II, described in this thesis, were inspired by this 
TIPI technology 143. Essentially, two N-terminal degradation sequence motifs (Table 2) were accordingly 
masked with a short peptide sequence including the first 6 aa of the optimum recognitions site of TEVP 
(rsTEVP; Table 2) in order to develop short N-terminal conditional degradation tags for ClpAP- or FtsH-
specific proteolysis (cryptic degradation motifs; Table 3). As described for TIPI 143, the TEVP was 
conditionally produced in-trans from a plasmid. In short, upon conditional production of TEVP, the cryptic 
N-terminal degradation motifs were released and accessible for the respective proteomes for subsequent 
degradation. 
 
TEVP (EC 3.4.22.44) is a 27 kDa protease from the tobacco etch virus (TEV) 142,146,147. It is part of the natural 
TEV precursor polyprotein and also responsible for its cleavage into functional viral proteins 142,146–149. TEVP 
has a high sequence specificity for amino acids within the first 6 aa in its 7 aa long recognition site (rsTEVP) 
and cleaves specifically after 6Q 142,147. The consensus recognition site from all rsTEVPs is represented as 
EXXYXQG/S whereas ENLYFQS/G has been shown to be optimal for TEVP recognition 149. This makes it a 
unique endopeptidase that has been largely exploited for multiple biotechnological applications 147,149. 
TEVP exerts a high tolerance (however not entirely unaffected) to the nature of amino acid seven in rsTEVP 
142,147 which is most relevant for TIPI-dependent release of N-terminal destabilising residues. Furthermore, 
TEVP is monomeric in solution 150. 
 
The TEVP variant used in Study I (Addgene ID 19978) consisted of residues 1–236 of the Nuclear Inclusion 
a protease (NIa) from TEV 148 including a S219D mutation known for moderating resistance towards auto-
proteolysis without compromising its catalytic activity 142,146. The influence of amino acid seven on cleavage 
efficiency for this TEVP mutant (referred to as TEVP for simplification; Figure 6f top) has been examined 
recently 142. In this study, any amino acid in position seven (with the exception of Pro) became exposed as 
new N-terminal residue upon TEVP cleavage with similar efficiency rates in vivo and in vitro 143 - yet 
seemingly with highest efficiency for any amino acid with short, unbranched polar or nonpolar side chain 
(Gly, Ser, Ala, Met, Cys). Additionally, its enzymatic activity was determined to be maximal at about 30 °C 
with a gradual decrease above 34 °C, most probably due to unfolding effects 151. Equally important, 
enzymatic activity at 4 °C was shown to be very low but existent 151. Even though limited heterologous 
production of active TEVP has been reported due to poor solubility (< 1 mg/mL) 146,152, preliminary 
experiments under the conditions for Study I showed satisfying activity (even at 37 C) in comparison to 
TEVP variants that were N-terminally stabilised with MBP (Addgene ID 8827 and 8835, data not shown). 
In Study II, the TEVP mutant described above was electively used with a C-terminal polyhistidine (His8)-tag 
(referred to as TEVP-His; Figure 6f bottom). An active TEVP variant with a C-terminal poly-arginine (RRRRR) 
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tail on the C-terminus had been recently published 146. Therefore, the C-terminal (His8)-tag was not 
expected to impair the activity of TEVP-His but still experimentally tested (STUDY II section 3.3). Both, TEVP 
and TEVP-His were produced each from a pSEVA33 backbone (pBBR1 replicon, CmR) under the control of 
the inducible rhamnose promoter rhaBp (INTRODUCTION section 4.1.3). 
 
3.2 Degradation motifs 
A necessary prerequisite for the chosen transferable degradation motifs used in Studies I and II was their 
N-terminal localisation. The idea was to mask each with an N-terminally fused oligopeptide harbouring the 
recognitions site for the TEV protease (rsTEVP) which would enable their conditional release and 
susceptibility for the respective proteasomes upon TEVP cleavage (details in INTRODUCTION section 3.1). 
Additionally, the degradation motifs were preferred to be short peptide sequences whose respective short 
coding sequence would be advantageous for efficient genome integration or optional sequence 
randomisation by single-stranded DNA (ssDNA) recombineering for the generation of protein libraries. 
 
3.2.1 Synthetic ClpAP-specific degradation motif 
The N-terminal degradation motif for ClpAP-specific degradation used in Studies I and II (referred to as 
unstable dgClpAP or short dgClpAP; Table 2B) derived originally from a synthetic oligopeptide developed 
by ERBSE et al. (2006) 3 (Table 2-B). This oligopeptide sequence (12 aa) is based on the modified 11 N-
terminal residues of native AvGFP (AvGFPaa1-11, Table 2B) including a short α-helix motif (GEELF, annotated 
in UniProt ID#P42212) 3. ERBSE et al. (2006) substituted the N-terminal 1Met in AvGFPaa1-11 with Phe-Arg 3. 
This synthetic Phe-Arg N-terminus is mimicking the result of an in vivo post-translational aminoacylation of 
Arg in E. coli (secondary degron); hereby aminoacyl-tRNA-transferase Aat would covalently attach the 
primary degron residue Phe 52. As a consequence, proteins beginning with the N-terminal primary 
destabilising Phe residue (equivalent a primary tether-degron of an prokaryotic N-terminal degradation 
motif; Figure 4) are recognised with highest efficiency by ClpS 33,52.  
 
As an important side note, the final unstable dgClpAP used in Study I and II showed one unintended amino 
acid substitution in position 8 at the end of the short α-helix motif, with respect to the oligopeptide from 
ERBSE et al. (2006) (see analysis in Table 2B). The 8Phe[TTC]®8Val[GTC] substitution is most probably a 
genetic design-flaw which occurred at an early stage of Study I. The impact of the 8Phe®8Val substitution 
on the short α-helix motif (GEELF) and eventual strength of the whole degradation motif for ClpAP-specific 
degradation, with respect to the original oligopeptide, is unclear. Both amino acids are non-polar and show 
similar helix propensity values 153, thus, we speculate that 8Val is still part of the helix, although the four 
amino acids GEEL solely might be enough to fold into an α-helix alone 154. Furthermore, the hydrophobic 
element (equivalent to the initiation site-degron of a prokaryotic N-terminal degradation motif; Figure 4) is 
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speculated to withhold its ClpA interacting properties despite the substitution (probably 7Leu-8Phe which 
turned upon substitution into 7Leu-8Val). Nevertheless, a general destabilising effect on proteins by the 
unstable dgClpAP was demonstrated in Study I.  
 
In order to contrast the effect of the unstable dgClpAP on a protein, a stable variant of dgClpAP (dg#ClpAP) 
was engineered and used in Studies I and II. Thereby, the N-terminal Phe was replaced with Ala. Ala is 
known as N-terminal stabilising residue and is accordingly not recognised by ClpS (dysfunctional tether-
degron). Thus, proteins N-terminally tagged with dg#ClpAP are supposed to have a considerably longer half-
life 56 (Table 2B). 
 
Table 2: Building blocks for the design of conditional N-terminal degradations tags for ClpAP- or FtsH-mediated 
proteolysis. The Amino acid properties are depicted for all sequences. (A) Short peptide sequence (rsTEVP[X]) that 
is designed to mask the N-terminal degron variants for their conditional release. The first 6 aa of the optimum 
rsTEVP are underlined. The TEVP cleavage site is annotated with an arrow. X represents the first N-terminal residue 
of a cryptic N-terminal degradation motifs that becomes released upon TEVP cleavage. (B) Stable and unstable 
ClpAP-specific degradation sequence motifs and multiple sequence alignment to their parental peptide sequences 
(see main text for explanation). (C) Unstable FtsH-specific degradation sequence motif. Multiple sequence 
alignment and determination of amino acid properties were done with Clustal Omega 155 and the Peptide Property 
Calculator (GenScript), respectively. Acidic (red), basic (blue), hydrophobic uncharged (green) and other residues 
(dark grey) are coloured as indicated. Consensus symbols in the multiple sequence alignment like fully conserved 
residues (*) and residues with conserved groups of weakly similar properties (.) are indicated accordingly. Amino 
acids annotated for the first α-helix motif in AvGFP are underlined. 
NAME N-TERMINAL SEQUENCE REFERENCE 
(A)   
rsTEVP(X) MVENLYFQX- Study I 
(B)   
AvGFPaa1-11 (parental sequence)  MSKGEELFTGV- 156 
oligopeptide from ERBSE et al. (parental sequence) FRSKGEELFTGV- 3 
unstable dgClpAP (dgClpAP) FRSKGEELVTGV- Study I 
stable dgClpAP (dg#ClpAP) ARSKGEELVTGV- Study I 
   ******.***  
(C)   
unstable dgFtsH (dgFtsH) MEIYENENDQVEAV- 2 
 
3.2.2 Native FtsH-specific degradation motif from YfgM 
YfgM has recently been identified as substrate for the FtsH proteasome in E. coli 157. YfgM is a bitopic MP 
located in the IM. It consists of a short cytoplasmic N-terminal region, a single transmembrane domain, and 
a longer C-terminus located in the periplasm (1 TMH, Nin-Cout topology) 2,158. It seems to play multiple roles 
in the two cellular compartments it is adjacent to: (1) in the periplasm, it serves as chaperon as it interacts 
with the chaperone PpiD and with the SecYEG translocon in E. coli 100,158,159; and (2) it acts as negative 
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regulator for RcsB in the cytoplasm 2 which is in turn a regulator within the envelope Rcs stress response 
system 160. There is substantial evidence that YfgM is degraded by the FtsH proteasome in a growth phase-
dependent fashion, most efficiently during stationary-phase stress conditions 2,100,157. Thus, YfgM has been 
stated to be the first MP degraded by FtsH in a conditional manner; the presence of an adaptor protein is 
suspected 2. The degradation motif for FtsH-specific degradation of YfgM (dgFtsH) has been recently 
determined as being its first 14 N-terminal cytoplasmic residues (Table 2-C) by BITTNER et al. (2015) 2. Thus, 
degradation efficiency is sequence-dependent which is unique among all known FtsH substrates so far 2. An 
indication for a conditionally abundant adaptor protein is given in the importance of different amino acids 
within the dgFtsH peptide sequence during different growth phases (Table 2-C): E2 and I3 are essential for 
degradation during stationary phase, while Y4 and E5 are important for stabilisation during early growth 
phases 2. Residues 6 to 14 seem to play a minor role in YfgM degradation 2. A small library of 26 systematic 
point-mutations and deletions let to this result and YfgM degradation was visualised by immunoblotting 2. 
Alternatively, PIATKOV et al. (2015) suspect 1Met in dgFtsH being an FtsH-dependent fMet/N-degron (see 
details in INTRODUCTION section 1.2.2) by referring to unpublished data and postulate also an interplay with 
a putative adaptor protein 69. Interestingly, from a synthetic biologist’s point of view, dgFtsH was graftable 
onto the cytoplasmic N-terminus of another IMP with similar topology (PpiD) and thereby conferring the 
same characteristic growth phase-dependent degradation profile as shown for YfgM 2. In contrast, dgFtsH 
grafted onto soluble glutathione S-transferase (GST) did not convert the latter into an FtsH substrate, which 
indicated a specificity for MPs 2. 
In Study II, dgFtsH was used as N-terminal degradation motif for FtsH-specific degradation and grafted onto 
the membrane proteins PpiD, YhaI and NavZ1. 
 
3.2.3 Engineering N-terminal degradation tags for the conditional release of N-terminal 
degradation sequence motifs 
In Studies I and II we designed three N-terminal degradation tags. Inspired by the TIPI technology 143, we 
masked N-terminal degradation motifs specific for ClpAP- or FtsH-dependent degradation (Table 2B and C), 
with a short oligopeptide including the first 6 aa of the optimal TEVP recognition site (rsTEVP; Table 2A) . 
The release of the N-terminal degradation motifs is directed by the conditional production of TEVP and 
subsequent TEVP-dependent cleavage within rsTEVP(X) (INTRODUCTION section 3.1). X represents the first N-
terminal residue of a degradation motif that gets released. An overview of the resulting degradation tags is 
given in Table 3. 
  
 46 
Table 3: Overview about the N-terminal degradation tags for the conditional release of unstable or stable N-
terminal degradation sequence motifs for ClpAP- or FtsH-mediated proteolysis used in Study I and II. rsTEVP(X) 
(orange); Remaining peptide sequence after TEVP cleavage (underlined); a-helix (red highlighted). The N-terminal 
amino acid residue X which corresponds to the seventh amino acid in rsTEVP(X) is emphasised in brackets.  
CONDITIONAL  
DEGRADATION TAG 
PEPTIDE SEQUENCE AFFILIATION 
Unstable  
rsTEVP(F)-dgClpAP 
                    MVENLYFQFRSKGEELVTGV- Study I, 
Study II 
Stable  
rsTEVP(A)-dg#ClpAP 
                    MVENLYFQARSKGEELVTGV- Study I, 
Study II 
Unstable  
rsTEVP(M)-dgFtsH 
             MVENLYFQMEIYENENDQVEAVKRFFA- Study II 
 
3.3 Proteins of interest 
Variants of the green fluorescent protein from A. victoria (AvGFP) have been proven to be prime candidates 
to demonstrate the utility of experimental set-ups for protein degradation of soluble proteins 26,50,103. 
AvGFP variants are soluble, easy to produce to high levels in the cytoplasm of E. coli 161, known to have a 
long half-life 125 and have a modifiable N-terminus 162. They embody their own reporter system due to their 
ability to exhibit, if functional, a bright green fluorescence as response to light in the UV-blue light  
range 163. Upon induced proteolysis, the fluorophore which is composed of modified amino acid residues 
within the polypeptide chain 163,164 should become destabilised, thereby affecting the proteins’ 
fluorescence intensity. AvGFP variants represent therefore an easy read-out to analyse degradation events 
in the cytosol. In Study I, we chose the GFP folding reporter (frGFP; INTRODUCTION sections 3.3.1 and 3.4.1) 
as POI to test our set-up for conditional ClpAP-mediated proteolysis.  
 
In contrast, choosing candidates for conditional FtsH-dependent proteolysis (Study II) was not trivial since 
there are no membrane proteins (MP) that also exhibit a fluorescent signal. The monitoring of MP 
proteolysis needed to be reconsidered and we opted for designing fusion proteins using fluorescent 
reporter (FR) proteins tagged on model MPs. We defined three criteria we believed essential for our MP 
candidates. First, their N-terminus needed to be cytoplasmic in order to make it accessible by the FtsH 
proteasome. Second, successful overproduction and integration in E. coli’s IM (preferably also as C-terminal 
fusion to a peptide/protein) should have been reported in the literature. Third, an excess of more than 
three TMHs was not desired to limit the complexity in preliminary experiments. Good matches were found 
for the three inner membrane proteins PpiD, NavZ1 and YhaI (see Figure 6b, c, d and INTRODUCTION sections 
3.3.2, 3.3.3, 3.3.4, respectively). 
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Table 4: N-terminal peptide sequences of all proteins of interest used in Studies I and II. The N-terminal peptide 
sequences from all soluble or IM-integrated POIs include the sequence until the end of the first N-terminal β-sheet 
or until the end of the first transmembrane helix (TMH), respectively. Annotated α-helix (red highlighted); 
Annotated β-strand (light blue highlighted); Predicted TMH (grey highlighted); Position at which the N-terminal 
sequence was replaced with an unstable or stable conditional degradation tag from Table 3 (w). YfgM is only 
indicated for comparison. Secondary structure annotations for frGFP were obtained from UniProt (P42212 
[AvGFP]). TMH prediction was performed with DGpred 165. 
POI N-TERMINAL PEPTIDE SEQUENCE REFERENCE 
frGFP              MwSKGEELFTGVVPILVELDGDV-frGFPaa23-238 4,166 
YfgM MEIYENENDQVEAVKRFFA-ENGKALAVGVILGVGALIGWRYW-YfgMaa43-206 2 
PpiD        MMDSLRTAANSLwVLKIIFGIIIVSFILTGVSGYL-PpiDaa35-623 2 
NavZ1             MLKRCLSwPLTLVNQVALIVLLSTAIGLAGMA-NavZ1aa32-467 Study II 
YhaI     MQWYLSVLKNYVGFSwGRARRKEYWMFTLINAIVGAIINVIQLIL-YhaIaa45-118 Study II 
 
 
 
 
Figure 6: Schematic illustration of the general structure and localisation of the POIs and TEV protease. PpiD (b), 
NavZ1 (c), YhaI (d) as well as the variants for frGFP (e) and TEV protease (f) are presented. YfgM (a) is shown for 
purpose of topological comparison. All N-termini in (b-e) are shown with their conditional degradation tags. The 
N- or C-terminus are selectively indicated with an N or C, respectively. Important N- or C-terminal protein features 
are indicated in colour or symbols: synthetic dgClpAP or dg#ClpAP (red bold line) and native dgFtsH (black bold 
line) for ClpAP- and FtsH-dependent proteolysis, respectively; the rsTEVP(X) capping (º) as part of the conditional 
element together with TEVP (f), varying fluorescence reporter including sfGFP, EcFbFP, phiLOV2.1 and CreiLOV are 
summarised in one symbol (ì); His8-tag (¢) as epitope tag. 
periplasm
cytoplasm
(a) (b) (c) (d)
NN N N
C
(f)(e)
N
N
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3.3.1 The globular frGFP 
The GFP folding reporter (frGFP) 4 is used simultaneously as cytoplasmic FR as well as soluble POI in  
Study I. frGFP is a full-length AvGFP variant with six characteristic amino acid substitutions which are 
discussed in detail in INTRODUCTION section 3.4.1. Until now, frGFP has no own Protein Data Bank (PDB)  
entry 167 but shows 97.5 % sequence similarity to AvGFP as calculated by ExPASy SIM 168. Thus, frGFP may 
most certainly exhibit the same structure as AvGFP that is a globular a/b-protein 169 folded as a β-barrel 
around an axial α-helix 163. 
 
For our Studies I and II, the aa2–238 of frGFP (Table 4) were N-terminally fused with either the unstable 
degradation tag rsTEVP(F)-dgClpAP-frGFP or the stable tag variant rsTEVP(A)-dg#ClpAP (Table 3). The 
resulting protein constructs were then (see Figure 6e):  
§ rsTEVP(F)-dgClpAP-frGFP  
§ rsTEVP(A)-dg#ClpAP-frGFP 
Upon TEVP cleavage in the degradation tag sequences, Phe (F) or Ala (A) are released as N-terminal 
destabilising or stabilising residues for ClpAP-dependent proteolysis, respectively. The coding sequences 
for both frGFP fusions have been independently integrated in the phage 186 integration site within the 
genomic tRNIleY gene of E. coli K-12 MG1655 and expressed by the IPTG-inducible T5 promoter. 
 
3.3.2 The membrane protein PpiD 
PpiD is a bitopic MP in the IM of E. coli (1 TMH, Nin-Cout topology); its single N-terminal TM helix is followed 
by three predicted domains facing the periplasm 170,171. Only the second periplasmic domain has been 
structurally determined so far 171. The first and the third periplasmic domains are putative chaperone 
domains, whereas the second domain is predicted to have cis-trans isomerase activity 171 for the catalysis 
of peptidyl-prolyl bonds which is, beside disulphide bond formation, another rate-limiting reaction in native 
protein folding 172.  
There are flagrant conflicting debates in literature regarding putative functions of PpiD, namely (a) being 
essential for growth, (b) exhibiting a specific folding function in outer membrane (OMP) biogenesis or (c) 
exhibiting a compensating function for SurAf; often those three hypotheses are supported by controversial 
results (170 versus 173, 174 versus 175, and 170 versus 175, respectively). For now, the overall function(s) of PpiD 
remain(s) unclear 176,177. Nevertheless, considering its co-localisation together with SecYEG, PpiD has been 
proposed as periplasmic gatekeeper and assisting in the initial folding steps of newly translocated proteins 
prior to their release into the periplasm as chaperone 174,178. If so, its substrates are more likely envelope 
proteins 175 and less probably OMP’s 174. 
 
                                                             
f SurA is a periplasmic chaperone which is known to prevent aggregation of unfolded OMPs 304. 
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Due to its topological resemblance (Nin-Cout) and its apparent complex formation in vivo with YfgM (1 TMH, 
Nin-Cout topology; INTRODUCTION section 3.2.2) in the IM 158, PpiD has already been used in the fundamental 
work of conditional proteolysis of IMPs by BITTNER et al. (2015). The authors replaced the initial twelve N-
terminal residues of PpiD with the N-terminal aa1-19 of YfgM which finally led to FtsH-mediated 
destabilisation in the stationary phase in E. coli K-12 W3110; YfgMaa1-14 were determined to represent the 
degradation signal 2 (alias dgFtsH; INTRODUCTION section 3.2.2). The coding sequence for the dgFtsH-PpiDN’ 
chimera was expressed from the pASK-IBA5plus derivative pBO3575 (ColE1 replicon, AmpR; personal 
communication with IBA GmbH, Germany and Lisa-Marie Bittner) by the anhydrotetracycline (AHT)-
inducible tet promoter. Production of the dgFtsH-PpiDN’ MP chimera was verified from whole cells by 
immunoblotting using an a-PpiD antibody 2. The latter detection method gives evidence about quantitative 
NavZ1 abundance, yet it does not differentiate in between folded and aggregated MP 179. 
 
The study of BITTNER et al. (2015) embodies the foundation for the presented Study II. In contrast to BITTNER 
et al. (2015), we replaced the N-terminal aa1-12 of PpiD with the unstable conditional degradation tag 
rsTEVP(M)-dgFtsH (Table 3) for FtsH-dependent degradation. Additionally, the FR proteins sfGFP or EcFbFP 
(INTRODUCTION section 3.4.2 or 3.4.3, respectively) were attached directly to PpiD’s C-terminus including an 
additional KLAA-(His)8-tag. Hence, the resulting PpiD chimera were then in short  
(see Figure 6b): 
§ rsTEVP(M)-dgFtsH-PpiD-EcFbFP-His 
§ rsTEVP(M)-dgFtsH-PpiD-sfGFP-His 
The respective coding sequences were integrated in a pCOLA vector (ColA replicon, KanR) and expressed 
from the IPTG-inducible T7 promoter in E. coli MG1655 (DE3) in Study II. 
 
3.3.3 The membrane protein NavZ1 
The synthetically engineered NavZ1-W0 protein (2 TMHs, Nin-Cin topology 180), referred to as NavZ1 below, 
is a functionally impaired polytopic MP chimera from the two functionally and topologically similar 
osmolarity sensor histidine kinases NarX and EnvZ 5. The two N-terminal TMHs and the periplasmic sensor 
domain derived from the aa1-217-moiety of NarX while the cytoplasmic TM-free C-terminal part derived from 
the aa222-450-moiety of EnvZ 5. Two TMHs and an Nin-Cin topology were determined for NarX and EnvZ by an 
experimental and in silico analysis on the N- and C-termini 180. The same topology has been determined 
experimentally for the chimeric NavZ1; furthermore, NavZ1 dimerises but N- and C-termini were expected 
being modifiable and the N-terminus being exposed enough to be accessible by a cytoplasmic protein 
(personal communication with Roger Draheim).  
 
NavZ1 was considered as an ideal MP candidate due to its cytoplasmic N-terminus and its impaired activity 
to prevent additional physiological stress to the cells throughout IMP-overproduction. Additionally, its 
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topology with two TMs was thought to be an advantage since this represents an increased structural 
complexity in comparison to PpiD. NavZ1 had previously been successfully produced from a modified 
pBR322 vector, pEnvZ-V5 (pMB1 replicon, AmpR, lacZ promoter), with a C-terminal V5 epitope tag in E. coli 
(NavZ1+-aa7-V5); protein production was monitored from whole cells by WESTERN blot using an a-V5 
antibody 5. One can speculate that the analysis use here is not enough to demonstrate successful 
integration of the folded protein into the membrane. 
 
Similar to PpiD, the first 7 aa at the N-terminus of NavZ1 were replaced with the degradation tag  
rsTEVP(M)-dgFtsH (Table 3) for conditional FtsH-dependent degradation in Study II. Furthermore,  
NavZ1’s C-terminus was directly fused with the FR proteins CreiLOV, phiLOV2.1 and sfGFP combined with a 
KLAA-(His)8-tag. Accordingly, the resulting NavZ1 chimera (Figure 6c) were then in short: 
§ rsTEVP(M)-dgFtsH-NavZ1-CreiLOV-His 
§ rsTEVP(M)-dgFtsH-NavZ1-phiLOV2.1-His 
§ rsTEVP(M)-dgFtsH-NavZ1-sfGFP-His 
Equally to PpiD, the respective coding sequences were integrated in a pCOLA vector (ColA replicon, KanR) 
and expressed from the IPTG-inducible T7 promoter in E. coli MG1655 (DE3) in Study II. 
 
3.3.4 The membrane protein YhaI 
YhaI has been assigned so far as a MP of the IM 180,181. It is the protein product of the yhaI gene which is yet 
a functionally uncharacterised and unnamed ORF that maps at 81 minutes on the genetic map of E.coli K-
12 MG1655 182. Therefore, the yhaI gene still belongs to the number of true y-genes which make still 
approximately 30% of the 4,377 annotated genes in E. coli K-12 MG1655 181.  
In retrospect, YhaI does not seem to be a perfect choice for Study II due to uncertainties in its topology. A 
THM analysis with DGpred 165 predicts three TM helices for YhaI (analysis in APPENDIX Table S 4). This was 
confirmed by a TMHMM 183 analysis which simultaneously predicted an Nin-Cout topology (analysis in 
APPENDIX Figure S 2). In contrast, DALEY et al. (2005) determined experimentally the C-terminus to be 
cytosolic and predicted a Nin-Cin topology with three predicted THMs 180. Thus, further experimental 
analyses are needed to firmly establish the topology and structure of this protein. However, the five 
positively charged amino acid residues (Lys, Arg) on the N-terminus (Table 4) could represent a strong 
argument for the cytosolic localisation, as needed for Study II, since basic residues have been reported 
being more abundant on cytosolic connecting loops than on periplasmic ones 184. Thus, besides a confirmed 
Cin topology, the cytoplasmic localisation of the N-terminus seems probable but still speculative. Similar 
speculative is the orientation of the three predicted TMH towards the membrane. In contrast to DGpred-
predicted TMH2 and TMH3 (analysis in APPENDIX Table S 4), the DGprep value for the predicted TMH1 is 
positive (0.283) which is an indication of lower hydrophobicity and also that it would need stabilising helices 
around it for an efficient insertion into the membrane 165. Based on this, one possible scenario is that TMH1 
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of YhaI can be amphipathic which might be emphasised in the one-sided arrangement of its hydrophobic 
residues in a helical wheel display (analysis in APPENDIX Figure S 1) generated with Membrane Protein 
Explorer 185. 
 
In essence, YhaI has been chosen for Study II due to its assumed cytoplasmic N-terminus, its small size and 
its topology with three helices associated with/in the IM. Here too, the predicted structure was thought to 
represent an increased complexity in comparison to PpiD and NavZ1. Additionally, despite its unknown 
function, YhaI has already been seemingly, successfully produced as fusion protein in E. coli in three 
instances: (a) from a modified pET28a(+) vector pWaldo (pBR322 replicon, T7p) 4 as YhaI+-linker-rsTEVP(G)-
linker-S11-linker-His construct (Morten HH Nørholm, unpublished data, YhaI abundance was confirmed 
based on fluorescence analysis of splitGFP complementation on whole cells); (b) from modified pBR322 
vectors, pHA-1 and pHA-4 (pMB1 replicon, araBp), as YhaI+-linker-PhoAN’, whereby cytoplasmic  
located PhoA activity was measured in vivo 180; and (c) from the modified pET28a(+) vectors  
pWaldo (pBR322 replicon, T7p) 4 or pGFPe (pBR322 replicon, T7p) 186 as YhaI+-linker-GFPN’ or  
YhaI+-linker-rsTEVP(G)-GFPN’-His, whereby cytosolic GFP abundance was measured as normalised emitted 
GFP fluorescence/OD600 180. For all genes in examples (b), (c) - and most probably also in (a) - the DNA-
coding region encompassing the region coding for the SD sequence until the ATG codon of the coding 
region, which only partially represents the translation initiation region (TIRg), was always the same 180. One 
should note, that fluorescence alone is not enough to demonstrate that the protein was folded correctly 
and integrated into the membrane 187. 
 
In Study II, the first 15 aa of the N-terminus were replaced with the degradation tag rsTEVP(M)-dgFtsH 
(Table 3) for conditional FtsH-dependent degradation. Furthermore, equally to NavZ1, YhaI’s C-terminus 
was directly fused with the FR proteins CreiLOV, phiLOV2.1 and sfGFP combined with a KLAA-(His)8-tag. 
Accordingly, the resulting YhaI chimera were in short (Figure 6d): 
§ rsTEVP(M)-dgFtsH-YhaI-CreiLOV-His 
§ rsTEVP(M)-dgFtsH-YhaI-phiLOV2.1-His 
§ rsTEVP(M)-dgFtsH-YhaI-sfGFP-His 
Equally to PpiD and YhaI, the respective coding sequences were integrated in a pCOLA vector (ColA replicon, 
KanR) and expressed from the IPTG-inducible T7 promoter in E. coli MG1655 (DE3) in Study II. 
 
                                                             
g The translation initiation region (TIR) is the nucleotide sequence around the START codon on the mRNA which is responsible for the 
efficiency of translation initiation and therefore protein biosynthesis. In detail, TIR comprises the Shine-Dalgarno (SD) sequence, a linker 
region in between the SD sequence and the translational START codon (1Met), approximately the first five codons after 1Met and optional 
translational enhancers such as A/U-rich sequences upstream of the SD sequence 305,306.  
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3.4 Fluorescent reporter proteins 
An easy and non-invasive read-out suitable for real-time observation in vivo of biological processes like 
protein degradation are genetically encoded fluorescence reporters (FRs). Genetically encoded FRs are 
protein sequences that can be fused to a POI to render it fluorescent (recently reviewed 188). At best, upon 
unfolding and processive proteolysis of the FR, the fluorophore becomes unprotected resulting in a loss of 
function. Proteasomal processivity is, among others, dependent on the unfolding power of the proteasome 
as well as on the intrinsic thermodynamic stability of the protein substrate 41,189. In contrast to eukaryotes 
that have only one highly processive proteasome 190, E. coli is equipped with five different proteasomes 
which apparently vary not only in their substrate preferences but also in their unfolding power 33,41,103,191. 
ClpAP is known for having a strong unfoldase activity 41,42 whereas the unfolding power of FtsH has been 
rated as weak 103. Thus, in order to visualise FtsH-dependent degradation, the FR choice for Study II needed 
careful considerations to avoid incompletely degraded FR that might be still (partially) fluorescent 103. In 
the ideal case, any chosen FR should be sufficiently thermodynamically unstable to match the unfoldase 
activity of the targeted proteasome. 
 
Since the discovery of AvGFP and the determination of its primary and tertiary structure in 1962 192,  
1992 156 and 1996 166,193, respectively, FRs from the GFP family and its modified variants have become the 
prime choice for scientific fluorescent applications. They belong to the class of intrinsically fluorescent 
proteins which become fluorescent after folding without addition of a fluorophore under aerobic conditions 
188. In the past, AvGFP variants have been successfully used to study cytosolic ClpAP-dependent degradation 
in E. coli 3,41,42. Crucial characteristics for this application were its bright green fluorescence when exposed 
to blue/UV light, its photostability and long half-life and its modifiability at the C- and/or N-terminus. 
Furthermore, AvGFP variants can be produced to high levels in the cytosol of E. coli. Thus, it was obvious to 
use a similar AvGFP variant - frGFP (INTRODUCTION section 3.4.1), to be precise – for the tool development 
part in Study I.  
 
In order to fold correctly, AvGFP variants usually need the reducing environment of the cytoplasm to form 
disulphide bridges 194,195. The amino acid substitutions in superfolder GFP (sfGFP; INTRODUCTION section 
3.4.2), however, contribute that this AvGFP variant is still able to become stably fluorescent in the highly 
oxidising periplasmic environment under aerobic conditions 6,194–196. Despite the apparent weak unfoldase 
activity of FtsH 103, sfGFP was integrated as C-terminal FR-tag in Study II in order to shed some more light 
on FtsH-dependent IMP degradation in general. We hypothesised that in case sfGFP were not or only 
partially degraded, it would remain as entity in periplasm/cytoplasm and could be detected with 
immunoblotting.  
 
 53 
 
Figure 7: Fluorescence properties and structures of GFP and LOV protein variants. Excitation (dashed lines) and 
emission (solid lines) spectra of (A) EGFP, an AvGFP variant, and (C) iLOV, the parental LOV protein from phiLOV2.1. 
Almost all LOV proteins exhibit a characteristic excitation spectra with a prominent three band feature in the blue 
spectral region and a maximum near 450 nm; the respective emission spectra are also spectrally very similar with 
a specific fluorescence maximum around 495 nm and a prominent shoulder in the range of 525–540 nm 197–200. 
Structural ribbon diagrams of (B) AvGFP, as an intrinsically fluorescent protein (PDB ID 1EMA 193) and (D) iLOV, the 
parental LOV protein from phiLOV2.1, as an extrinsically fluorescent protein that binds FMN as the fluorophore 
(PDB ID 4EES 201). All protein backbones are shown as cartoon, and the fluorophore is drawn as a stick model 
(green, carbon; blue, nitrogen; red, oxygen; orange, phosphorus). In some cases, parts of the protein cartoon have 
been made transparent to better show the fluorophore. (A) has been generated with Spectrumviewer (BD 
Biosciences); (C) is reproduced from BUCKLEY et al. (2015) 202; (B) and (C) are a reproduction from THORN (2017) 188. 
 
A new emerging generation of genetically encoded FRs for bioimaging are chromophore-binding domains 
from plant and bacterial photoreceptor proteins; in particular the flavin-binding light-oxygen-voltage (LOV) 
domains 202. Their discovery and first application as FRs took place in 1999 203 and 2007 199, respectively. 
LOV domains or LOV proteins are native protein sensors 197 and belong to the extrinsically green fluorescent 
proteins that can bind endogenous FMN as a fluorophore 188. Although considerably less bright than  
AvGFP 188 (see APPENDIX Table S 2), LOV proteins have few advantages over green AvGFP variants, namely a 
smaller size (ca. 10-15 kDa), improved pH stability and their independence towards oxygen 188,202. LOV 
protein have been shown suitable for applications in both cytoplasm and periplasm of E. coli. The latter was 
particularly important to Study II since a FR was needed to fit the C-termini of the different MP candidates 
which were either cytoplasmic or periplasmic located. We finally chose to work with the LOV proteins 
EcFbFP, phiLOV2.1 and CreiLOV. The determining factors for the choice were brightness, predominantly 
A B
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monomeric state or documented application in the periplasm. Besides, equally important were their similar 
excitation and emission wavelength peaks in comparison to sfGFP (see Figure 7 and APPENDIX Table S 2). 
 
However, a LOV protein feature that, in retrospective, slipped our attentions were their thermal stability 
198,200,204. From a thermodynamic point of view, the thermostability of a protein is represented by the 
melting temperature (Tm) at which a protein is completely unfolded and inactive after heat denaturation 
(ΔG[Tm] = 0; APPENDIX Figure S 3) 205,206. The bigger the Tm of a protein, the more resistant is a protein’s 
fold/structure towards heat. In contrast, from a functional point of view, a thermostable protein can also 
describe a protein that can unfold reversibly. More precisely, upon having passed a protein’s Tm due to heat 
shock, a fully unfolded thermostable protein can resume refolding into a fully functional protein upon 
decreasing temperatures 24,207. Importantly, EcFbFP and CreiLOV have been shown to be 
thermodynamically as well as functionally thermostable FRs 198,204. Furthermore, a proteins Tm seems to be 
on average positively correlated with its free energy change of unfolding (ΔG[T]) hence its intrinsic 
thermodynamic stability 205. Thus, one should bear in mind that LOV proteins, against all initial assumptions, 
might belong to the group of thermodynamic stable proteins which might counteract with FtsH’s poor 
unfoldase activity. To present, the free energy changes (ΔG[T]) for the chosen LOV proteins have not been 
experimentally determined yet. 
 
3.4.1 The AvGFP variant frGFP 
frGFP (APPENDIX Table S 3) has been previously engineered as conventional C-terminal folding reporter for 
overproduction of normally aggregating proteins 4. In regards to AvGFP, frGFP includes the following amino 
acid substitutions: F64L, S65T, Q80R, F99S, M153T and V163A.  
Substitution F64L is increasing folding efficiency at 37°C 208,209. Besides increasing fluorescence and 
photostability, amino acid substitution S65T causes a 6-fold higher amplitude of the excitation peak and a 
shift of the latter to 488 nm in comparison to AvGFP 208,210. F64L and S65T are also known as enhanced GFP 
mutations 6. Q80R is stated to be a neutral mutation possibly resulting from a PCR error 211. Finally, F99S, 
M153T and V163A, known as the so-called cycle 3 (C3) mutations (originally reported as F100S, M154T, 
V164A), are believed to result in reduced aggregation and increased chromophore activation 212. frGFP 
carries none of so-called monomerising GFP mutations (A206K, L221K, F223R) and is therefore prone to 
dimerise in solution at high concentrations 213. 
frGFP had been chosen for pragmatic reasons: its sequence availability and good practical experience during 
other projects 214. In the Studies I and II, frGFP was used as soluble fluorescent target protein for conditional 
ClpAP-dependent degradation. 
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3.4.2 The AvGFP variant sfGFP 
Superfolder GFP (sfGFP; APPENDIX Table S 3) is an AvGFP variant and engineered for robust folding 6. 
Compared to AvGFP, sfGFP’s primary sequence carries the following mutations: S2R, S30R, Y39N, F64L, 
S65T, S72A, F99S, N105T, Y145F, M153T, V163A, I171V, and A206V.  
S2R is thought as silent mutation which happened apparently accidentally by PCR during the development 
of GFPmut3*, an ancestral AvGFP variant of sfGFP 215. S72A is a mutation on the chromophore-bearing  
helix 216. Either alone or in combination with other mutations e.g. F64L, S72A gives greater brightness over 
AvGFP at warmer temperatures e.g. 37°C 163. Furthermore, the same S72A/F64L combination can enhance 
GFP folding at 37°C 163,208,209. S65T is increasing fluorescence and photostability, and causes a 6-fold higher 
amplitude of the excitation peak and a shift of the latter to 488 nm in comparison to AvGFP 208,210. The cycle 
3 (C3) mutations F99S, M153T and V163A (originally reported as F100S, M154T, V164A), are thought to 
reduce aggregation and to increase chromophore activation 212. Finally, the so-called superfolder GFP 
mutations S30R, Y39N, N105T, Y145F, I171V and A206V have been proven to increase maturation speed, 
folding kinetics and protein stability in comparison to the parent frGFP variant 6,194. Those sfGFP mutations 
enable sfGFP folding and maturation in the oxidising periplasm under aerobic conditions 194–196. 
Furthermore, sfGFP is documented to be monomeric 6.  
In Study II, sfGFP is fused to the C-termini of the inner membrane proteins PpiD, NavZ1 and YhaI (Figure 6b, 
c and d) and functions as FR located in cytoplasm or periplasm. 
 
3.4.3 The LOV protein EcFbFP 
EcFbFP (APPENDIX Table S 3) is an E. coli codon-optimised version of fluorescence reporter BsFbFP that is 
derived from the LOV domain of B. subtillis blue-light photoreceptor YtvA (UniProt ID O34627) 199. EcFbFP 
encompasses almost unchanged the first 135 aa of YtvA besides the substitution C62A that substantially 
increases fluorescence intensity 199. EcFbFP is a thermostable protein: it remains stably active until a 
temperature of 50 °C and shows also rapid as well as fully fluorescence recovery after a short thermal 
deflavination and denaturation step of up to 90 °C in vitro 204. Additionally, EcFbFP is pH-stable over a broad 
pH range. Furthermore, EcFbFP is known to form stable homodimers in solution 199. In comparison to other 
LOV proteins, EcFbFP is relatively bright and was even shown to outperform YFP during real-time 
measurements when overproduced alone 217. Interestingly, EcFbFP has been used recently as N- or  
C-terminal translational fusion tag for the heterologous overproduction of soluble proteins in E. coli 218,219. 
Using EcFbFP as N-terminal tag could even increase protein stability of its soluble fusion partner resulting 
from higher-order oligomerisation probably due to dimerisation of the FbFP tag 218.  
EcFbFP has been published and patented as first LOV protein suitable for anaerobic and periplasmic 
applications (transport via SecYEG pathway) with relative high fluorescence intensities in vivo 199,220. For 
Study II, EcFbFP was therefore used as C-terminal fusion tag for PpiD, an IMP with periplasmatic C-terminus 
(Figure 6b).  
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3.4.4 The LOV protein phiLOV2.1 
phiLOV2.1 (APPENDIX Table S 3) is derived from the improved LOV protein (iLOV) 201. iLOV, in turn, was 
engineered from A. thaliana blue-light receptor Phot2 (UniProt ID P93025) 201,202. Accordingly, phiLOV2.1 
consists of the aa387-496 of AtPhot2 including the following substitutions relative to the wild-type sequence: 
the iLOV substitutions C426A, S409G, F470L, S394T, I452T, M475V and six additional substitutions N390S, 
N401Y L422M, Q468R, E471G and D491V 201. The latter six substitutions increased phiLOV2.1’s 
photostability and photobleaching resistance compared to iLOV while brightness was decreased by half 
201,221. Importantly, phiLOV2.1 has been used as C-terminal FR-tag to a cytosolic globular protein in the 
obligate anaerobe Clostridium difficile in order to track its transport over the membrane 222. Furthermore, 
it was C-terminally tagged to a soluble protein as well as a MP for translocations studies in E. coli and 
Shigella flexneri 223.  
In Study II, phiLOV2.1 is fused to the C-terminus of NavZ1 and YhaI which are IMPs with their C-termini 
located in the cytoplasm (Figure 6c and d).  
 
3.4.5 The LOV protein CreiLOV 
CreiLOV (APPENDIX Table S 3) is a more recently discovered and engineered LOV protein. Besides being 
thermo- as well as photostable, fast-maturing and monomeric, CreiLOV even outperforms existing FbFPs in 
brightness and operational pH range (APPENDIX Table S 2) 198. CreiLOV is the aa16-133-fragment from  
C. reinhardtii blue-light photoreceptor Phot (UniProt ID Q8LPE0). Equally to EcFbFP, it carries a single amino 
acid substitution (C57A) in the FMN-binding pocket to improve fluorescence stability 198. As demonstrated 
for EcFbFP, CreiLOV exhibits a high degree of functional thermal stability: under denaturising condition of 
70 °C for 1 h, CreiLOV fluorescence rapidly recovered 60 % of its original fluorescence upon cooling to RT in 
vitro 198. Due to its robustness and enhanced brightness among all actual LOV protein candidates in vitro, 
CreiLOV is suggested being one of the most promising LOV protein candidates for biotechnological 
applications 198,200. However, an exemplary application in vivo remains to be proven. 
Accordingly, we incorporated CreiLOV in the list of FRs in Study II and fused it to the cytoplasmic C-termini 
of the inner membrane proteins NavZ1 and YhaI (Figure 6c and d). 
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4 MOLECULAR BUILDING BLOCKS OF THE PRESENTED STUDIES 
Promoters are designed to recruit the transcriptional machinery from the expression host and provide the 
platform for gene transcription initiation. The classical elements for bacterial promoters include the -35 and 
-10 site, as regulatory binding motives for the RNA polymerase 224. Besides, various abundant regulatory 
elements are located within the promoter region and can co-regulate gene expression initiation, promoter 
strength, promoter tightness in the repressed state and translation initiation 225. Promoters are therefore 
one of the centrepieces for recombinant gene expression from the genome as well as from a plasmid. The 
regulatory set-up and function of the promoters used in Studies I and II are described here in more detail. 
 
4.1.1 The synthetic T7 promoter 
The bacteriophage T7 expression system was introduced for recombinant protein production in 1986 226 
and became soon part of many popular bacterial expression systems, including the pET system  
(Novagen) 227. In the pET system, gene expression is driven from the bacteriophage T7 promoter (T7p) which 
requires the abundance of bacteriophage T7 RNA polymerase (T7 RNAP) 227. The T7p from the pET system 
is actually the renamed equivalent of T7lac, an engineered fusion of the bacteriophage T7 F10 promoter 
and the lac operator site (lacIo) 228 (Figure 8). T7 RNAP is a very active and processive enzyme, due to its 
high selectivity to T7p 229. It is usually produced from the genome of pET system host strains 227. Its 
production in E.coli hosts is regulated by a lac promoter derivative, the L8-UV5 lac promoter (lacUV5p) 227 
which itself is driven by the endogenous E. coli RNAP 230. lacUV5p can be induced with the supply of lactose 
or its synthetic analogue isopropyl β-D-1-thiogalactopyranoside (IPTG) 231 which interact with the operator 
site-binding lac repressor (LacI) and thereby enable transcription 227.  
 
In the wild type lac promoter, efficient transcription initiation requires the additional presence of the 
activated cyclic AMP receptor protein (CRP). CRP become activated upon binding cyclic AMP (cAMP). 
Complexed CRP/cAMP is called CAP complex (CAP) 227. CAP can bind upstream from the -35 region and is 
able to promote transcription by endogenous E. coli RNAP directly 227. Full induction of lacUV5p is only 
achieved by the presence of both, inducer and CAP 227. lacUV5p has three point mutations in comparison 
to the wild type lac promoter: two point mutations in the –10 region increase promoter strength and 
decrease its dependence on CAP stimulation for full activation; the third-point mutation is located in the 
CAP binding site and decreases the affinity for CAP 227. However, although the lacUV5 promoter is reported 
to be well repressed in the absence of inducer, it still exhibit a detectable basal activity which lead a basal 
production of T7 RNAP 227. This might be problematic when the gene of interest, driven by T7 RNAP-
dependent T7p from a plasmid, actually encode for a toxic protein 227. However, the basal gene expression 
level of T7p can be reduced by supplying small but constitutive amounts of T7 lysozyme 232, a natural 
inhibitor of T7 RNAP, using the plasmids pLysS and pLysE 233. 
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4.1.2 The synthetic T5 promoter 
The historical development of the T5 promoter (T5p) had its origin as fusion between the strong T5 
bacteriophage promoter PN25 234 and the E. coli lacIo in the late 1980s; this construct was first termed T5 
PN25/O 235. PN25 is dependent on the E. coli RNA polymerase (RNAP) and exhibits a sequence with remarkably 
high translation initiation rates in vivo and in vitro in E. coli 234–237. Upon fusion with lacIo, PN25 became 
negatively controlled by the endogenous LacI repressor which binds lacIo 235. LacI repression is released 
upon supply with lactose or IPTG. In a following developmental step, another lacIo was introduced 
upstream of the first one, right between the -35 and -10 sites to ensure an increased repression level, 
leading to T5 promoter variant PN25/O3/O4 238 (Figure 8). This promoter was finally picked, renamed T5 
promoter, and commercialised in the pQE vector collection from Qiagen 237. Sufficient negative regulation 
of dual operator sequence can only be achieved in the presence of high levels of LacI 237. Since the pQE 
vectors do not carry the lacI gene, excess LacI supply is suggested in two ways: (1) with an E. coli host strain 
that carries one of the lacIq genes (lacIq or lacIq1) for increased LacI production; or (2) from a co-propagated 
medium copy plasmid (p15A replicon) from Qiagen that harbours the constitutively expressed  
lacI gene 237,239. 
 
 
Figure 8: Structure of the promoter systems used for recombinant gene expression in E. coli. Promoter regions for 
T7p 228, T5p 238 and rhaBp 240,241 and some regulatory elements for transcription (-35 and -10 sites; lacIo; CAP) and 
translation (SD) are illustrated. Binding sites for sigma factors which can interact with RNAP (-35 and -10 sites) 242; 
operator site for LacI binding (lacIo); binding site for CAP complex (CAP); sequence representing the Shine-
Dalgarno sequence on mRNA level (SD). 
 
4.1.3 The native rhaB promoter from E. coli 
The E. coli rhaB promoter system (rhaBp) is originally derived from the rhaBAD operon. In nature, rhaBAD 
together with the rhaT gene and the rhaSR operon encode for all genes necessary for the rhamnose 
metabolism, the rhamnose-H+ symporter and the regulatory proteins that control expression from rhaBAD 
and rhaT, respectively 243. rhaBAD, rhaSR and rhaT have all individual promoters which are activated in the 
presence of L-rhamnose 243.  
However, the rhaBp system for recombinant gene expression only encompasses the rhaSR operon with its 
promoter rhaSp and the adjacent rhaBp (originally the promoter for the rhaBAD operon) which acts in the 
ATG…rhaR rhaS
rhaSp rhaBp
T7p-35 -10 lacIo SD ATG…
T5p-35 -10 lacIo SD ATG…lacIo
-35 -10 SD ATG…CAPCAP-35-10SD…CAT rhaSp/rhaBp
promoter >>><<< promoter
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opposite direction (Figure 8). RhaR, an transcriptional activator, is always present at low levels 244 but 
becomes only activated upon binding of L-rhamnose and induces efficiently the expression of its own 
encoding rhaSR operon 240. Accumulated RhaS, another transcriptional regulator, can then contribute to 
the activation of rhaBp which leads to the expression of the downstream genes in a L-rhamnose dependent 
manner 245. However, gene expression from rhaSp as well as rhaBp is also subject to catabolite repression. 
In both promoters, there is a CAP binding site located upstream of the -35/-10 sites 240,241. Thus, in addition 
to RhaS, CAP is needed for full activation of rhaBp 246. The activation status of CAP is thereby positively 
regulated by cAMP, which in turn is upregulated at low glucose concentration or down-regulated at high 
glucose abundance 247.  
Consequently, by being controlled by positive activation and catabolite repression, the rhaB promoter 
system is tightly regulated 248 and tuneable 249. As for any other sugar-inducible promoter system, there are 
drawbacks by using the rhaB promoter system for recombinant gene expression. On one hand, 
monosaccharides other than L-rhamnose can activate rhaBp gene expression to a certain extend 243. On the 
other hand, L-rhamnose concentration will decrease over time followed by decreasing gene expression and 
eventually its omission in a L-rhamnose-metabolising host 243. An L-rhamnose catabolism deficient mutant 
would not only avoid decreasing gene expression, it would also enable gene expression in a truly 
concentration-dependent manner 249.  
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STUDY I – TOOL DEVELOPMENT FOR CONDITIONAL DEGRADATION OF 
SOLUBLE PROTEINS IN E. COLI 
 
1 INTRODUCTION 
Generating peptide or protein libraries and then screening those peptides or proteins for improved or 
modified characteristics has been proven to be an useful application in fundamental research as well as 
protein engineering 250. While peptide libraries can be to date routinely generated by automated  
synthesis 251, the most straightforward method of constructing a library of protein variants is still to 
construct a library of protein encoding DNA sequences from which the protein library can be subsequently 
translated 250. Many various methods have been developed until now for gene library construction with 
improved process efficiency and ever-increasing library size. Additionally, recent advances in screening 
methodologies allow screening of growing library sizes. A popular application for protein libraries has been 
the area of protein stability and protein-protein interaction 250. In the late 1980s and early 1990s, the  
N-end-rule for protein degradation in eukaryotes 48 and prokaryotes 56 was deciphered by only using 15 and 
19 cloned plasmid constructs, respectively, which only differed in the codon that encoded the outermost 
N-terminal residue of a POI. The nature of this N-terminal residue, once it became released, was shown to 
determine the proteins half-life in both domains 48,56. Protein degradation was visualised by pulse-chase 
analysis (detection of radiolabelled proteins in SDS-PAGE) 48,56,252. While the ClpAP proteasome, the key 
player for N-end rule degradation in bacteria, was soon discovered 56, its cognate adaptor protein ClpS was 
not confirmed until 2006 3. In order to systematically analyse the specificity of ClpS for proteic N-terminal 
residues, a library of 508 oligopeptide pools (13-mer) were generated and c-terminally attached to a 
cellulose membrane in a chessboard pattern 3. The peptide-bound ClpS was thereby visualised by 
immunoblotting leading to mosaic-like pattern representing ClpS-binding efficiency 3,253. A new area for 
randomising protein encoding DNA sequences emerged with the introduction of single-stranded 
oligonucleotide mutagenesis (ssDNA recombineering 254). The novelty was, that an automated synthesis of 
randomised oligonucleotides allowed complete control over library size, the nature and the position of the 
randomisation 250. Coupled with Flow-Seq, which combines Fluorescence Assisted Cell Sorting (FACS) and 
high-throughput sequencing 255, it became a powerful method to assess comprehensive data sets for 
increased understanding of physiological principles as demonstrated recently 256.  
 
With the aim for an in-depth understanding of the N-end-rule in bacteria including the modulating effects 
of neighbouring amino acids on degradation efficiency, we integrated frgfp on the E. coli K-12 MG1655 
genome including a 5’ in-frame insertion encoding for an N-terminal conditional degradation tag. The latter 
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consisted of an N-terminal degradation sequence motif for ClpAP-mediated degradation (dgClpAP) masked 
by the restriction site for the TEV protease (rsTEVP), similar to the published TIPI system 143:  
rsTEVP(F)-dgClpAP-tag (described in INTRODUCTION section 3.2.3). We used ssDNA recombineering 254 to 
change the sequence coding for the first five aa of dgClpAP. This resulted in a protein library of theoretically 
3,125 combinations. Upon TEVP-specific cleavage the randomised N-terminus of frGFP became 
conditionally accessible to ClpAP/ClpS resulting in a broad fluorescing library as visualised by FACS 
(unpublished data from Virginia Martínes, Tonja Hobel and Morten HH Nørholm). We finally pooled cells 
with the least fluorescence levels and analysed with Flow-Seq. The results only confirmed existing 
knowledge on N-end rule destabilising residues (unpublished data from Virginia Martínes, Tonja Hobel and 
Morten HH Nørholm). 
 
However, motivated about the efficacy of the experimental set-up, we then developed PROTi (protein 
interference). Referring to the literature, PROTi is the second technology in bacteria for controlled  
N-terminal degradation of soluble proteins in a ClpAP-mediated fashion 18. The idea was to engineer target 
proteins by fusing rsTEVP(F)-dgClpAP (PROTi-tag) to their N-terminus. The conditional element for PROTi is 
the inducible production of TEVP from a plasmid. Furthermore, the tool was upgraded in a second step by 
combining PROTi with CRISPRi (CRISPR interference 257), this combined technology was named CRiPi. This 
combination makes it a unique tool to control protein levels by targeting both protein biosynthesis and 
degradation. Thus, in parallel to PROTi function, an RNA-guided dCas9 endonuclease could be targeted 
specifically towards the DNA sequence coding for the PROTi-tag. For CRiPi, the production of TEVP as well 
as dCas9 was independently inducible from a plasmid. The sCas9-cognate gRNA was expressed 
constitutively from another plasmid. The author of this thesis takes only credits for the development of 
PROTi. 
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ABSTRACT
Interference with genes is the foundation of reverse
genetics and is key to manipulation of living cells for
biomedical and biotechnological applications. How-
ever, classical genetic knockout and transcriptional
knockdown technologies have different drawbacks
and offer no control over existing protein levels.
Here, we describe an efficient genome editing ap-
proach that affects specific protein abundances by
changing the rates of both RNA synthesis and pro-
tein degradation, based on the two cross-kingdom
control mechanisms CRISPRi and the N-end rule for
protein stability. In addition, our approach demon-
strates that CRISPRi efficiency is dependent on en-
dogenous gene expression levels. The method has
broad applications in e.g. study of essential genes
and antibiotics discovery.
INTRODUCTION
The combined impact of synthesis and degradation dynam-
ically determines protein levels in living cells. There is a
growing need for synthetic biology tools that can control
the abundance of specific proteins, e.g. for the fine-tuning of
enzymes in metabolic pathways or studies of essential genes
for which genetic knockouts are lethal (1). Existing meth-
ods typically focus either on genetic knockouts, conditional
repression of transcription or direct interference with pro-
tein function or stability. However, a combination of these
approaches is desirable to achieve amore controllable, rapid
or stronger repression of the amount of selected proteins in
the cell. Furthermore, for conditional removal of proteins,
stability is a key factor even in fast-growing microbes such
as yeast where the majority of proteins are very long-lived
(2).
Given the recent rapid development in synthetic biology
and genome editing technologies, we asked to what extent it
was possible to harness generic molecular mechanisms for
simultaneously controlling both protein synthesis and sta-
bility. To this end we first looked for a cross-kingdom pro-
tein regulatory mechanism. The N-end rule states that the
identity of the N-terminal residue (N-degron) of a protein
is a prime determinant of its half-life across all kingdoms
of life (3). Conveniently, the tobacco etch virus (TEV) pro-
tease can accommodate most amino acid residues in the P1’
position following the cleavage site (ENLYFQ↓X, where X
denotes all amino acids except proline) and thus this small
recognition site can mask an N-degron (4,5), and we noted
that the N-terminal location enables simultaneous manipu-
lation of the translational initiation region (TIR) - a region
surrounding the start codon that has a major impact on
gene expression levels (6,7). This enables manipulation of
both protein degradation and translation initiation, which
is important when manipulating essential genes as shown
later.
The CRISPR–Cas9 system enables cutting of very spe-
cific DNA sequences in a wide variety of living organisms
and has revolutionized our ability to edit genetic informa-
tion (8). The system has also been repurposed to regulate
transcription––e.g. to activate (9) or repress gene expres-
sion in e.g. Escherichia coli (10), Bacillus subtilis (11), hu-
man cells (12) and Saccharomyces cerevisiae (13) in a gen-
eral approach known as CRISPR interference (CRISPRi).
CRISPRi is based on a catalytically inactive Cas9 endonu-
clease (dCas9), which can interfere with transcription by
binding to specific DNA sequences with the aid of a guide
RNA. However, the efficiency of CRISPRi-based systems
is affected by endogenous gene expression levels (9). Thus,
concomitant manipulation of endogenous gene expression
levels may expand the applicability of CRISPRi. Here, we
develop a single workflow that combines conditional pro-
tein degradation with CRISPRi and TIRmanipulation and
apply the system to study essential genes and develop strains
hypersensitive to antibiotics.
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MATERIALS AND METHODS
Plasmid construction
The pPROTi plasmid resulted from a triple PCR-fragment
assembly via USER cloning, as described previously (14).
For further details on all the plasmids described here
see Supplementary Table S1. We amplified the pSEVA33
backbone, the L-rhamnose inducible promoter PrhaBAD,
and the S219D mutant of TEV protease from pSEVA331
(15), pKS1 (16) and pKM586 (17) with the oligonucleotides
oMSB1270/1267, oMSB1268/1269 and oMSB1271/1273,
respectively. For further details on all the oligonucleotides
described here see Supplementary Table S2. The pMAZ-
SK plasmid with different guide RNAs used to PROTi
tag essential genes by CRMAGE were constructed by
USER cloning (18). This was done by mixing two annealed
oligonucleotides that were complement to the amplified
pMAZ-SK backbone after USER treatment, as described
previously (19). Specifically, for the genes accD, fabG, ftsZ,
glmS, ileS, murE, pheS, ribD, prfB, rnpA, tmk, acpS, ispH,
murA, dapE, lpxC and ribE, the oligonucleotide pairs
oMSB2565/2566, oMSB2591/2592, oMSB2569/2570,
oMSB2571/2572, oMSB2573/2574, oMSB2575/2576,
oMSB2577/2578, oMSB2593/2594, oMSB2579/2580,
oMSB2583/2584, oMSB2585/2586, oMSB2750/2551,
oMSB2740/2741, oMSB2742/2743, oMSB2748/2749,
oMSB2744/2745 and oMSB2746/2747 were used, re-
spectively. To construct the pCRiPi plasmid, the pPROTi
plasmid was PCR amplified using the oligonucleotide pair
oMSB1865/2312, and the dCas9 gene (including the aTc
promoter and the terminator) was amplified from pdCas9
with the oligonucleotides oMSB2313/oMSB1866. For
construction of the pgRNA-CRiPi plasmid targeting the
PROTi tag for the CRiPi system, the pSLQ1236 (Sup-
plementary Table S1) was used as backbone. The gRNA
was changed by standard Gibson assembly (20) with
oligonucleotides oSONG145/146. Nucleotide sequences of
pPROTi, pCRiPi and pgRNA-CRiPi are provided in the
supplementary information.
Bacterial strains, media and growth conditions
The parental strain for all experiments was E. coliMG1655
(ATCC 47076). E. coli MG1655 with GFP integrated into
the genome (21) was initially used to tag gfp first by re-
combineering (22) with the ssDNAMAGE oligonucleotide
oMSB1277 and then with the ssDNA MAGE oligonu-
cleotides oMSB1275 (unstable GFP variant with pheny-
lalanine as the N-degron) or oMSB1276 (stable GFP vari-
ant with alanine). These two GFP variants were used as
PCR templates to add the IPTG inducible T5 promoter
with the oligonucleotides oMSB1661 and oMSB1662. Af-
ter, T5-GFP variants were integrated into the E. coli
MG1655 genome by clonetegration (23), using pOSIP-KT,
and the oligonucleotides oMSB1297 and oMSB1298. FLP-
mediated excision was performed as previously described
(23). All E. coli strains were grown in lysogeny broth (LB)
at 37◦C shaking at 300 rpm. The antibiotics ampicillin (100
!g/mL), chloramphenicol (30 !g/ml) or kanamycin (50
!g/ml) were added when needed. gfp expression was in-
duced with 0.1 mM IPTG; tev protease expression was in-
duced with 5 mM rhamnose; and dCas9 endonuclease ex-
pression was induced with 200 ng/ml aTc.
Genomic integration of the PROTi tag
The PROTi tag was inserted after the first codon down-
stream of the start codon in genes of interest, according
to the previously described CRMAGE protocol (19).
The starting strain for CRMAGE was MG1655 K-12
harboring the pMA7CR 2.0 and pZS4Int-tetR plasmids.
The pMA7CR 2.0 plasmid expresses the Cas9 nuclease,
the "-red #-proteins and the dam protein that represses
the mismatch DNA repair system for obtaining higher
genome editing efficiency (19) 5!M of ssDNA CRMAGE
oligonucleotide and 250 ng of pMAZ-SK plasmid with in-
serted gRNA were used for electroporation. Cultures were
grown at 37◦C in Julabo SW22 linear-shaking water-bath
at 250 rpm. After aTc addition to express Cas9 according
to the previously published protocol (19), recovery was per-
formed overnight. The ssDNA CRMAGE oligonucleotide
contained 35–45 nucleotide end homology on each side of
the insertion. For each gene, a PAM sequence (5′-NGG-3′)
and the adjacent gRNA (20 nucleotides) were chosen
in the coding sequence. The pMAZ-SK plasmids with
inserted gRNA were constructed as described above. One
nucleotide in the PAM sequence was changed in the ssDNA
CRMAGE oligonucleotide to avoid Cas9 recognition of
mutants with the inserted PROTi tag. Randomization of
the TIR was done by changing the specific nucleotides in
the ssDNA CRMAGE oligonucleotide used for insertion
of the PROTi tag. For the genes accD, fabG, ftsZ, glmS,
ileS, murE, pheS, ribD, prfB, rnpA, tmk, acpS, ispH, murA,
dapE, lpxC and ribE, the ssDNA CRMAGE oligonu-
cleotides oMSB2595, oMSB2596, oMSB2597, oMSB2598,
oMSB2599, oMSB2600, oMSB2601, oMSB2651,
oMSB2602, oMSB2603, oMSB2604, oMSB2757,
oMSB2752, oMSB2753, oMSB2756, oMSB2754 were
used, respectively.
PROTi characterization
E. coliMG1655 strains containing the PROTi tagged gfp in
the genome and harboring the pPROTi plasmid, were inoc-
ulated from an overnight culture to OD600 0.01 in LB sup-
plemented with chloramphenicol and IPTG. After 4 h of
growing, the cultures were induced by adding 5 mM rham-
nose. To wash out IPTG from the culture medium before
inducing with rhamnose, the cultures were centrifuged and
resuspended in the same volume of LB with chlorampheni-
col and rhamnose. After 1–4 h, cultures were analyzed in a
SynergyMx Microplate reader from Biotek. For GFP flu-
orescence quantification, emission was detected at 512 nm
with the excitation light of 480 nm and 80 level gain.
Flow cytometry
Flow cytometry measurements were performed on a FACS
Aria (Becton–Dickinson, San Jose, USA) with 488 nm exci-
tation from a blue solid-state laser. Cells were diluted 1:100
in PBS for analysis. At least 20 000 cells were collected
for each measurement. FlowJo (Treestar) was used for data
analysis.
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Growth profiles
Growth was monitored in the BioLector® from m2p-labs.
Each of the tagged PROTi clones were diluted 1:100 in 1
ml LB supplied with appropriate antibiotics in a Flower-
Plate (48-well MTP, flower) for the BioLector®. Cultures
were induced with rhamnose and aTc from the beginning
of growth and grown at 37◦C, shaking at 1200 rpm.
CFU assays and drop tests
To determine colony forming units (CFU), cultures of
PROTi tagged essential genes harboring the pPROTi plas-
mid were inoculated in 1 ml LB supplied with chloram-
phenicol and rhamnose in a 96-well microtiter plate. After 4
h of growth, cultures were plated on LB agar plates in serial
dilutions. For the CRiPi system, cultures were inoculated in
1 ml LB supplied with chloramphenicol and ampicillin and
grown for 4 h. The CRiPi system was induced with rham-
nose and aTc and the cultures were grown for additional 4 h
before plating. For drop tests, overnight cultures of tagged
essential gene variants were diluted to the same OD and 10-
fold serial dilutions were performed. From each dilution, 10
!l were placed on LB agar plates with appropriate antibi-
otics.
Fosfomycin sensitivity
Fosfosmycin sensitivity was determined with minimum
inhibitory concentration (MIC) assays as previously de-
scribed (24). Stock solution of fosfomycin disodium (Sigma
Aldrich) salt was dissolved in MiliQ water (1 mg/ml).
Briefly, 2-fold serial dilutions of antibiotic stocks (from
0.015 to 256 g/l) were made in 150 !l LB medium sup-
plemented with the appropriate antibiotics, rhamnose and
aTc (for CRiPi-induction) and OD after 18 h was deter-
mined and plotted relative to the growth of the same cells in
the absence of fosfomycin. For testing fosfomycin sensitiv-
ity upon PROTi induction, cultures of murE1-tagged cells
harbouring the CRiPi system were inoculated in 1 ml LB
supplied with chloramphenicol, ampicillin and rhamnose in
a 96-well microtiter plate. After 4 h of growth, cultures were
plated on LB agar plates supplied with different concentra-
tions of fosfomycin.
RESULTS
We first engineered a pro-N-degron module by incorporat-
ing the corresponding nucleotide sequence at the 5′ end
of a gene on the E. coli chromosome using CRMAGE
genome editing (19). The pro-N-degron module consists of
a seven amino acid peptide recognition site of the tobacco
etch virus (TEV) protease (ENLYFQ↓F) (5) and an eleven
amino acid-linker (25). In the presence of TEV protease, the
peptide is cleaved and an N-end-rule substrate is generated
with phenylalanine as the prime protein-destabilizing factor
(Figure 1A). Importantly, the entire coding sequence for the
pro-N-degron module is small enough to fit into a standard
oligonucleotide compatible with CRMAGE.With this pro-
tein interference (PROTi) system, by rhamnose-inducible
expression of the TEV protease from a plasmid, the N-
degron becomes de-protected and the protein is targeted for
proteasomal degradation through the N-end rule pathway.
To characterize the system, the PROTi tag was fused to
the N-terminus of GFP by integrating the coding sequence
into the E. coli genome with a synthetic IPTG-inducible
T5 promoter (Figure 1A). In the resulting strain, GFP pro-
duction was induced by adding IPTG followed by growth
for four hours. At this stage, expression of the TEV pro-
tease was induced with rhamnose. Three hours after ad-
dition of rhamnose, GFP levels showed a strong decrease
(83%––measured by whole cell fluorescence) compared to
the uninduced control (Figure 1B). Further characteriza-
tion of the system by flow cytometry revealed a broad pop-
ulation of cells with different fluorescence levels upon in-
duced protein degradation (Figure 1C), which we hypoth-
esized was caused by simultaneous strong GFP synthesis
driven by the T5 promoter.Washing out IPTG from the cul-
ture medium prior to the induction of the PROTi system
with rhamnose confirmed this hypothesis as it resulted in a
homogeneous non-fluorescent population (Figure 1D). The
reduction in GFP fluorescence can be ascribed to the gen-
erated N-degron, since GFP fluorescence remained high in
cells harboring a stable PROTi tag variant, with the pheny-
lalanine of the N-degron replaced by an alanine (Figure
1D).
The fact that protein abundance is a function of both syn-
thesis and stability prompted us to turn to the broadly ap-
plicable CRISPR–Cas9-based gene regulation technology.
With the aim of gaining control over both transcription and
protein stability with a single genome-editing step, we devel-
oped a CRISPRi–PROTi (CRiPi) system, where dCas9 can
be produced together with the TEV protease (Figure 2A),
thereby enabling simultaneous inhibition of gene expression
as well as degradation of the target protein.
Based on previous studies, the gRNA was designed to
bind to the non-template DNA in the 5′ end of the gene,
and dCas9was expressed from a plasmid with an anhydrous
tetracycline (aTc)-inducible promoter (10). Moreover, we
designed the gRNA so that it only targets the CRMAGE-
inserted sequence, which encodes the TEVprotease recogni-
tion site and the N-degron-linker, thereby creating a generic
gRNA target independent from the site of insertion (Figure
2A).
As shown in Figure 2B, cellular depletion of GFP was
rapidly achieved with high efficiency when the CRiPi sys-
tem was induced with both rhamnose and aTc. Specifically,
76% of the cells showed complete loss of fluorescence after
two hours of induction. In contrast, the induction of dCas9
expression alone caused only a slightly reduced GFP fluo-
rescence, denoting the high stability of GFP (Figure 2B).
The technology described above is particularly useful for
analysis of genes that are essential for the organism and thus
inaccessible with traditional knockout approaches. Thus,
to further demonstrate the functionality of the system, we
compared the effectiveness of the PROTi, CRISPRi and
CRiPi technologies to control the level of proteins encoded
by essential genes in E. coli. In a previous approach all es-
sential genes in E. coli were individually targeted with a se-
quence encoding a C-terminal protein degradation tag (mf-
ssrA) but 67 proteins could not be tagged this way despite
repeated attempts (26). We noted that 54 of these 67 ‘inac-
cessible’ genes were part of operons, making lethal polar ef-
fects a likely explanation. Thus, the N-terminal location of
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Figure 1. PROTi:Development and characterization of the PROTi system to control protein abundances. (A) Schematic illustration of the PROTi system.
The coding sequence for the pro-N-degron module (orange) is integrated by CRMAGE at the 5′-end of a genomically integrated gfp (green). gfp is under
control of the IPTG-inducible T5 promoter. With PROTi, the TEV protease (blue) is expressed from the PrhaBAD promoter leading to de-protection of
the N-degron followed by degradation of GFP (green) through the N-end rule pathway. (B) Whole-cell fluorescence measurement of cells expressing GFP
tagged with the pro-N-degron––with and without the PrhaBAD inducer rhamnose (Rham). Data represents the average of three biological replicates and
bars show the standard error. (C) Flow cytometry histogram displaying the fluorescence signals after 0, 2, 3 or 4 h induction with rhamnose or without
induction (Ø). (D) Fluorescence signals after 3 h of PROTi induction with rhamnose, while removing the IPTG inducer from the culture medium by
washing. A stable PROTi tag with alanine (Ala) replacing phenylalanine was included as control.
the PROTi tag could enable the targeting of some of these
essential genes and since the inserted module overlaps with
the TIR, expression tuning by nucleotide variation in this
region could minimize polar effects caused by e.g. changes
in translational speed.
Using CRMAGE, we attempted targeting of ten essen-
tial genes that were not previously mf-ssrA-tagged (glmS,
ileS, murE, pheS, ribD, tmk, accD, prfB, fabG and rnpA)
and seven that were previously mf-ssrA-tagged (ftsZ, acpS,
ispH, murA, dapE, lpxC and ribE) (26) using the pro-N-
degron module designed with a TIR library made of six
random nucleotides upstream from the start codon and all
synonymous codons sampled in two positions following the
start codon (Figure 3A). Remarkably, this way we were able
to identify insertions in seven of the 10 genes that were not
previously mf-ssrA-tagged, despite their location in essen-
tial operons––as well as three out of the seven previously
mf-ssrA-tagged genes (Supplementary Table S3). Not sur-
prisingly, we also noted a high variability in colony size di-
rectly after CRMAGE, and in cell viability assays (Supple-
mentary Figure S1), as a directly observable consequence of
the TIR variation. This is highly useful both for gauging the
success rate of CRMAGE and when searching for variants
with wild type gene expression levels. For example, for ileS,
11 small colonies were screened by colony PCR and all had
the PROTi tag inserted. From 12 big colonies, 11 were neg-
ative. For the rnpA gene, five out of 12 small colonies were
positive, whereas 10 out of 11 of the big colonies were not
tagged.
To demonstrate the value of the TIR variation approach,
for five of the genes (murE, pheS, rpnA, ileS and ribD), we at-
tempted to insert the corresponding sequences without TIR
variation – preserving the six nucleotides upstream from the
start codon from the native gene context. For three of these
genes we were unable to isolate tagged clones, indicating a
lethal effect, whereas we could isolate clones with the ileS
and rnpA genes tagged (Figure 3B and C). However, these
clones clearly exhibited growth defects both directly after
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Figure 2. CRiPi: Schematic illustration of the CRISPRi-PROTi (CRiPi) system. (A) Cellular depletion of the targeted protein can be accelerated by simul-
taneous expression of dCas9 (red) from the Ptet promoter and the TEV protease (blue) from the PrhaBAD promoter. Here shown for gfp as an example.
The dCas9 targets the genomically integrated pro-N-degron encoding sequence with the aid of a guide RNA (gRNA, brown, curved line) and represses
transcription. (B) Fluorescence after 3 h of PROTi, PROTi and wash, CRISPRi, or CRiPi induction with rhamnose and the Ptet inducer anhydrous
tetracycline (aTc), or with no induction (Ø).
CRMAGE and in subsequent viability tests (Figure 3B and
C). In contrast, using the TIR randomization approach, we
were able to isolate tagged gene variants without any ob-
servable growth defects.
After having obtained both growth-affected and unaf-
fected PROTi-tagged gene variants, we moved on to study
the CRiPi system, by inducing protein degradation and/or
gene silencing. Most of the strains were unaffected in
growth in liquid cultures after PROTi induction with rham-
nose (Supplementary Figure S2). In fact, rhamnose had a
small stimulatory effect on growth in several cases (Supple-
mentary Figure S2). However, the tagged murE, ribD and
pheS strains exhibited 1–2 orders of magnitude decrease in
viability when plating the cells after PROTi induction (Fig-
ure 3D) and most of the strains showed growth retardation
after CRISPRi induction with aTc (Supplementary Figure
S2). Only the taggedmurE strain showed a clear effect when
inducing PROTi directly in liquid culture (Figure 3E). Of
the two approaches utilized in the CRiPi method, CRISPRi
had the strongest overall effect (Supplementary Figure S2).
However, for the ileS and pheS-strains the repression of
growth after plating was clearly enhanced by simultaneous
targeting of both transcription and protein stability (Fig-
ure 3F), thereby showing the versatility and strength of the
CRiPi method.
To demonstrate the relevance of CRiPi and PROTi for
applied biotechnology, we explored its performance as a
tool for creating antibiotic hypersensitive strains for use
in antibiotic discovery. When screening large compound
libraries it is challenging to supply sufficiently high con-
centrations of each compound, which leads to false neg-
atives in the screen. Lowering the concentration of essen-
tial protein targets, enable high-throughput screening with
sub-inhibitory drug concentrations and discovery of com-
binatorial drugs and targets (27). We focused on MurE, a
central enzyme in peptidoglycan biosynthesis (Figure 3G).
When CRiPi or PROTi were induced in cells harboring
PROTi-tagged MurE, a significant decrease in viability was
observed (Figure 3D and H). We next demonstrated murE
as a potential target for creating hypersensitive strains that
can be used for screening compound libraries to identify
agents with antibacterial activity. Fosfomycin is an antibi-
otic that causes specific inhibition of the enzyme MurA,
which is involved in the same peptidoglycan biosynthetic
pathway as MurE (Figure 3G). By applying fosfomycin to
cells with an induced CRiPi or PROTi system targeting
MurE, the sensitivity to the antibiotic increased, depicted as
complete growth inhibition at lower concentrations of the
antibiotic, compared to the non-induced control (Figure 3I
and Supplementary Figure S3). Moreover, fosfomycin sen-
sitivity varied markedly in clones with different murE-TIR
backgrounds upon induction of CRiPi (Figure 3I and Sup-
plementary Figure S4).
DISCUSSION
Our approach has some limitations: N-terminal peptide
tagging of essential proteins may not always be allowed as
the tag itself could compromise activity. Furthermore, when
attached to some proteins, TEV cleavage or subsequent tar-
geting to the ClpP protease may not be efficient. However,
PROTi could serve as a complement to other protein desta-
bilizing technologies (e.g. proteins that are compromised by
C-terminal tagging). Here, we were able to target 7 out of 10
proteins that previously had failed with a C-terminal desta-
bilizing tag approach. It is possible that an even higher suc-
cess rate could be obtained with additional screening efforts
(and almost certainly for targeting of non-essential genes).
Four out of these seven proteins (encoded by murE, ribD,
ileS and pheS) were sensitive to induction of PROTi.
CRISPRi generally had the highest growth-effect on es-
sential genes, compared to PROTi, possibly due to the re-
duced affinity of TEV protease with the N-end rule sub-
strate Phe in the P1’ position (5) or because essential protein
depletion is compensated for by gene expression upregula-
tion. The approach could potentially benefit from increas-
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Figure 3. PROTi, CRiPi and TIR randomization can control protein levels and produce antibiotic hypersensitive bacteria. (A) Randomization of the
translation initiation region (TIR, red font) in a ssDNA oligonucleotide enables CRMAGE-based insertion of the PROTi tag (orange) containing the TEV
protease recognition site (blue) in genes of interest (GOI). (B) CRMAGE cultures plated directly after insertion of the PROTi tag in ileS (left) and rnpA
(right) genes without TIR variation. Note the presence of both small and large colonies. The small colonies contained the PROTi tagged gene variants, as
verified by colony PCR. (C) Drop tests of cells with ileS and rnpA tagged with and without TIR variation (rt: randomized TIR, nt: non-random TIR). TIR
region sequences are indicated next to the different drop test lanes - red font indicates nucleotides different from the wild type sequence, blue font highlights
the TEV protease recognition site and the start codon is highlighted in green. (D) Viability of control strain (WT with the PROTi plasmid) and PROTi
variants tagged in the essential E. coli genes murE, ribD and pheS with and without rhamnose (Rham) induction. (E) Growth profile of murE-rt1 cells
carrying the PROTi system with and without Rham induction. (F) Agar plates illustrating the effect of ileS- and pheS-tagged cells with CRISPRi (aTc),
PROTi (Rham) or CRiPi (aTc + Rham) induced after 4 h and plated after an additional 4 h of growth. Without inducers (Ø) growing bacteria completely
cover the plate. (G) Illustration of the Mur enzymes involved in peptidoglycan biosynthesis pathway. (H) Growth profile of uninduced murE-rt1 cells (Ø)
or induced with Rham and/or aTc. (I) Fosfomycin sensitivity upon CRiPi induction in murE-tagged clones or no induction (Ø). Growth was tested in
increasing concentrations of fosfomycin after 18 h incubation. All values are the averages of three biological replicates and bars show standard error.
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ing the in vivo TEV protease activity, or by increasing the
activity of the endogenous ClpA/P/S factors as shown pre-
viously in a similar system (29).
We were initially surprised by the almost complete lack
of effect of PROTi in log phase cultures whereas subsequent
plating resulted in several orders of magnitude reduction in
growth for some of the PROTi targeted essential gene prod-
ucts. A similar observation was made recently in a high-
throughput targeting of essential genes with CRISPRi in B.
subtilis (11). There, it was suggested that (essential) protein
levels are important for outgrowth from stationary phase,
whereas maximal growth rate in log phase is less affected. It
is possible that our CRISPRi system is more efficient than
the one described for Bacillus, whereas the weaker effect of
PROTi more resembles the Bacillus CRISPRi efficiency.
By inserting the sequence as a TIR variation library it is
possible to create expression variants that can be screened
with minimal polar effects, mimicking the natural gene ex-
pression level. Furthermore, some of the TIR variants, e.g.
rnpA-rt1 and rnpA-rt1 (Supplementary Figure S2) ormurE-
rt1 and murE-rt2 (Figure 3H and Supplementary Figure
S2) varied significantly in their sensitivity to CRISPRi, pro-
viding further support for the relationship between gene
expression and CRISPRi efficiency (9). Thus, this type of
multi-level reverse genetics toolmay further expand the util-
ity of the highly successful CRISPR/Cas system.
Bacterial antibiotic resistance is rapidly exhausting the
number of available effective antimicrobial agents. Con-
sequently, there is an urgent need to identify new target-
specific inhibitors to develop antimicrobial compounds
(28). With our combined CRiPi approach, insertion of a
simple and inexpensive oligonucleotide enables subtle tun-
ing of potential antibiotic targets on both the transcrip-
tional and posttranslational level. Furthermore, the system
represents a unique and versatile workflow that may enable
future in-depth characterization of essential genes located
in operons.
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STUDY II – TOOL DEVELOPMENT FOR CONDITIONAL DEGRADATION OF 
MEMBRANE PROTEINS IN E. COLI 
 
1 INTRODUCTION 
In the early of Study I, ssDNA recombineering 254 and Flow-Seq 255 have been successfully implemented as 
a combinatorial methodology for a comprehensive understanding on N-end rule degradation criteria in 
bacteria. Even though no new insights could be gained, existing criteria of the bacterial N-end rule 52,56 
based on the outermost N-terminal peptide sequence composition of ClpAP/ClpS substrate proteins could 
be validated in a comprehensive manner (unpublished data from Virginia Martínes, Tonja Hobel and 
Morten HH Nørholm). The discovery of the apparent MP-specific N-terminal degradation sequence motif 
of YfgM (YfgMaa1-14 alias dgFtsH; INTRODUCTION section 3.2.2) by BITTNER et al. (2015) 2 seemed ideal to apply 
thereon the combinatorial ssDNA recombineering/Flow-Seq as a proof-of-concept study. The aim was to 
shed more light on the physiological principles of IMP proteolysis, in general, by deciphering sequence-
specific physiological principles of FtsH-mediated IMP proteolysis, taken as first main objective upon 
starting this study. The second objective of this study was the development of a tool for conditional FtsH-
dependent degradation of IMPs by using dgFtsH as transferable N-terminal degradation sequence motif.  
However, it was crucial to test first whether and to what extend the PROTi technology from Study I was 
applicable to FtsH-mediated membrane protein degradation, and second, if a screening methodology with 
FR proteins was suitable in this context. Unfortunately, due to the accumulation of recurring technical 
obstacles, only marginal aspects of the project’s objectives could be touched upon. Therefore, the following 
section will focus primarily on exposing the first attempts to clarify the methodological basis of the project. 
On a side note, our data demonstrated most surprisingly that L-rhamnose, as inducer for rhaBp was able to 
de-repress – to a certain extent – LacI repression of LacI-based promoter systems. This peculiarity has been 
seemingly neglected by the scientific community until now, supporting that all caution should be exercised 
when combining both L-rhamnose- and LacI-regulated promoters in a single cell. 
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2 MATERIAL AND METHODS 
2.1 Strains, media and growth conditions 
All E. coli strains used in this study are listed in Table 5. E. coli NEB 5-α and NEB Turbo (both from New 
England Biolabs (NEB), Ipswich, MA, USA) were used for cloning and propagation of the plasmids. The K-12 
strains ssp. MG1655 and its lDE3 lysogen, MG1655 (DE3), were used unmodified or engineered for 
expression experiments (Table 5). Chemical competent cells of all strains were obtained as described 
elsewhere 258. Electro-competent cells were prepared with sequential pelleting and resuspension of the 
cells with ice-cold MQ water. The strains were generally cultivated in lysogeny broth (LB) 259,260 with shaking 
(250 rpm) or on LB agar plates at 30 °C or 37 °C depending on the application. LB and LB agar were 
supplemented with antibiotics when required. If not stated otherwise, MG1655 (DE3) strains were 
cultivated on LB plates supplemented with 0.5 % (w/v) glucose when transformed with plasmids harbouring 
LacI-dependent promoters. Similarly, the LB media for such strains also contained 0.5 % (w/v) glucose 
during pre-culturing (overnight) prior to expression conditions. LB media and agar plates contained 
antibiotics if required.  
 
Table 5: Overview about strains and genotypes used in Study II. 
STRAIN NAME GENOTYPE COMMENT REFERENCE 
NEB 5-α (NEB) fhuA2 Δ(argF-lacZ)U169 phoA glnV44 Φ80 
Δ(lacZ)M15 
Cloning strain. DH5α™ 
(Invitrogen) derivative.  
K-12 strain. 
NEB 
NEB Turbo (NEB) F' proA+B+ lacIq ∆lacZM15 / fhuA2  
∆(lac-proAB) glnV galK16 galE15  
R(zgb-210::Tn10)TetS endA1 thi-1  
∆(hsdS-mcrB)5  
Cloning strain. K-12 
strain. 
NEB 
MG1655 F- λ- ilvG- rfb-50 rph-1  Expression strain. Wild-
type K-12 strain which 
was sequenced. 
181 
MG1655 (DE3) F- λ- ilvG- rfb-50 rph-1  
Ω[lacUV5p/T7 gene 1] 
Expression strain with 
genome-integrated 
lDE3 cassette. 
 
MG1655Ω[T5p/rsTEVP(A)-dg#ClpAP-
frGFP]  
F- λ- ilvG- rfb-50 rph-1  
tRNIleY::[T5p/rsTEVP(A)-dg#ClpAP-frgfp] 
Expression strain with 
genomic integration of 
the coding sequence of 
a frGFP fusion variant 
(stable frGFP). 
Study I 
MG1655Ω[T5p/rsTEVP(F)-dgClpAP-frGFP]  F- λ- ilvG- rfb-50 rph-1 
tRNIleY::[T5p/rsTEVP(F)-dgClpAP-frgfp] 
Expression strain with 
genomic integration of 
the coding sequence of 
a frGFP fusion variant 
(unstable frGFP). 
Study I 
 
If applied, antibiotics were used in the following concentrations: kanamycin (50 µg/mL) and 
chloramphenicol (50 µg/mL). All pre-cultures (overnight) were inoculated from fresh colonies and 
cultivated shaking at 37 °C. The volumes of the precultures depended on the following application and 
ranged 0.5 to 10 mL. Generally, expression cultures were inoculated with a calculated OD600nm of 0.01 which 
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corresponded approximately to a dilution of 1:100 of the preculture. Furthermore, all expression 
experiments were performed by using either re-usable polypropylene square 24-deep well (DW) 
microplates or polypropylene square 96-DW microplates and their re-usable cognate sandwich covers 
(EnzyScreen, MB Heemstede, Netherlands).  
 
2.2 Plasmids and plasmid construction 
Plasmid construction was performed essentially using PCR-based uracil excision (USER) cloning for multi-
fragment assembly 261. Uracil-excision based site-directed mutagenesis (U-SM) 7 was applied for site-
specific integration of short sequences into plasmid DNA. All oligonucleotides (APPENDIX Table S 1) for PCR 
were purchased from Integrated DNA Technologies (IDT, Coralville, IA, USA). The PCR fragments for USER 
cloning were generated with the Phusion U Hot Start polymerase (Thermo Fisher Scientific, Waltham, MA, 
USA). All plasmids were isolated using QIAprep Spin Miniprep Kit (Qiagen, Hilden, Germany) and the PCR 
fragments were purified using NucleoSpin® Gel and PCR clean-up Kit (Macherey and Nagel, Düren, 
Germany). Each constructs’ identity and sequence integrity upon cloning were checked by sequencing of 
the full sequence between both the 5’ and 3’ ends. 
An overview about the plasmids used in this study is given in Table 6. A detailed description of the 
constructed plasmids will follow below. 	 
Table 6: Cloning and expression plasmids used in Study II. The protein which can be produced from each plasmid 
is shown in bold letters within the brackets (excluding N-terminal or C-terminal attachments). STOP codon (*); 
gBlock endings (/). 
PLASMID ABBREVIATION RELEVANT 
CHARACTERISTICS 
COMMENT REFERENCE 
pSEVA47Ω[T5p/rsTEVP(*)-frGFP]  pSC101, Sm/SpR template Camilla Krogsgaard 
pMA-TΩga[T7p/His-rsTEVP(S)-sfGFP] pMSB0881 ColE1, AmpR template Sara Petersen Bjørn 
rsTEVP(M)-dgFtsH-CreiLOV pMSB1226 gBlock (IDT) template Study II 
rsTEVP(M)-dgFtsH-phiLOV  pMSB1227 gBlock (IDT) template Study II 
reTEVP(M)-torA-EcFbFP pMSB1228 gBlock (IDT) template Study II 
pEnvZΩga[lacZp/NavZ1-V5]  ColE1, AmpR, lacI template Roger Draheim 
pSEVA33Ω[rhaBp/TEVP] pPROTi pBBR1, CmR  Study I 
pSEVA33Ω[rhaBp/TEVP-His] pPROTi -His pBBR1, CmR  Study II 
pSEVA33Ω[T7p/MCS]  pBBR1, CmR control Daniel C. Volke 
pCOLADuetTM-1 pCOLA ColE1, KanR, lacI control Novagen 
pCOLAΩ[T7p/rsTEVP(M)-dgFtsH-sfGFP-His]  ColE1, KanR, lacI  Study II 
pCOLAΩ[T7p/rsTEVP(M)-dgFtsH-CreiLOV-His]  ColE1, KanR, lacI  Study II 
pCOLAΩ[T7p/rsTEVP(M)-dgFtsH-phiLOV2.1-His]  ColE1, KanR, lacI  Study II 
pCOLAΩ[T7p/rsTEVP(M)-dgFtsH-EcFbFP-His]  ColE1, KanR, lacI  Study II 
pCOLAΩ[T7p/rsTEVP(M)-dgFtsH-navZ1-CreiLOV-His]  ColE1, KanR, lacI  Study II 
pCOLAΩ[T7p/rsTEVP(M)-dgFtsH-navZ1-sfGFP-His]  ColE1, KanR, lacI  Study II 
pCOLAΩ[T7p/rsTEVP(M)-dgFtsH-yhaI-phiLOV2.1-His]  ColE1, KanR, lacI  Study II 
pCOLAΩ[T7p/rsTEVP(M)-dgFtsH-yhaI-CreiLOV-His]  ColE1, KanR, lacI  Study II 
pCOLAΩ[T7p/rsTEVP(M)-dgFtsH-yhaI-sfGFP-his]  ColE1, KanR, lacI  Study II 
pCOLAΩ[T7p/rsTEVP(M)-dgFtsH-ppiD-EcFbFP-His]  ColE1, KanR, lacI  Study II 
pCOLAΩ[T7p/rsTEVP(M)-dgFtsH-ppiD-sfGFP-His]  ColE1, KanR, lacI  Study II 
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Construction of the pPROTi plasmids 
Two TEVP encoding plasmids were used. The pPROTi plasmid, described in Study I (5622bp) consisted of 
the high-copy pSEVA33 backbone (pBBR1 ori, CmR). It carried the TEVP-S219D-encoding tev gene under the 
control of the L-rhamnose-inducible promoter rhaBp. A second plasmid was constructed as follows: a 
sequence coding for a [(GGS)3GG-(His)8]-tag was inserted as gene-fusion at the 3´-end in frame with tev in 
pPROTi via whole plasmid synthesis and U-SM 7 by using the primer pair oMSB3268/oMSB3269, resulting 
in the pPROTi-His plasmid. 
Construction of the pCOLAΩ[T7p/rsTEVP(M)-dgFtsH-MP-FR-His] plasmids 
The cloning strategy was re-adjusted multiple times. The initial cloning of the MP-FR fusions (including a N-
terminal FtsH-specific degradation tag and a C-terminal (His)8 epitope) in the low-copy pSEVA47 (pSC101 
replicon, Sm/SpR) combined with the IPTG-inducible T5p failed systematically even in an E. coli NEB Turbo 
background (Table 5), due to apparent leakiness of the T5p and possible protein toxicity. Eventually cloning 
was successful in NEB 5-α cells with a pCOLA backbone (ColA replicon, KanR, lacI) artificially stripped of its 
promoter (Table 5). We created here a small library of pCOLAΩ[-/MP-FR-His] plasmids using PpiD, NavZ1 or 
YhaI (as MP target proteins) and sfGFP, CreiLOV, phiLOV2.1 or EcFbFP (as FR-tags), respectively. This was 
done in multiple steps where we re-used primers and PCR fragments from previous cloning attempts. 
  
(1) Creating a pCOLA template that incorporates the N-terminal rsTEVP of the degradation tag  
and the C-terminal His-epitope 
The pCOLA backbone, harbouring the replicon and the resistance cassette, and a small fragment encoding 
for rsTEVP ([rsTEVP(*)-frGFP]) were amplified from pCOLADuetTM-1 (Novagen) and 
pSEVA47Ω[T5p/rsTEVP(*)-frGFP] (Camilla Krogsgaard, unpublished) with the primer pairs 
oMSB3151/oMSB3152 and oMSB3257/oMSB3258, respectively. The two PCR fragments were assembled 
by USER cloning, resulting in pCOLAΩ[-/rsTEVP(*)-frGFP-His], referred to as template1.  
 
(2) Integration of the encoding sequences for [dgFtsH-FR] modules 
The DNA sequences coding for dgFtsH-EcFbFP, dgFtsH-phiLOV2.1 and dgFtsH-CreiLOV were ordered as 
gBlock® gene fragments from IDT (Coralville, IA, USA). The nucleotide sequence for EcFbFP has been 
published recently 220 and those for phiLOV2.1 and CreiLOV were codon-optimized for E. coli from their 
respective peptide sequence 198,262 using JCat 263. The respective gBlocks® are listed as pMSB1228, 
pMSB1227 and pMSB1226, respectively, in Table 6. Besides, pMSB0881 (Sara Petersen Bjørn, unpublished) 
was used as template for the amplification of sfgfp. The coding sequences for phiLOV2.1, CreiLOV, EcFbFP 
and sfGFP were amplified from pMSB1227, pMSB1226, pMSB1228 and pMSB0881 with the primer pairs 
oMSB3290/oMSB2951, oMSB3289/oMSB2951, oMSB2953/oMSB3291 and oMSB3292/oMSB3293, 
respectively. The PCR fragments were USER-assembled with a pCOLA backbone PCR-fragment which 
resulted from an amplification of template1 with oMSB2233/oMSB3288. The [(*)-frGFP]-region from 
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template1 was thereby substituted with the different [dgFtsH-FR] fragments. This generated four new 
templates for subsequent integration of the MP-coding sequences: pCOLAΩ[-/rsTEVP(M)-dgFtsH-
phiLOV2.1-His] (template3), pCOLAΩ[-/rsTEVP(M)-dgFtsH-CreiLOV-His] (template4), pCOLAΩ[-/rsTEVP(M)-
dgFtsH-EcFbFP-His] (template5) and pCOLAΩ[-/rsTEVP(M)-dgFtsH-sfGFP-His] (template6).  
 
(3) Integration of the membrane protein coding genes 
For the integration of the MP encoding genes, template3, template4, template5 and template6 were then 
amplified by PCR with the primer pairs oMSB3045/oMSB3054, oMSB3045/oMSB3053, 
oMSB3045/oMSB3055 and oMSB3045/oMSB3332 to create the pCOLA backbone (bb) fragment3, 4, 5 and 
6, respectively. The navZ1 gene was amplified from pEnvZΩ[lacZp/NavZ1-V5] 5 with either 
oMSB3061/oMSB3063, oMSB3061/oMSB3062 or oMSB3061/oMSB3334 which created the compatible 
USER-overhangs for an USER assembly with the pCOLA bb fragment3, 4, and 6, respectively. Furthermore, 
the yhaI gene was amplified from genomic DNA of E. coli MG1655 (Table 5) with either 
oMSB3058/oMSB3060, oMSB3058/oMSB3059 and oMSB3058/oMSB3335 which created in turn USER-
fragments compatible with pCOLA bb fragment3, 4, and 6, respectively. Finally, genomic DNA of E. coli 
MG1655 served also as template for the ppiD gene. With oMSB3056/oMSB3057 and oMSB3056/oMSB3333 
we amplified PCR fragments thereof which were in turn USER-compatible with pCOLA bb fragment5 and 6, 
respectively. The result was an intermediate plasmid library of eight pCOLAΩ[-/rsTEVP(M)-dgFtsH-MP-FR-
His] variants without promoter. 
 
(4) Integration of T7p 
In a final step, the T7p was inserted in each resulting construct of (2) and (4) via U-SM 7 with the generic 
primer pair oMSB3336/oMSB3337. NEB 5-α (Table 5) cells were used for plasmid propagation. Eleven out 
of twelve constructs showed a correct assembly after sequencing (Table 6). pCOLAΩ[T7p/rsTEVP(M)-
dgFtsH-NavZ1-phiLOV2.1-His] could not be obtained. Due to time pressure, the experimental part was 
initiated in absence of the 12th construct. One should note that with T7p, the Shine Dalgarno sequence and 
the 5’ coding region for [rsTEVP(M)-dgFtsH] of all genes, all constructs had the same TIR.  
 
2.3 Methods and technical details 
If not indicated otherwise all chemicals were ordered from Sigma Aldrich (St. Louis, MO, USA). 
Measurement of cell biomass and fluorescence 
Cell biomass (optical density, OD, 600nm) and fluorescence data (lEx = 485nm, lEm = 528nm; gain 100) were 
collected as end-point measurements from 200 µL aliquots of culture broth in optical 96-well microplates 
(flat-bottom; Greiner Bio-One, Kremsmünster, Austria) in a MX plate reader (Biotek, Winooski, VT, USA) 
 75 
without path length correction. If needed, cultures were diluted with peptone saline solution 264 consisting 
of 0.1 % casein peptone and 0.85 % (w/v) NaCl.  
Replacing the growth medium of bacterial cultures 
24-DW plates with bacterial cultures were spun at 4818 x g and 4 °C for minimum of 20 min in a swing-
rotor. The plates were then quickly inverted to remove the supernatant; the plate edges were cleaned with 
70 % (v/v) ethanol to prevent cross-contamination (plates up-side-down). Subsequently, the bacterial 
pellets were resuspended on ice with the appropriate medium for re-cultivation. The volume of the new 
medium corresponded to the medium volume prior to spinning. Plates were kept on ice during all 
intermediate steps, e.g. between cultivation, centrifugation, medium replacement. 
Plaque assay with top agar for phage detection 
An overnight culture was prepared from colony of a non-lysogenic E. coli K-12 MG1655 (DE3) strain (host 
strain) exhibiting the same plasmid-based resistances as cultures suspected for phage lysis (CamR, KanR). 
The overnight culture was diluted subsequently 1:30 with warm 0.5% (w/v) LB top agar supplemented with 
kanamycin and chloramphenicol and poured onto a pre-warmed LB agar plate without antibiotics. A volume 
of 5 µL of supernatants of suspected phage-infected cultures, such as the respective supernatants of the 
pre-cultures, but also media and supplements used during the experiment were spotted onto the cooled 
and dried top-agar surface. The plate was incubated at 30 °C overnight mimicking the growth conditions of 
the problematic experiments. 
 
2.4 Experimental details 
Besides relevant information for the experimental performance, only details will be noted that were 
differed from the general growth conditions and procedures described above. 
Controlling basal expression from T7p in E. coli (DE3) strains 
MG1655 (DE3) was transformed either with pCOLA or with pCOLAΩ[T7p/rsTEVP(M)-dgFtsH-sfGFP-his]. 
Additionally, empty NEB 5-α and MG1655 (DE3) were run as control strains. One single clone (rB = 1) of each 
strain was used for the experiment. Overnight cultures were supplemented with 1 % D-glucose (w/v) as 
recommended elsewhere 227. The expression experiment was performed in a volume of 1 mL LB medium 
cultivated in 96-DW plates at 37 °C and 250 rpm. The LB medium was supplemented with kanamycin (for 
plasmid stability if needed) and different concentrations of D-glucose ranging from 0 to 4 % (w/v). Eight 
technical replicates incubated in parallel for each strain and condition (rT = 8). Cell biomass and fluorescence 
development was measured after 20 h.  
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The functionality of the TEVP variants and finding a sugar candidate to complement growth advantages  
due to L-rhamnose supply 
MG1655Ω[T5p/rsTEVP(A)-dg#ClpAP-frGFP] (stable frGFP) and MG1655Ω[T5p/rsTEVP(F)-dgClpAP-frGFP] 
(unstable GFP) were transformed either with pPROTi or pPROTi-His. Three clones of each strain without 
technical replicates (rB = 3, rT = 1) were used for the experiment. The expression experiment was performed 
in a volume of 4 mL LB cultivated in 24-DW plates at 30 °C and 250 rpm. The LB medium was supplemented 
with chloramphenicol and MQ water or 0.1 mM IPTG. The IPTG induced the production of stable or unstable 
frGFP right from the beginning of the experiment. After 6h of growth the growth medium was replaced 
(procedure described in Study II 2.3) with LB medium containing either 5 mM L-rhamnose, 5 mM D-
galactose or 5 mM L-fucose, resulting in six growth conditions. Cell biomass and fluorescence were 
continuously measured over 20 h.  
Fluorescence intensities of the selected LOV proteins versus sfGFP 
pCOLAΩ[T7p/rsTEVP(M)-dgFtsH-FR-his] was co-transformed with pPROTi into MG1655 (DE3). FR in 
pCOLAΩ[T7p/rsTEVP(M)-dgFtsH-FR-his] corresponded to the coding sequences for either sfGFP, EcFbFP, 
CreiLOV or phiLOV. Thus, the transformation resulted in four different strains. Three clones of each strain 
without technical replicates (rB = 3, rT = 1) were used for the experiment. The expression experiment was 
performed in a volume of 4 mL LB cultivated in 24-DW plates at 30 °C and 250 rpm. The LB medium was 
supplemented with kanamycin and chloramphenicol as well as and MQ water or 0.1 mM IPTG. The IPTG 
induced the production of the N- and C-terminally modified FRs right from the beginning. After 6h of growth 
the growth medium was replaced (procedure described in Study II 2.3) with LB medium containing either 5 
mM L-rhamnose, or 5 mM L-fucose, resulting in four growth conditions. Cell biomass and fluorescence were 
continuously measured over 20 h.  
Optimising membrane protein production with different inducer concentrations and inducing membrane 
protein’s susceptibility towards FtsH-specific proteolysis 
All pCOLAΩ[T7p/rsTEVP(M)-dgFtsH-MP-FR-His] plasmid constructs were individually co-transformed with 
pPROTi-His (or pPROTi, depending on the experiment) into E. coli K-12 MG1655 (DE3). MP-FR in 
pCOLAΩ[T7p/rsTEVP(M)-dgFtsH-MP-FR-His] corresponded to the coding sequences for either ppiD-EcFbFP, 
ppiD-sfGFP, navZ1-CreiLOV, navZ1-sfGFP, yhaI-CreiLOV, yhaI-phiLOV2.1 or yhaI-sfGFP. Thus, this 
transformation resulted in seven different strains. In parallel, empty pCOLA was co-transformed with either 
pPROTi-His or empty pSEVA33Ω[T7p/MCS] into MG1655 (DE3), resulting in the control strains 1 and 2. 
Three clones of each strain without technical replicates (rB = 3, rT = 1) were used for the experiment. The 
expression experiment was performed in a volume of 4 mL LB cultivated in 24-DW plates at 30 °C and 250 
rpm. The LB medium was supplemented with kanamycin and chloramphenicol.  
In order to optimised the T7 promoter strength for IMP-FR production, IPTG was supplemented in a 
concentration range in between 0 to 1.6 mM after 4h of growth. IPTG induced the production of the N- and 
C-terminally modified IMP-FRs. Cell biomass and fluorescence were continuously measured over 20 h.  
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For testing the susceptibility of produced IMP-FR constructs towards FtsH-specific degradation, cell cultures 
were grown for 4 h when IMP-FR production was induced with 0.1 mM IPTG (or MQ water). After further 6 
h the growth, LB/±IPTG medium was replaced (procedure described in Study II 2.3) with LB medium 
containing either 5 mM L-rhamnose, or 5 mM L-fucose, resulting in four growth conditions. Cell biomass 
and fluorescence were continuously measured over 20 h. 
 
 
3 RESULTS AND DISCUSSION 
3.1 Plasmid cloning for the production of membrane proteins N-terminal 
fused to a conditional degradation tag 
The genetic set-up for Study II was initially designed alike the one in Study I. However, due to increased 
complexity we opted for a plasmid-based system which provided more flexibility for genetic re-engineering. 
Low copy plasmids are generally preferred for the overproduction of recombinant membrane proteins 
(MPs) 265 since this strategy would avoid the saturation of co-translational integration of nascent MP 
polypeptides into the membrane by the E. coli Sec translocon 266. Accordingly, we chose to work with the 
pSEVA47 backbone (pSC101 replicon, Sm/SpR) from the pSEVA collection 267 harbouring the pSC101 
replicon which ensures an average plasmid copy number of 3-5 per chromosome 268,269 - this was first 
thought to be an acceptable substitute to a genome-based gene expression system.  
As used for Study I, we kept the synthetic IPTG-inducible T5p (INTRODUCTION section 4.1.2) for the expression 
of the engineered genes encoding for the PpiD, NavZ1 or YhaI (INTRODUCTION section 3.3) – all N-terminally 
tagged with the FtsH-specific conditional degradation tag (rsTEVP(M)-dgFtsH-; INTRODUCTION section 3.2.3) 
and C-terminally fused to a variety of FR-polyhistidine (His)-tags (INTRODUCTION section 3.4); the resulting 
gene product can be sketched as: rsTEVP(M)-dgFtsH-MP-FR-His.  
 
However, a mutation-free integration of the MP-encoding genes into a pSEVA47Ω[T5p/FR-His] backbone 
proved to be difficult even in an E. coli NEB Turbo (NEB) background 270. NEB Turbo (NEB) harbours the 
endogenous lacI gene driven by a mutated lacI promoter (lacIq gene) which is responsible for higher 
transcription rates of lacI and therefore increased levels of the LacI repressor within cells (Table 5). The 
cloning result was a repeated overflow of missense, nonsense and frameshift mutations in the respective 
coding regions after T5p, as documented by gene sequencing (data not shown) h. Two possible conclusions 
were drawn from these results: (1) the increased endogenous LacI levels from NEB Turbo were apparently 
                                                             
h This phenomenon was also observed when integrating the same MP coding genes into a similar pSEVA47Ω[T5p/S11-his, J23106/gfpopt1-10] 
backbone but not when the genes encoded for soluble proteins 270. 
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insufficient to repress T5p expression in-trans, which contrasts with the recommendations from Qiagen 
regarding plasmid-based T5p usage 237; and (2), the leaky T5p expression lead to the basal production of 
protein products toxic to the host. Conclusion (1) could be easily addressed, whereas conclusion (2) was 
interesting in the sense that PpiD, YhaI and NavZ1 had been previously successfully overproduced in E. coli 
even from high copy plasmids (see details in INTRODUCTION sections 3.3.2, 3.3.4 and 3.3.3, respectively); in 
those studies gene expression was driven by promoters dependent either of the bacteriophage T7 RNAP 
(T7p) or of the endogenous E. coli RNAP (tetp, lacZp). The suspicion of protein toxicity raised the additional 
question regarding which impact the N-terminal FtsH-specific degradation tag or its coding sequence might 
have on transcription, translation or MP integration into the IM. Generally, bacteria encounter metabolic 
burden with genetic plasmid reorganisation which might either lead to loss of function of the protein 271 or 
plasmid instability, allowing the cells to survive 272. However, the basis of this phenomenon seems to be 
still poorly understood 273. 
 
Nevertheless, in order to address conclusion (1), we switched the plasmid backbone to pCOLADuetTM-1 
(Novagen; ColA replicon, KanR), termed pCOLA for simplification, and pursued all intermediate cloning 
steps in an E. coli NEB 5-α (NEB) background (Table 5). pCOLA directly harbours the wildtype E. coli lacI gene 
which constitutively provides an elevated constant pool of LacI additionally to the endogenous one from 
the NEB 5-α genome. Nevertheless, mutations still persisted (data not shown) 270. This was again surprising 
since pCOLA has been designed for dual gene expression with two separated multi cloning sites (MCS) 
starting each with a T7p; every T7p contains one lacIo for LacI regulation. T5p, with its two lacIo sites, 
provides an equal amount of LacI binding sites. Thus, one might think the additional LacI pool derived from 
pCOLA should also be sufficient for T5p repression.  
We finally carried out a multiple sequence alignment of all lacIo sites from the original T7 promoters on 
pCOLA and of those from T5p (APPENDIX Figure S 4). According to SASMORE AND BETZ (1990), the optimal 
binding site for LacI is a symmetric DNA sequence consisting of two 10 bp operator halves (highlighted in 
grey in APPENDIX Figure S 4) 274. Interestingly, this optimal LacI binding site can be found as a whole in both 
T7p-located lacIo sites on pCOLA but only in the first lacIo in T5p. The second lacIo in T5p consists of a 
shorter palindromic sequence (underlined in APPENDIX Figure S 4) which shortens the optimal binding site 
for LacI. Thus, it might be probable that in order to get a similar LacI repression, as for the two T7p in pCOLA, 
T5p would need a larger LacI pool to complement for the reduced LacI binding affinity to the second lacIo. 
 
We resumed cloning with the pCOLA backbone but without promoter and progressed rapidly, bypassing 
thereby all considerations regarding promoter repression. As a final step, we inserted the coding region for 
T7p in all of the pCOLA constructs to restore them as pET-like vectors. T7p has the advantage that in the 
complete absence of T7 RNAP (INTRODUCTION section 4.1.1) leaky expression is naturally prevented. 
Eventually, all cloning steps were carried out successfully in a NEB 5-a background (all obtained pCOLA 
constructs are listed in Table 6), keeping in mind that mutations might re-occur after transformation into 
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an expression strain that carries the gene for the T7 RNAP (DE3 strain), such as E. coli K-12 MG1655 (DE3). 
Strict precautions were taken at least during the overnight growth of pre-cultures. It is however impossible 
to rule out that such mutations did not occur during the expression studies. 
 
3.2 Controlling basal expression from promoter T7p in E. coli (DE3) strains  
 
 
Figure 9: Different glucose concentrations regulating basal T7p gene expression from pCOLA and medium 
acidification which affect growth of E. coli DE3 strains grown to stationary phase. Cell biomass (OD) and 
fluorescence end point measurements of T7p expression cultures were performed after 20h of growth. Different 
E. coli strains were grown in LB medium supplemented with kanamycin (except empty K-12 MG1655 [DE3] and 
NEB 5-α) and different glucose concentrations ranging from 0 to 4 % (w/v). Empty K-12 MG1655 (DE3) and NEB 5-
α were included as negative controls. rB = 1, rT = 8, n = 1. 
 
E. coli K-12 MG1655 (DE3) is an engineered lDE3 lysogen (DE3 strain) which harbours the gene encoding 
for the bacteriophage T7 RNAP (bacteriophage T7 gene 1 275) in its genome. As stated earlier (INTRODUCTION 
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section 4.1.1), gene 1 transcription is under the control of lacUV5p which requires an inducer (lactose or 
IPTG) and the CRP/cAMP complex (CAP) for full induction 227. However, although being well repressed in 
the absence of inducer, T7 RNAP can be produced from lacUV5p in small amounts 227. Consequently, basal 
levels of T7 RNAP can induce T7p-driven genes prior to the actual induction. Interestingly, cAMP levels, and 
therefore also CAP levels, are negatively affected by the presence of glucose 227,247. In other words, when 
the glucose level gets low, as it is for DE3 strains grown to stationary phase in complex medium, increased 
basal lacUV5p and consequently also T7p expression can be prevented by supplementing glucose 227,276. 
Due to additional glucose supply, an initial rapid growth phase can be monitored 227. Afterwards however, 
glucose is responsible for a rapid acidification of the extracellular medium leading to inhibited cell growth 
and death 227,277. The medium acidification is a result of increased efflux of organic acids from the cells, 
specifically lactic and acetic acids 277, which are breakdown products of the glucose metabolism 227,277. There 
does not seem to be a coherent opinion in literature about the recommended glucose supply that prevents 
basal T7 RNAP production from lacUV5p and yet minimises the acidification of the medium. This might be 
related to both, different levels of leakiness depending on the respective promoters 278 and strains 
exhibiting different acid tolerances 279.  
 
In an effort to reduce the risk of mutations prior to induction as experienced during cloning  
(STUDY II section 3.1), we tested systematically the impact of different glucose concentrations on overnight 
cell growth and T7p-dependent basal sfGFP production from pCOLA in E. coli K-12 MG1655 (DE3) grown in 
LB medium. Accordingly, E. coli K-12 MG1655 (DE3) was transformed either with pCOLAΩ[T7p/rsTEV-
dgFtsH-sfGFP-his] or empty pCOLA plasmid. The obtained strains were grown overnight in LB medium with 
different concentrations of glucose ranging from 0 to 4 % (w/v), whereby 1 % (w/v) glucose is equivalent to 
55 mM. Empty K-12 MG1655 (DE3) and NEB 5-αi were grown in parallel as negative controls for basal GFP-
production and for the purpose of comparability to another K-strain, respectively. The end point 
measurements for cell biomass and fluorescence after 20 h of growth are summarised in Figure 9.  
 
Up to 0.25% or 0.125% (w/v) glucose could be supplied to all K-12 MG1655 (DE3) strains or NEB 5-α, 
respectively, before cell growth was dramatically inhibited due to medium acidification (Figure 9a). This 
indicated that K-12 MG1655 (DE3) generally exhibits a higher acid tolerance than NEB 5-α. Basal sfGFP-
production can be seen by comparing the K-12 MG1655 (DE3) strains harbouring either pCOLAΩ[T7p/rsTEV-
dgFtsH-sfGFP-his] or empty pCOLA plasmid (Figure 9b and c). A minimum of 0.5% (w/v) glucose was needed 
to decrease sfGFP-derived fluorescence levels produced from uninduced K-12 MG1655 (DE3) with 
pCOLAΩ[T7p/rsTEV-dgFtsH-sfGFP-his] even down to the auto-fluorescence levels seen for K-12 MG1655 
(DE3) with empty pCOLA or empty K-12 MG1655 (DE3). We don’t have any plausible explanation for the 
mountain silhouette-shaped sfGFP fluorescence ranging from 0 to 0.5% (w/v) glucose, nor for the 
                                                             
i E. coli NEB 5-α (Novagen) is a DH5-α derivative which is known to be a K-strain 307. 
 81 
fluorescence peaks at circa 0.25% (w/v) and 0.5% (w/v) glucose for all K-12 MG1655 (DE3) strains and NEB 
5-α, respectively. The latter might be the result of an impaired take up and metabolising of fluorescent 
components from the medium which is reflected in higher auto-fluorescence levels at those conditions. The 
sfGFP-fluorescence landscape, however, might be due to effects of a superior gene expression regulation. 
Nevertheless, the results show that glucose is necessary to repress promoter leakiness but too much is 
harmful for the cells due to medium acidification which leads to impaired cell growth and death. In the 
favour for a condition with upmost lacUV5p tightness, we determined the glucose concentration for K-12 
MG1655 (DE3) overnight cultures in LB medium to 0.5% (w/v) which corresponds to 28 mM. 
 
3.3 Functionality of the TEVP variants and finding a sugar candidate to 
complement growth advantages due to L-rhamnose supply 
The mandatory requirement to cleave N-terminal conditional degradation tags in our MP constructs to 
induce FtsH-mediated proteolysis was the presence of active TEPV. For that purpose, we re-used the TEVP 
producing pPROTi plasmid (pSEVA33Ω[rhaBp/tev]) from Study I. Additionally, we cloned a pPROTi variant 
in which we simply inserted the coding sequence of an (His)8-tag at the 3’ end of the tev gene and termed 
it pPROTi-His (pSEVA33Ω[rhaBp/tev-His]. To ensure that TEVP activity was unaltered regardless of the C-
terminal (His)8-tag, we transformed pPROTi and pPROTi-His into the two E. coli K-12 strains 
MG1655Ω[T5p/rsTEVP(F)-dgClpAP-frGFP] and MG1655Ω[T5p/rsTEVP(A)-dg#ClpAP-frGFP] which were 
constructed for pPROTi characterisation in Study I (Figure 10). Both strains harboured the coding sequence 
for frGFP variants with N-terminal conditional degradation tags for ClpAP proteolysis. The difference 
between both was the N-terminal residue which would be released upon TEVP cleavage. A released Phe (F) 
has a destabilising effect on the whole frGFP construct since it directly triggers ClpAP degradation whereas 
Ala (A) acts as a stabiliser for frGFP (referred to as unstable frGFP and stable frGFP, respectively). We 
induced the production of unstable and stable frGFP with IPTG (or MQ water) at the starting point of the 
experiment. Within the exponential phase we removed the LB/IPTG medium and replaced it with fresh LB 
supplied with L-rhamnose for the induction of TEVP. Plain E. coli K-12 MG1655 (referred to as no frGFP) was 
equally transformed with pPROTi or pPROTi-His and served as control. 
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Figure 10: Experimental set-up for testing the functionality of TEVP and TEVP-His. (A) The coding sequence of 
frGFP, N-terminally tagged with the ClpAP-specific conditional degradation tag, was integrated into the genome 
of E. coli MG1655. Electively, the strain was co-transformed with either (B) pPROTi or (C) pPROTi-His plasmid for 
TEVP or TEVP-his production, respectively. The example illustrates the ClpS/ClpAP-mediated degradation of the 
unstable frGFP variant upon TEVP(-His) cleavage (stable frGFP not shown). Details in the main text. 
 
In previous experiments we experienced growth advantages of E. coli strains grown in LB medium 
supplemented with L-rhamnose compared with strains that grew under the same conditions but without 
the sugar supplement (data not shown). To correct artificial growth divergences, we explored the 
substitution of L-rhamnose with a sugar candidate with the following characteristics: (1) a hexose 
monosaccharide (C6 sugar) and E. coli metabolite (such as L-rhamnose) whose (2) transport is independent 
from a phosphotransferase system (PTS) which might be coupled to endogenous cAMP levels and therefore 
regulate lacUV5p -driven T7 RNAP production via the CRP/cAMP (CAP) complex in E. coli DE3 strains. This 
would become important for later experiments in DE3 strains. Finally, (3) the sugar candidate had to be a 
non-inducer for the promoter rhaBp. We chose to test D-galactose and L-fucose (Figure 11): after being 
taken up by their specific transporters, L-fucose (alike L-rhamnose) is metabolised in the cytosol in two 
enzymatic steps before it enters the glycolysis as two di-hydroxy-acetone-phosphate moieties (C3 sugar) 
280,281; in contrast, D-galactose undergoes five to six enzymatic modification reactions after uptake, before 
it enters the second step of glycolysis as glucose-6-phosphate (C6 sugar) 282; both sugars have been reported 
as non-PTS carbohydrates (like L-rhamnose) 247 and as non-inducers for rhaBp (unlike L-rhamnose) 243. Cell 
biomass and fluorescence were monitored over 20 h. The results are illustrated in Figure 12. The complexity 
of the results was unexpected. 
 
E. coli MG1655 genome
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Figure 11: Chemical structures of synthetic IPTG and E. coli sugar metabolites. Molecules are classified as rhaBp-
inducing (orange frame) and as effector for LacI (green frame). L-fucose is neither of the two. L-rhamnose as 
putative effector for LacI (marked with a question mark, ?) is discussed in the main text.  
 
Both TEVP variants are equally active 
First of all, the growth curves for all strains and conditions were almost identical. Thus, growth was generally 
not impaired independently of the nature and variety of the proteins produced. Additionally, E. coli K-12 
MG1655 harbouring pPROTi or pPROTi-His (controls) showed under all conditions almost constant auto-
fluorescence levels, as expected. The activity of TEVP was not impaired by the C-terminally His-tag since all 
data sets from cultures with pPROTi or pPROTi-His were identical. Furthermore, both TEVP variants 
indicated highest cleavage efficiency: at time point 10 h (4 h after L-rhamnose supply), fluorescence/OD 
levels for the unstable frGFP dropped significantly and were comparable to auto-fluorescence levels (no 
frGFP) whereas stable frGFP signals were highest. However, fluorescence/OD levels of stable and unstable 
frGFP deviated substantially after supplying the different sugars, seemingly as an effect of the sugars 
themselves. This phenomenon was evaluated furthermore. 
D-galactose and L-rhamnose are effector molecules for LacI 
Even though unexpected, there is a significant difference between the fluorescence/OD levels of IPTG-
negative conditions for stable frGFP in comparison to the plain auto-fluorescence/OD levels for no frGFP. 
The supply with D-galactose and L-rhamnose seemed to increase basal production of stable frGFP until time 
point 10 h (4 h after sugar supply) whereby the effect triggered by D-galactose appeared more enhanced. 
In contrast, the fluorescence/OD levels of the IPTG-negative/L-fucose condition remained stable within the 
same time frame and beyond.  
 
It is already known since the early 1950s, that besides allolactose and IPTG, there are many more effector 
molecules that can alter the affinity of LacI for its DNA binding site 283–285. Those molecules can mimic the 
effect of the conventional lactose/IPTG induction of the endogenous lac operon 285 and accordingly of 
heterologous LacI-regulated expression systems. D-galactose is listed as weak effector molecule for LacI 
L-rhamnoseL-fucose D-galactose lactose IPTG
?
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283,284. While IPTG, as most efficient effector, can decrease LacI affinity for lacIo 1000-fold 286, D-galactosej 
only shows 1/1000 of the efficiency of IPTG 287. Other galactosides, tested as functional inducers, showed 
efficiencies in the same range 286,287 which suggested a common mechanism of interaction with LacI 285. It 
seems that a hydroxyl-group on C6 of the sugar ring plays an essential role for effector/LacI interaction; 
however, it is not sufficient alone to induce enough conformational change in LacI to reduce its affinity to 
lacIo 285. To accomplish the latter, it appears that the substituent on the C1 position also needs to provide 
optimal effector/LacI binding 285. Fucosides, like L-fucose, do not possess the hydroxyl group in C6 and are 
therefore considered as non-inducers 285 which would underline our findings. In contrast to D-galactose and 
L-fucose, we do not have any explanation for the enhancing effect of L-rhamnose on basal production of 
stable frGFP: (1) upon screening the literature, L-rhamnose has neither been associated nor tested as 
effector for LacI; and (2) it does not possess the C6 hydroxyl-group. Nevertheless, it remains possible that 
L-rhamnose can interact structurally with LacI in a different way than reported until now. 
 
A similar pattern of differentiated fluorescence/OD levels for the stable frGFP can be seen for the IPTG-
positive conditions after replacement of the LB/IPTG media with the LB/sugar media: cultures 
supplemented with D-galactose and L-rhamnose showed significantly increased levels in fluorescence/OD 
until timepoint 10 h (4h after sugar supply) compared to those of L-fucose. It is regrettable, that we missed 
to include the condition IPTG-positive/sugar-negative in the experiment. This way, we would have achieved 
maximal production levels for stable frGFP only due to IPTG. Yet, we did not expect increased production 
rates from T5p due to D-galactose or L-rhamnose acting as effector molecules for LacI. Having said so, 
maximal production levels for stable frGFP from IPTG alone are obtained in the IPTG-positive/L-fucose-
positive condition since L-fucose is considered being a LacI-non-effector 285. 
After timepoint 10 h, the effective levels for stable frGFP in all conditions decreased slowly until the end of 
the experiment. This might be due to two – potentially synergetic – root causes: (1) the supplied sugar 
levels were metabolised by the host, which tightened LacI/lacIo interaction and therefore stabilised the 
protein levels of stable frGFP; (2) the cells are entering the stationary phase but continued growing slowly 
until the end of the experiment, thus, the stabilised levels for stable frGFP were just slowly diluted over 
time. 
Leaky expression from genomic T5p in the absence of an increased LacI pool 
As stated earlier, the presence of L-fucose did not affect the basal production of stable frGFP. However, the 
baseline of the fluorescence/OD level of stable frGFP (IPTG-negative/ L-fucose) was still higher as the auto-
                                                             
j Enhanced basal expression from pET expression systems was observed in host strains with impaired cytosolic D-galactose metabolism like 
E. coli BL21 strains (galK-) grown in complex media such as LB 233. LB contains among others enzymatic digest of milk protein casein 233. Since 
milk is rich in lactose, variable amounts of residual lactose may be present in different lots of enzymatic digests 233. Thus, when D-galactose 
is well transported into the cell (in the absence of glucose) and accumulating in the cytoplasm, it can contribute to an increased basal 
expression from LacI-dependent promoters 233. This effect is usually redundant in D-galactose-metabolising hosts 233. 
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fluorescence/OD levels measured under any conditions for no GFP. This might be interpreted as leaky 
production of stable frGFP from pT5. Thus, the endogenous LacI pool appeared not enough for sufficient 
repression of a single genome-integrated T5p, as assumed from Qiagen (personal communication). 
Consequently, even pT5 as single copy per chromosome would need a bigger LacI pool than E. coli can 
provide by itself: either produced from a genomic lacIq or lacIq1 gene or from a medium-copy plasmid 
harbouring the lacI gene 237. This had not been tested yet from Qiagen (personal communication) and would 
need therefore experimental validation. This finding has no impact on later experiments in Study II but 
might be relevant for future applications with genomic T5p expression systems. 
D-galactose and L-fucose are true non-inducer for rhaBp 
The sugar-specificity of rhaBp can be indirectly observed by comparing the fluorescence/OD levels of stable 
frGFP with those of unstable frGFP under IPTG-positive/sugar-positive conditions. What can be seen 
directly is the ClpAP-dependent proteolysis of unstable frGFP once its N-terminal destabilizing degradation 
sequence motif became released upon TEVP cleavage. A discussed earlier, L-rhamnose supply led to a 
prompt production of active TEVP which finally led to the rapid and complete degradation of unstable frGFP 
in comparison to stable frGFP. Interestingly the effective protein levels for unstable frGFP and stable frGFP 
behaved exactly similarly upon supply with D-galactose or L-fucose which disqualified both sugars as 
inducers for rhaBp, like published recently 243. 
D-galactose as sugar candidate to complement growth advantages due to L-rhamnose supply in E. coli 
strains with Rha+ phenotype 
Independent of the nature of supplemented sugar all growth curves for all strains and conditions were 
almost identical. This makes both D-galactose and L-fucose suitable candidates to replace L-rhamnose and 
to complement growth advantaged on first glance. On second glance, by having uncovered L-fucose as non-
effector for LacI as well as non-inducer for rhaBp, L-fucose would make the ideal sugar candidate we initially 
looked for. However, by considering (1) that D-galactose and L-rhamnose are apparently both effectors for 
LacI with similar efficiency and (2) that D-galactose is a non-inducer for rhaBp, then D-galactose would 
become best choice at third glance (Figure 11). 
 
  
Figure 12: Functionality of TEVP or TEVP-His on the stability of frGFP variants. The general cytoplasmic fusion construct produced from the genome was rsTEVP(X)-dgClpAP-frGFP. 
X represented hereby the outermost N-terminal residue of the dgClpAP degradation sequence motif which would become released upon TEVP cleavage. A released Phe (F) has a 
destabilising effect on frGFP whereas Ala (A) is stabilising, referred to as unstable frGFP and stable frGFP, respectively. (A) unmodified E. coli K-12 MG155; (B) E. coli K-12 MG155 
W[T5p/ rsTEVP(A)-dgClpAP-frGFP]; (C) E. coli K-12 MG155 W[T5p/ rsTEVP(F)-dgClpAP-frGFP]. All strains harboured either pPROTi or pPROTi-His. The line at 6 h represents the time 
point of media change from LB/±IPTG to LB/sugar in order to induce TEVP production. Details in the main text. rB = 3, rT = 1, n = 1
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3.4 Fluorescence intensities of the selected LOV proteins versus sfGFP and 
their degradability as soluble proteins by the FtsH proteasome 
In order to visualise MP degradation, we designed IMP fusions with different FR proteins. The idea was, 
that if FtsH-mediated IMP degradation follows the pulling model (INTRODUCTION section 1.4.2; Figure 5A) the 
C-terminal FR i (translocated), unfolded and degraded, similar to a globular IMP domain. The FR candidates 
were sfGFP, CreiLOV, phiLOV2.1 and EcFbFP. sfGFP, CreiLOV, phiLOV2.1 were used for applications in 
cytoplasm; sfGFP and EcFbFP in the periplasm.  
 
The fluorophore in AvGFP variants such sfGFP is not a separate, synthesized prosthetic group but is 
composed of modified amino acid residues within the polypeptide chain 163,164. Moreover, fluorophore 
formation in AvGFP variants relies on successful protein folding and the presence of oxygen. With the 
exception of sfGFP, AvGFP variants usually need the reducing environment of the cytoplasm to form 
disulphide bridges necessary for correct folding 194,195. The amino acid substitutions in sfGFP, however, 
contribute to robust folding of the protein (without disulphide bridges) even in the highly oxidising 
periplasm of E. coli; the fluorophore is formed subsequently under aerobic conditions 6,194,195. Therefore, 
we still expected a bright periplasmic sfGFP signal in an aerated (shaking) E. coli culture, as published 
previously 195.  
In contrast, maturation of LOV proteins is independent of the presence of oxygen 288 but need the non-
covalently binding of flavin mononucleotide (FMN) as chromophore 197,262. FMN is an endogenous cytosolic 
metabolite in E. coli 204, shown to be sufficient for cytosolic LOV protein applications in vivo 199. The use of 
complex media, including LB medium, which contain naturally certain amounts of FMN, 289 has been proven 
to be sufficient as FMN source for the production LOV protein fusions in the periplasm 290. Similarly to sfGFP, 
we expected cytoplasm-located CreiLOV and phiLOV2.1 and periplasm-located EcFbFP to fluoresce upon 
cell cultivation in LB medium, as reported 199,220. 
 
Due to its apparent weak unfoldase activity, FtsH was shown unable to degrade soluble GFP-SsrA or GFP-
cI108 substrates whereas other soluble protein substrate exhibiting lower intrinsic thermodynamic stability 
and C-terminally fused with the same degradation tags were degraded 103 (INTRODUCTION section 1.4.1). The 
latter is an issue that we particularly kept in mind for the IMP-sfGFP fusions and considered those as 
negative controls. In contrast, the three LOV protein variants were initially thought to have a lower intrinsic 
thermodynamic stability than most AvGFP variants. We expected therefore the LOV proteins to be fully 
degraded granted FtsH-mediated degradation followed the pulling model (INTRODUCTION section 1.4.2; 
Figure 5A). If not, the IMP-FR fusions were otherwise expected to be partially degraded, whereas sfGFP or 
the LOV proteins alone would remain as fluorescing entities in the periplasm or cytoplasm. Immunoblotting 
would be the method of choice to observe these different phenomena.  
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According to the literature, the relative fluorescence brightness of the LOV proteins EcFbFP and CreiLOV 
are approximately in the same range as for the enhanced blue (eBFP) and cyan (eCFP) fluorescent variants 
of AvGFP (APPENDIX Table S 2). The brightness of the two AvGFP variants correspond to 1/7 or 1/5 of the 
relative fluorescence brightness measured for sfGFP, respectively (APPENDIX Table S 2), although one should 
note that all data provided in APPENDIX Table S 2 were obtained at the respective optimal excitation and 
emission wave lengths of those proteins. However, in order to standardize and compare data generated 
during different experiments and in different equipment (e.g. fluorescence plate reader, FACS), we 
performed all fluorescence measurements with the excitation and emission at 485 nm and 528 nm, 
respectively. These wavelengths are rather optimal for sfGFP but suboptimal for LOV protein detection (see 
individual fluorescence characteristics in APPENDIX Table S 2). Thus, it was essential to compare the 
fluorescence intensities of all selected FRs under the given conditions. We chose to test the latter with 
constructs producing only the soluble FR entities in the cytosol of E. coli.  
 
Furthermore, the specificity of dgFtsH (INTRODUCTION section 3.2.2) had been only proven for a single case; 
soluble dgFtsH-GST was not degraded by FtsH 2. Thus, as an additional feature of this experiment, soluble 
sfGFP, CreiLOV, phiLOV2.1 and EcFbFP were each fused N-terminally to the FtsH-specific conditional 
degradation tag (rsTEVP(M)-dgFtsH-). Upon induced TEVP cleavage we would enable putative FtsH-
mediated degradation of the four soluble target proteins. 
Accordingly, we induced the production of all four rsTEVP(M)-dgFtsH-FR constructs at the starting point of 
the incubation with IPTG or used MQ water as negative control. Within the exponential phase we removed 
the LB/IPTG medium and replaced it with fresh LB supplied either with L-rhamnose for the induction of 
TEVP, or with L-fucosek as negative control for TEVP production and balance of L-rhamnose-related growth 
advantages in the control cultures (discussed in STUDY II section 3.3). Cell biomass and fluorescence were 
monitored over 20 h. The results are summarised in Figure 13. 
Soluble LOV proteins CreiLOV and EcFbFP affect cell growth 
Even though all cell cultures grew, at some point, to the same cell density in the stationary phase, the 
growth rates of the exponential phase upon production of the soluble CreiLOV and EcFbFP variants were 
significantly reduced and reached the stationary phase only after approximately 20 h. In contrast, cell 
growth was not affected by the production of phiLOV2.1 and sfGFP variants nor by the conditional 
abundance of TEVP (in comparison to the control conditions); those cultures reached the stationary phase 
after approximately 12 h. Nevertheless, we do not have an explanation for the negative effect on cell 
growth due to the production of soluble CreiLOV and EcFbFP variants.  
  
                                                             
k We initially mis-interpreted the data in 3.3. D-galactose would have been the better sugar candidate to complement for L-rhamnose growth 
advantages in E. coli strains with Rha+ phenotype (see discussion in 3.3). 
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Fluorescence brightness of EcFbFP highest among LOV proteins 
The fluorescence intensities (fluorescence/OD levels) among all soluble LOV proteins were in the same low 
range but significantly elevated in comparison to auto-fluorescence levels. The fluorescence intensities for 
EcFbFP were highest among the selected LOV proteins which agrees with the literature 202,204. In contrast, 
fluorescence intensities of soluble sfGFP outperformed significantly those of the LOV proteins. Most 
importantly, the fluorescence data was obtained from cytoplasmic FRs. 
No fluorescence intensities were measured from FRs located in the periplasm although sfGFP and EcFbFP 
would locate into the periplasm when fused to the C-terminus of PpiD (INTRODUCTION section 3.3.2). Given 
the robust folding ability of sfGFP in the periplasm 6 and the aerated culture condition, as well as the 
evidence of EcFbFP fluorescence in the periplasm 220 combined with the presence of FMN from the complex 
medium we still expected robust fluorescence signals for both reporter proteins. 
CreiLOV, phiLOV2.1, EcFbFP and sfGFP are no FtsH substrates under the given condition 
None of the rsTEVP(M)-dgFtsH-FR constructs exhibited drops in relative fluorescence intensities 
(fluorescence/OD levels) upon media change from LB/IPTG to LB/L-rhamnose or LB/L-fucose (negative 
control). Thus, it would appear that none of the rsTEVP(M)-dgFtsH-FR constructs became susceptible 
towards FtsH-specific degradation upon TEVP production. This result can be interpreted in three different 
ways: (1) dgFtsH is essential but not sufficient alone for FtsH-mediated degradation, and needs membrane-
anchoring to become a complete degradation motif, as suggested previously (MP-specificity of dgFtsH) 2; 
(2) the intrinsic thermodynamic stability of all FRs are too high for the weak unfoldase activity of FtsH 103 
which was expected for sfGFP 103 and, with retrospect, also assumed for the LOV proteins (see discussion 
in INTRODUCTION section 3.4); and/or (3), due to the medium change, necessary for TEVP induction from the 
pPROTi plasmid, the cells were artificially re-shifted into a second or prolonged exponential phase which is 
seemingly unfavourable for FtsH-mediated degradation of dgFtsH-tagged target proteins 2. While 
conclusion (1) would reflect a unique and interesting characteristic of dgFtsH from a synthetic biologist 
point of view, (2) and (3) would actually be methodological flaws in our experimental set-up. 
L-rhamnose as effector for LacI is confirmed 
The relative fluorescence intensities (fluorescence/OD levels) of sfGFP in the IPTG-negative conditions 
showed an enhanced basal level after the replacement of the initial growth medium to LB/L-rhamnose in 
comparison to LB/L-fucose. This confirmed earlier observations, that L-rhamnose (but not L-fucose) might 
act as an effector for LacI and de-repress LacI-regulated promoters (STUDY II section 3.3). This effect was 
particularly enhanced for the relatively bright sfGFP. 
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Figure 13: Comparison of the fluorescence intensities for selected LOV proteins versus sfGFP and their 
susceptibility towards FtsH-specific degradation. The general cytoplasmic fusion construct produced from a pCOLA 
backbone and T7p was rsTEVP(M)-dgFtsH-FR-His in E. coli K-12 MG1655 (DE3). FR was thereby either CreiLOV, 
phiLOV2.1, EcFbFP or sfGFP. All strains contained also the pPROTi-His plasmid for the induction of TEVP 
production. The line at 6 h represents the time point for media change from LB/±IPTG to LB/sugar. The growth 
conditions are indicated in colours. The development of cell biomass and fluorescence were followed over 22h. 
Details in the text. rB = 3, rT = 1, n = 1. 
 
3.5 Optimising membrane protein production with different inducer 
concentrations 
The biogenesis of integral membrane proteins (MPs) from their nascent polypeptide chains involves many 
steps starting with the targeting of nascent MP to the membrane, the insertion and folding therein and 
finally, in case of polytopic membrane proteins, the assembly 291,292. Each of these steps requires distinct 
components and interactors whose activities are inter-dependently balanced to maintain the dynamic 
integrity of the whole process 179,291,292. Due to an oversaturation of the aforementioned steps, the 
overproduction of MPs targeted in E. coli for its inner membrane (IM) often results in insoluble protein 
aggregates (inclusion bodies) in the cytosol 179,293. Whether an overproduced MP ends up in inclusion bodies 
or successfully becomes integrated in the IM is not possible to predict 293. This depends on several 
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parameters such as the expression strain, induction temperature, growth medium and promoter  
strength 179.  
GFP fused to the C-terminus of MPs has been successfully introduced as folding indicator to distinguish 
between IM-insertion versus inclusion body formation 187 where the proper folding of the GFP depended 
on the correct folding of its MP fusion partner 179. However, it is emphasised that C-terminal GFP is only an 
indicator and does not guarantee for successful IMP-integration. Moreover, inclusion bodies of MP-GFP 
fusions may stay fluorescent and the GFP moiety may also be clipped off by proteases in vivo 187. 
Immunoblot protocols that can differentiate between integrated and aggregated MP have been developed 
to eliminate doubts 179,187. 
Provided that we could use the fluorescence signal of CreiLOV, phiLOV2.1, EcFbFP and sfGFP as an indication 
for folding/integration of our IMP-FR constructs, we tested different IPTG concentrations ranging from 0 to 
1.6 mM IPTG, to regulate their production from the promoter T7p located on the pCOLA plasmid. After 4 h 
of growth, IMP-FR production was finally induced in the exponential phase. We integrated two controls to 
evaluate the levels for auto-fluorescence. Cell growth and fluorescence were monitored over 24 h.  
The results are summarised in Figure 14. 
  
  
Figure 14: Optimising the promoter strength of T7p for rsTEVP(M)-dgFtsH-MP-FR-His production from pCOLA by taking FR fluorescence as indicator for functional IMP integration 
in E. coli K-12 MG1655 (DE3). The colour codes for the IMP-FR constructs are indicated in the legend. The line at 4 h represents the time point of IPTG supply (or MQ water). The 
final IPTG concentrations are specified. rB = 3, rT = 1, n = 1. 
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In this experiment, we observed pronounced physiological stress related to IPTG toxicity 294 (especially seen 
in the controls) and likely related to metabolic load upon the production of the different IMPs; the YhaI 
constructs showed the most prominent negative effects on growth. The maximum relative fluorescence 
levels (fluorescence/OD) increased proportionally with increasing IPTG concentrations for all constructs, 
and the levels were maximal 6 h after IPTG supply (time point 10 h). This time point was then chosen for 
TEVP induction with rhamnose, hypothesising that the fluorescence pool was highest for all constructs and 
thus its putative decay would be easier to follow during proteolysis. A dose of 0.1 mM IPTG was chosen in 
order find a compromise between IPTG toxicity and maximum fluorescence during growth.  
 
3.6 Inducing membrane protein’s susceptibility towards FtsH-specific 
proteolysis 
After having defined the optimal experimental conditions, we carried out the main experiment addressing 
the IMP-FR production in E. coli followed by L-rhamnose-triggered TEVP cleavage to induce the IMP’s 
susceptibility towards FtsH degradation (Figure 15). Simultaneously, we planned to sample cell cultures for 
immunoblotting to visualise the abundance of successful integrated IMP-FRs, on one hand, and, on the 
other hand, putative degradation events directly on protein level. 
 
Rapidly during the first attempt, aberrant cell density data were observed (Figure 16B): within the first 1 to 
15 h of the experiment, the cell density no longer followed the trend observed during the initial test 
experiment (Figure 16A) and cells seemed to die during cultivation. The experiment was repeated three 
more times with the similar outcome. This was followed by thorough troubleshooting activities.  
 
The problematic growth curves seemed randomly distributed yet apparently related to specific deep well 
plates used during the experiments. A physiological explanation for the symptoms was ruled out, thanks to 
all previous experiments demonstrating the non-lethal effect(s) of the many different parameters chosen. 
More reasonable, although somehow far-fetched, seemed a phage contamination. 
 
A collection of samples – from media, ingredients to supernatants of culture broths of the shown 
experiment – were tested in a plaque assay. To our surprise, the supernatant of the culture broth samples 
that had exhibited the unusual growth behaviour showed a clear plaque upon incubation (Figure 17). Here, 
phages were lysogenic on growing E. coli K-12 MG1655 (DE3) – a similar behaviour we have observed in the 
exponential phase during the growth experiment. The plaque assay was negative for all media and 
ingredients as well as for the pre-culture of the tested clone. None of lab equipment seemed to be a cause 
of infection. The only likely explanations were therefore, (1) a bacteriophage was responsible for the death 
of the cells during the experiments and (2) the only reasonable source for a phage contamination were the 
 94 
re-usable 24-deep-well plates. Due to lack of time, this essential experiment could not be repeated once 
again with newly ordered consumables. 
 
 
Figure 15: Experimental set-up for testing the susceptibility of all inner MP-FR candidates towards FtsH-mediated 
proteolysis. pCOLAW[T7p/rsTEVP(M)-dgFtsH-MP-FR-His] encoding for PpiD-FR, NavZ1-FR and YhaI-FR fusion 
proteins were each co-transformed with pPROTi into E. coli MG1655 (DE3). All MP-FR fusion were N-terminally 
tagged with the FtsH-specific conditional degradation tag which was assumed to turn them into FtsH substrates 
upon TEVP cleavage. Legend: Important N- or C-terminal protein features are indicated in colour or symbols: 
native dgFtsH (black bold letters or line) for FtsH-dependent proteolysis; the rsTEVP(M) capping (orange 
highlighted or º) as part of the conditional element together with TEVP, varying FR including sfGFP, EcFbFP, 
phiLOV2.1 and CreiLOV are summarised in one symbol (ì); His8-tag (¢) as epitope tag. 
 
 
periplasm
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MP                 FR
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Figure 16: Testing the susceptibility of the overproduced rsTEVP(M)-dgFtsH-MP-FR-His constructs towards FtsH proteolysis upon TEVP cleavage. (A) Test experiment. All E. coli 
MG1655 (DE3) strains harboured a pCOLAW[T7p/rsTEVP(M)-dgFtsH-MP-FR-His] construct and the pPROTi-His plasmid. No cultures sampled for immunoblotting. rB = 3, rT = 1, n = 
1. (B) Representative growth curves of phage-infected expression experiments: Here, the strains were co-transformed with a pCOLAW[T7p/rsTEVP(M)-dgFtsH-MP-FR-His] and the 
pPROTi plasmid. rB = 3, rT = 1, n = 4. Legend: The respective MP-FR fusions are specified above the graphs. The line at 4 h and 10 h represent the time point of IPTG supply (or MQ 
water) or media change from LB/±IPTG to LB/sugar, respectively. The colour codes for the different conditions and MP-FR fusions were kept from previous experiments and are 
indicated in the legends. 
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Figure 17: Plaque assay with top agar shows typical plaque formation only in culture with suspicious growth 
phenotype. All media, supplements and respective ON cultures were tested in parallel: (1) supernatant of two 
culturesl with suspicious growth phenotype from experiment; (2) respective ON culture; (3) LB medium 
supplemented with 0.5 % (w/v) D-glucose used for the pre-culture; (4) LB stock medium from which all LB variants 
were prepared; (5) fresh LB medium supplemented with 0.1 mM IPTG from the stock solution used for the 
experiment; (6) LB medium supplemented with 5 mM L-fucose and (7) LB medium supplemented with 5 mM L-
rhamnose, both used during the experiment. Plate was incubated at 30 °C overnight. E. coli MG1655 (DE3) with 
plasmid-derived CamR and KanR resistance was used as host in the top agar. rB = 2, rT = 1, n = 1. 
 
However, some statements can be provided on the outcome of the test experiment. The relative 
fluorescence levels for PpiD fused to its periplasmic FRs did not significantly increase upon IPTG supply 
compared to the control condition (IPTG-negative). It is conceivable that PpiD-EcFbFP and PpiD-sfGFP could 
not be integrated in the IM or have not even been produced. Furthermore, even though EcFbFP as well as 
sfGFP have been both shown active as part of a soluble fusion protein in the periplasm after SecYEG 
transport, it is possible that both FRs were here inactive due incorrect folding. The same applies for YhaI-
CreiLOV and YhaI-phiLOV2.1. Nevertheless, a significant increase for relative fluorescence levels upon IPTG 
addition was observed for both NavZ1 constructs and YhaI-sfGFP. Interestingly, for none of these three 
protein fusions the relative fluorescence dropped upon induction of TEVP production, which might be 
interpreted as the following: (1) those IMP fusion constructs could not be turned into a FtsH substrate by 
the present method which might also be related to their higher topology grade or (2), similar to an 
assumption in STUDY II section 3.4, the medium change, necessary for TEVP induction from the pPROTi 
plasmid, caused a prolonged exponential growth phase which is unfavourable for FtsH-mediated 
degradation of dgFtsH-tagged proteins 2. Only an immunoblot could have provided insights on the 
abundance and quality of IMP-FR integration and the occurrence of FtsH-mediated proteolysis via the 
developed conditional degradation tag (rsTEVP(M)-dgFtsH-). 
 
                                                             
l One clone each of E. coli MG1655 (DE3) co-transformed with either pCOLAW[T7p/rsTEVP(M)-dgFtsH-PpiD-EcFbFP-His] or 
pCOLAW[T7p/rsTEVP(M)-dgFtsH-PpiD-EcFbFP-His] and pPROTi cultured in condition IPTG/L-rhamnose during the experiment. 
1 1 2 2
3 3 4 4
5 5 6 6
7 7
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3.7 Concluding remarks 
The transfer of the PROTi technology on membrane proteins was an ambitious project which was 
unfortunately hampered by succession of technical challenges. With the present data, it is not possible to 
conclude if the project failed to deliver its results – the unfortunate bacteriophage incident combined with 
lack of time did not allow to carry out the last, most crucial experiment including immunoblotting of IMP-
FR integration into the IM and putative degradation events. Albeit optimised during the preliminary trials, 
we believe that our experimental setup may still not have been suitable to match the intrinsic biological 
nature of the different components involved. 
 
For a start, TEVP, as part of TIPI or PROTi, may be limited – to a certain extend – by type of amino acid in 
the 7th position of its rsTEVP (discussed in INTRODUCTION section 3.1) and therefore this makes this 
endopeptidase unfavourable when creating libraries of random degradation tags since TEVP will skew the 
results towards its preferred residues. Another protease with even lower or no specificity for the released 
amino acid, as eventually UBP1 56 (discussed in INTRODUCTION section 2.2.3) would be preferable. However, 
if the N-terminal residue to be released remains identical throughout experiments (except Pro) then the 
use of TEVP can be of advantage due to its high specificity and for its relatively small recognition site. 
 
Secondly, with retrospect, we identified several pitfalls related to the choice of promoters used during these 
studies. The use of an IPTG-inducible promoter for target protein production was not suitable when 
combined with TEVP induction. The medium change (for the removal of residual IPTG and to stop POI gene 
expression) was not only laborious but also increased the risk for cross-contamination in our deep-well 
plate setup. The use of a metabolite alternatives to IPTG for LacI-regulated promoters, for instance lactose, 
could have been an alternative option (see APPENDIX Figure S 5) although such a strategy would increase 
significantly in terms of complexity. Indeed, there is a great need to maximize the level of POI gene 
expression while the inducer should be reduced to the lowest possible prior to triggering TEVP production. 
Another type of promoter could have alleviated the need for removing the inducing molecule, for instance 
light-driven and temperature driven promoters – there would still be risks that such promoters may not be 
as tight.  
Speaking of tightness, we have surprisingly observed increased basal expression from LacI-regulated 
promoters upon the addition of galactose or rhamnose; abolishing LacI repression should be by all means 
avoided when considering the production of toxic proteins or when certain protein activities are 
unfavoured at a given time namely in an engineered metabolic pathway. The combination of IPTG-driven 
protein production with rhamnose-driven TEVP production should therefore be re-evaluated such as both 
promoter types to be switched. By doing so, one would avoid interrupting the experiment by a medium 
change, including adding a substantial physiological stress to the cells, although a certain degree of T7p 
leakiness may not be avoided; the co-expression of T7 lysozyme 295 which binds T7 RNAP might help 
improving the leakiness of T7p indirectly. Moreover, the medium change is thought to lead to a second or 
 98 
prolonged exponential phase which is unfavourable for FtsH proteolysis from dgFtsH-tagged POIs, whose 
activity peaks during the stationary phase 2. It would therefore be crucial to reach the stationary phase as 
rapidly as possible. 
In addition, it would have been preferable to use a L-rhamnose catabolism deficient strain for our studies 
due to two reasons: (1) L-rhamnose would not confer any physiological advantages thus no replacing sugar 
would be needed during growth (discussed in STUDY II section 3.3) and (2) the rhaB promoter would become 
directly titratable, as recently published 249. It is obvious that there is no ideal combination of promoters in 
our case and one would have to design a substantially more complex set up in order to achieve full promoter 
tightness, no interruption of growth and optimal production of all desired targeted proteins. 
 
Thirdly, a more focused study using only one, well characterized model of membrane protein might have 
increased our chances to meet our goals. To start the cloning of all proteins of interest was unexpectedly 
troublesome and some immunoblot data (data not shown) might indicate that most of the proteins were 
not even produced. As stated in the INTRODUCTION (sections 3.3.2, 3.3.3 and 3.3.4), PpiD, NavZ1 and YhaI 
were little or poorly characterized in their natural, physiological context. Among other there aren’t any 
information about the respective mechanisms of insertion into the IM, including also which topological 
determinants are responsible for this insertion. Hypothetically, upon replacing parts of the wild-type N-
terminal sequence of those proteins with the FtsH-specific conditional degradation tag (rsTEVP(M)-dgFtsH-
) we might have disturbed the natural signals involved with membrane insertion and assembly. There aren’t 
any certainties either that the fusion with our FRs did not alter the insertion properties of the different 
target membrane proteins. It is yet still unclear why all the mutations in the ORFs of the different plasmids 
occurred when cloning in presence of active promoters (T5p in non-(DE3) cloning strains) – those mutations 
may very well be the root cause for defective or unsuccessful protein production. 
 
Finally, there are to date only few reporter fluorescent proteins that are active in the periplasm so the 
number of molecules to choose from in our study was limited. The nature of the FR should match the 
proteasome’s unfoldase abilities but should, of course, still allow for a clear read-out. The choice of LOV 
proteins as alternatives to GFP appeared considerate enough but this may have backfired in the sense that 
they may exhibit a higher intrinsic thermodynamic stability (discussed in INTRODUCTION section 3.4) – and 
hence being a more reluctant substrate for FtsH - than initially assumed. 
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FUTURE PERSPECTIVES 
The work presented in this thesis is ambivalent. We have successfully addressed conditional protein 
degradation of soluble proteins (Study I) yet failed to obtain the same results for membrane proteins (Study 
II). Thanks to the synergy between PROTi with CRISPRi, we anticipate that our technology would enable 
faster discoveries in the fields of fundamental biology but also applied biotechnology; one example could 
be the discovery of new antibiotics.  
Addressing our work in Study II: despite the outcome of our trials, we believe that this project would still 
be able to deliver its promises. As such, mechanisms for degradation of membrane proteins are still vastly 
unknown. A simplified study encompassing a thorough re-examination of the items discussed here above 
might be able to uncover initial aspects of membrane protein proteolysis, and by extension paving the way 
towards new tools in synthetic biology.  
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APPENDIX AND SUPPORTING INFORMATION 
1 FIGURES 
 
Figure S 1: Helical wheel display and amino acids characteristics of the predicted transmembrane helices from 
YhaI. Analysis was done with MPEx 185 version 3.2.15. Details in text. 
 
A # YhaI Length: 118 # YhaI Number of predicted TMHs:  3 
# YhaI Exp number of AAs in TMHs: 63.53852 
# YhaI Exp number, first 60 AAs:  33.34606 
# YhaI Total prob of N-in:        0.94105 
# YhaI POSSIBLE N-term signal sequence 
YhaI TMHMM2.0 inside      1    22 
YhaI TMHMM2.0 TMhelix    23    45 
YhaI TMHMM2.0 outside    46    48 
YhaI TMHMM2.0 TMhelix    49    71 
YhaI TMHMM2.0 inside     72    77 
YhaI TMHMM2.0 TMhelix    78   100 
YhaI TMHMM2.0 outside   101   118 
 
B 
 
Figure S 2: Prediction of transmembrane helices and their topology in YhaI. The analysis was performed by using 
TMHMM Server v. 2.0. (A) Statistics and a list of the location of the predicted TMHs and the predicted location of 
the intervening loop regions. (B) Plot illustrates the probable topology of the TMHs inside the membrane releative 
to the cytosol (inside). 
THM1 THM2 THM3
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Figure S 3: Schematic representation of the stability curve illustrating the temperature dependence of the free 
energy of unfolding (DG). The temperatures of maximal stability (T*) and heat denaturation (Tm), are indicated. 
Figure is modified from REES AND ROBERTSON (2001) 205, BECKTEL AND SCHELLMAN (1987) 296. 
 
 
pCOLA_T7p-1_laco      GGAATTGTGAGCGGATAACAATTCC 25 
pCOLA_T7p-2_laco      GGAATTGTGAGCGGATAACAATTCC 25 
T5p_laco-2            TCAATTGTGAGCGGATAACAATTTC 25 
T5p_laco-1            TGCTTTGTGAGCGGATAACAATTAT 25 
                          *******************   
Figure S 4: Multiple sequence alignment of symmetric lacIo sites in the two T7 promoters on pCOLA and the two 
in T5p. The multiple sequence alignment was performed with the Clustal Omega tool (EMBL-EBI). The perfect 
palindromic lac operator sequences are underlined. The nucleotide which represents the center of symmetry is in 
bold. Optimal binding site for LacI according to SAMOR AND BETZ (1990) 274 are highlighted in grey. 
 
  
Temperature
ΔG
(T
)
0
T* Tm
  
Figure S 5: Optimising the T7 promoter strength with lactose for rsTEVP(M)-dgFtsH-MP-FR-His production from pCOLA by taking FR fluorescence as indicator for functional IMP 
integration in E. coli K-12 MG1655 (DE3). The colour codes for the IMP-FR constructs are indicated in the legend. The line at 4 h represents the time point of IPTG supply (or MQ 
water). The final lactose concentrations are specified. 8 mM lactose corresponds to 0.28 % (w/v). For comparison, Studier (2005) suggested, besides 0.05 % (w/v) glucose, 0.2 % 
(w/v) lactose for usage in auto-inducing media 297. rB = 3, rT = 1, n = 1. 
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2 TABLES 
Table S 1: Overview about the oligonucleotides used in Study II. 
OMSB# SEQUENCE 
2951 ACTTCCAGAUGGAAATTTACGAGAAC  
2953 ACTTCCAGAUGGAAATTTACGAGAACGAAAACGACCAGGTAGAAGCGGTTAAACGCTTTTTTGCTGCGTCGTTCCAGTCGTTC  
3045 AAGCGTTUAACCGCTTCTAC 
3053 ACCTTCGUTGTTGCTGAC 
3054 ATCGAAAAAUCTTTCGTTATCACCGAC 
3055 AAGGCGCUGGATCACG 
3056 AAACGCTUTTTTGCTGTGCTCAAGATTATTTTCGGTATCATTATC 
3057 AGCGCCTUCTTGATGACTTCCAGCTGGCCCGGGATGCCGAACGACTGGAACGACGCTTGCTGTTCCAGCGCATC 
3058 AAACGCTUTTTTGCTGGTCGCGCACG 
3059 ACGAAGGUGTGACGCAGACCAGCATTTGAACCAAACTTCGGATCG 
3060 ATTTTTCGAUATTTGAACCAAACTTCGGATCGT 
3061 AAACGCTUTTTTGCTCCGCTCACCCTG 
3062 ACGAAGGUGTGACGCAGACCAGCCCCTTCTTTTGTCGTGC 
3063 ATTTTTCGAUCCCTTCTTTTGTCGTGCC 
3151 AAACGCTUTTTTGCTATGAAAATCGAAGAAGGTAAACTGG  
3152 ATCCAGGUACCGAAGTCTGCGCGTCTTTC  
3257 ATGCGACUCCTGCATTAGGAAATATGGTGGAAAACCTGTACTTC 
3258 AGCCTAGGUTAATCAGTGGTGGTGGTGGTGATGATGATGGGCCGCAAGCTTTTTGTAGAGCTCATCCATGCC 
3268 ACCACCAUTAAACUAGTCTTGGACTCCTGTTG 
3269 ATGGTGGUGGTGATGATGATGGTGACCGCCAGAACCGCCAGAACCGCCAGAACCGCCATTCATGAGTTGAGTCGCTTC 
3288 ACCACTGAUTAACCTAGGCTG 
3289 ATCAGTGGUGGTGGTGGTGATGATGATGGGCCGCAAGCTTAGCCAGAGCTTTACCTTCGG 
3290 ATCAGTGGUGGTGGTGGTGATGATGATGGGCCGCAAGCTTAACGTGGTCAGAACCAACC 
3291 ATCAGTGGUGGTGGTGGTGATGATGATGGGCCGCAAGCTTCAGCTTTTCATATTCCTTCTGCTTGG 
3292 ACTTCCAGAUGGAAATTTACGAGAACGAAAACGACCAGGTAGAAGCGGTTAAACGCTTTTTTGCTCGTAAAGGCGAAGAGCTG 
3293 ATCAGTGGUGGTGGTGGTGATGATGATGGGCCGCAAGCTTTTTGTACAGTTCATCCATACCATG 
3294 ATCTGGAAGUACAGGTTTTCCACCATCT 
3332 AGAGCTGTUCACTGGTGTC 
3333 AACAGCTCUTCGCCTTTACGTTGCTGTTCCAGCGCATCG 
3334 AACAGCTCUTCGCCTTTACGCCCTTCTTTTGTCGTGCC 
3335 AACAGCTCUTCGCCTTTACGATTTGAACCAAACTTCGGATCG 
3336 AGGGGAATUGTTATCCGCTCACAATTCCCCTATAGTGAGTCGTATTAATTTCCTAATGCAGGAGTCG 
3337 AATTCCCCUCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGACTCGAGGATGGTGGAAAACCTGTACTTC 
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Table S 2: Fluorescence properties of selected FR proteins. Two numbers separated by a dash indicate a range of estimates from different authors working under slightly different 
conditions. Maximum excitation and emission wave length, λEx and λEx, respectively; extinction coefficient, E; quantum yield, QY. Table supplemented and modified from WINGEN et 
al. (2014) 197, BUCKLEY et al. (2015) 202 and THORN (2017) 188 with supplements from other sources. 
FLUORESCENT 
PROTEIN 
ORGANISM MOLECULAR 
MASS (kDa) 
OLIGOME
RIC STATE 
λEx  
(nm) 
λEm  
(nm) 
E 
(mM-1*cm-1) 
QY BRIGHTNESS 
E*QY 
PHOTO-
STABILITY 
t50% (min) 
COMMENTS REF 
AvGFP A. victoria 26.8 Weak 
dimer 
395-397 504-508 25-30 0.79 19.8-23.7  Native protein from A. victoria 163,166 
eGFP A. victoria 26.8 Weak 
dimer 
488-489 507-509 56 0.6 33.6 2.9 AvGFP variant 166,298 
YFP 
 
A. victoria 26.8 Weak 
dimer 
514  
(2nd peak) 
528     AvGFP variant 299 
eBFP 
 
A. victoria 26.8 Weak 
dimer 
383 445 31 0.25 7.75  AvGFP variant 199,300 
eCFP 
 
A. victoria 26.8 Weak 
dimer 
434 477 26 0.40 10.4  AvGFP variant 199,300 
sfGFP A. victoria 26.8 Monomer 485 510 83 0.65 54.1  AvGFP variant 6 
 
EcFbFP B. subtilis 15.1 Dimer 448 495 12.5-13.9 0.34-0.44 4.3-6.1 2.8 BsFbFP codon-optimised for E. 
coli; thermostable until 50 °C 
197–
199,204 
phiLOV2.1 A. thaliana 12.1 Monomer 447-450 496-497  0.2  13 iLOV variant with increased 
photostability and enhanced 
photobleaching resistance 
197,201,221 
CreiLOV C. reinhardtii 13.0 Monomer 450 495 12 0.51 6.4  Enhanced brightness, 
photostability, thermal and pH 
tolerance in vitro 
198 
 
  
  
 
 
Table S 3: Overview about selected characteristics of the unmodified proteins relevant for Study II. Theoretical average MW calculated with the ExPASy Compute pI/Mw tool; If not 
found in literature the theoretical molecular weight (MW) was calculated with ExPASy Compute pI/MW tool 301; in regards to membrane protein topology, the orientation of the 
peptide chain N- and C-termini are given relative to the cytosol. 
PROTEIN SIZE (aa) MW 
(kDa) 
UNIPROT ID TMHS PROTEIN CLASS  MP TOPOLOGY RCSB PDB ID GENE  ECOGENE 
ID 
ORGANISM REFERENCE 
NarX 598 67.1 P0AFA2 2 Membran protein Polytopic, Nin-Cin 3EZH, 3EZI 
(partially) 
narX EG10646 E. coli 5,180,302 
EnvZ 450 50.3 P0AEJ4 2 Membran protein Polytopic, Nin-Cin 1BXD, 5XGA 
(partially) 
envZ EG10269 E. coli 180 
NavZ1-W0 467 51.0 - 2 Membran protein Polytopic, Nin-Cin  navZ1-
w0 
- Gene chimera of  
narX and enzZ (E. 
coli) 
5 
YhaI 118 13.5 P64592 3? Membran protein Polytopic, Nin-Cin  yhaI EG12748 E. coli 180 
PpiD 623 68.1 P0ADY1 1 Membran protein Bitopic, Nin-Cout 2KGJ (partially) ppiD EG13249 E. coli 171 
YfgM 206 22.2 P76576 1 Membran protein Bitopic, Nin-Cout  yfgM EG14209 E. coli 2 
AvGFP 238 26.9 P42212 - Globular protein - 1GFL gfp - A. victoria 166 
frGFP 238 26.8 - - Globular protein -  frgfp - A. victoria 4 
sfGFP 238 26.8 - - Globular protein - 2B3P sfgfp - A. victoria 6 
TEVP 237 27.0 P04517 (NIa) - Globular domain - 1LVM (TEVP-S219D) tev - Tobacco etch virus 150 
phiLOV2.1 110 12.7 A0A178URG7 
 (Phot2) 
- Globular domain - 4EEF  - A. thaliana 201,202 
EcFbFP 135 15.4 O34627 (YtvA) - Globular domain - 2PR5 (BsYtvA)  - B. subtilis 199,220 
CreiLOV 119 12.9 Q8LPE0 (Phot) - Globular domain - 1N9L  - C. reinhardii 198 
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Table S 4: Predicted transmembrane helices of POIs used in Study II. Predictions are a result from a full protein 
scan using DGpred 165. In regards to membrane protein topology, the orientation of the peptide chain N- and C-
termini are given relative to the cytosol. 
PROTEIN POSITION LENGTH PREDICTED ΔG SEQUENCE COMMENT 
YfgM     Nin-Cout topology. 
 23-42 20 -0.709 KALAVGVILGVGALIGWRYW  
PpiD     Nin-Cout topology. 
 12-34 23 -2.221 LVLKIIFGIIIVSFILTGVSGYL  
YhaI     Nin-Cin topology. 
 23-44 22 0.283 YWMFTLINAIVGAIINVIQLIL In theory, TMH1 is unlikely to exist but not 
impossible. Amphiphatic character possible. 
 50-71 22 -1.407 YLSMLYLLATFLPVLALAIRRL  
 78-100 23 -3.187 GAWALLFFVPFIGWLVLLVFFCT  
NarX     Nin-Cin topology. 
 9-31 23 -0.225 LTLVNQVALIVLLSTAIGLAGMA  
 157-179 23 -4.020 RVMAVFMALLLVFTIIWLRARLL  
EnvZ     Nin-Cin topology. 
 12-34 23 -2.928 FARTLLLIVTLLFASLVTTYLVV  
 160-181 22 -3.239 LFRYTLAIMLLAIGGAWLFIRI  
 395-413 19 2.926 SARTISGTGLGLAIVQRIV In theory, TMH3 is unlikely to exist but not 
impossible. Practically it is not existent. 
NavZ1-W0     Nin-Cin topology. 
 9-31 23 -0.225 LTLVNQVALIVLLSTAIGLAGMA  
 157-179 23 -4.020 RVMAVFMALLLVFTIIWLRARLL  
 391-409 19 2.926 SARTISGTGLGLAIVQRIV In theory, TMH3 is unlikely to exist but not 
impossible. Practically it is not existent. 
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Figure S1 
 
Figure S1. Growth drop tests of isolated variants of ten essential genes tagged with TIR 
variation. 10-fold serial dilutions were performed from overnight cultures and 10 µL were 
plated on LB agar. E. coli K12 MG1655 serves as control strain (WT). 
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Figure S2 
 
 
Figure S2. Growth profiles of wild type E. coli K12 MG1655 and 14 different tagged essential 
gene variants when inducing CRiPi with aTc, rhamnose or both. Growth was monitored over 
time in a BioLector® where scattered light represents biomass concentration. Rhamnose 
(red) aTc (green), or rhamnose and aTc (blue) were added from the beginning of growth or 
without inducers (black). The different variants of the same essential gene have different TIR 
regions. The CRiPi system was not tested for tagged essential gene variants of glmS due to 
growth defects as shown in Figure S1.Results are mean values of biological triplicates with 
error-bars showing standard error. Rham: rhamnose, aTc: anhydrotetracycline, a.u.: arbitrary 
unit.  
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Figure S3 
 
 
 
Figure S3. Fosfomycin sensitivity upon PROTi induction in murE-rt1-tagged clone or no 
induction (Ø). Cells carrying the CRiPi system were grown for 4 hours and plated on LB agar 
with different fosfomycin concentrations. All values are the averages of five biological 
replicates and bars show standard error. Representative LB agar plates with 0 mg/mL(top 
pnael) or 0.25 mg/L (bottom panel) of fosfomycin.  
 
Figure S4 
 
 
 
Figure S4. Fosfomycin sensitivity upon CRiPi induction in murE-tagged clones or no 
induction (Ø). Growth was tested in increasing concentrations of fosfomycin after 18 h 
incubation. All values are the averages of three biological replicates and bars show standard 
error. Same data as in Figure 3I.   
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Table S1 
 
Table S1. Plasmids used in this publication 
Plasmid ID Relevant genotype, description 
  
Reference/source 
pSEVA331 pBBR1, CmR (1) 
pPROTi pSEVA331 derivative plasmid with 
tev protease under the PrhaBAD 
promoter 
 
This publication 
pdCas9 dCas9 expression plasmid, dCas9 
gene expressed under aTc inducible 
promoter 
 
Addgene (2) 
pCRiPi pPROTi derivative plasmid with 
dCas9 gene under aTc inducible 
promoter 
This publication 
pSLQ1236 gRNA expression plasmid, gRNA 
was expressed under aTc inducible 
promoter 
(3) 
pgRNA-CRiPi pSLQ1236 derivative plasmid with 
gRNA targeting the PROTi tag under 
aTc inducible promoter 
 
This publication 
pZS4Int-tetR Expression of tetR for CRMAGE 
 
(4) 
pMA7CR_2.0 Expression of λ-Red β -proteins, 
dam protein and Cas9 for CRMAGE 
 
(4) 
pMAZ-SK 
 
 
 
Expression of target gRNA for Cas9 
recognition for CRMAGE 
 
 
(4) 
pKS1 
 
Expression of mCherry under 
rhamnose inducible promoter 
(5) 
pKM586 tev protease expression plasmid  Addgene (6) 
   
 
Table S2 
 
Table S2. Oligonucleotides used in this publication  
Oligo ID Oligo sequence (5’ to 3’) 
 
 
oMSB1267 
 
AAAGGCAUCAAATAAAACGAAAGGCTC 
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oMSB1268 ATGCCTTUAATTAATAAAAATAGGCGTATCACGAGGCCCTTTC 
oMSB1269 ATGGTATATUCCTCCTGAATTTCATTACGAC 
oMSB1270 ACTAGTCTUGGACTCCTGTTGATAGATC 
oMSB1271 AATATACCAUGGGAGAAAGCTTGTTTAAG 
oMSB1273 
 
oMSB1275 
 
 
oMSB1276 
 
 
oMSB1277 
 
AAGACTAGUTTAATTCATGAGTTGAGTCGCTTCCTTAAC 
 
AGTGACAAGTTCTTCTCCTTTGCTACGAAACTGGAAGTACAGGTTTT
CCACCATCTAG 
 
AGTGACAAGTTCTTCTCCTTTGCTACGAGCCTGGAAGTACAGGTTTT
CCACCATCTAG 
 
GACAACTCCAGTGAAAAGTTCTTCTCCTTTGCTAACTCCAGTGAcAA
GTTCTTCTCCTTTGCTACGTTACTGGAAGTACAGGTTTTCCACCATC
TAGTATTTCTCCTCTTTAATCTCTAGTAGCTAGCACTGTACCTAGGAC
TGAGC 
 
oMSB1661 
 
ATGCATCUTCATAAAAAATTTATTTGCTTTGTGAGCGGATAACAATTA
TAATAGATTCAATTGTGAGCGGATAACAATTTCACACAGAATTCATTA
AAGAGGAGAAATTCTAGATGGTGGAAAACCTGTACTTCCAG 
 
oMSB1662 AGAGGGCUTCATTTGTAGAGCTCATCCATGCCATG 
oMSB1865 ACGTTGAUACGCCTATTTTTATTAATTAAAGGCATCAAATAAAACGAA
A 
oMSB1866 
 
ATCAACGUCTCATTTTCGCCAGATATCGACGTC 
oSMB2312 
 
AAGAAATUCACCACAATTCAGCAAATTGTGAACATC 
oMSB2313 AATTTCTUTATAAACGCAGAAAGGCCCACCCGAAGG 
 
oMSB1297 
 
AGATGCAUGGCGCCTAACC 
 
oMSB1298 
 
AGCCCTCUAGAGGATCCCCGGGTAC 
 
oMSB2595 ACACCCCTTCAGGAATGCTCGCCTTGCGGGTTGGAGTAATGTTGCT
TTTAATTCGTTCAATCCAAACTCCAGTGACAAGTTCTTCTCCTTTGCT
ACGAAACTGGAAGTACAGGTTYTCRCTCATNNNNNNCCTTTCTGTCT
GAACCTGGTTCGATGCCAGT 
 
oMSB2596 CGTTTCAGCAATTGCGCGGCCAATTCCGCGACTTGCACCGGTTACC
AGTGCGATTTTTCCTTCAAAAACTCCAGTGACAAGTTCTTCTCCTTTG
CTACGAAACTGGAAGTACAGGTTYTCRTTCATNNNNNNCCTCTTTTA
AAGCTCGAGCGCCGCTGCC 
 
oMSB2597 CCGCCGACGCCGATGACTTTAATCACCGCGTCATTTGTAAGTTCCAT
TGGTTCAACTCCAGTGACAAGTTCTTCTCCTTTGCTACGAAACTGGA
AGTACAGGTTYTCRAACATNNNNNNTCTCCGATTTGTGCCTGTCGC
CTGAGGCCGTAATCA 
 
oMSB2598 GTATTCCAGACGACGTAAACCTTCAAGAAGTATTTCTGCTACATCAC
GTTGCGCGATCGCGCCAACAATTCCAACTCCAGTGACAAGTTCTTC
TCCTTTGCTACGAAACTGGAAGTACAGGTTYTCRCACATNNNNNNTG
ATTCCGATTTATATCGTTGTCGGTCAACCTGT 
 
oMSB2599 CCACGCATCGGGAACCCTGTTTCCGGCAAATTCAGTGTTGATTTATA
GTCAACTCCAGTGACAAGTTCTTCTCCTTTGCTACGAAACTGGAAGT
ACAGGTTYTCRCTCATNNNNNNCTCGGTTCCGTATTTCGGTTTGATT
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ACATAACAGGCTTA 
 
oMSB2600 CGCGAAGGTGCGTCTGGCACCCACGGAGCAAGAAGATCGCGCAAA
TTACGATCAACTCCAGTGACAAGTTCTTCTCCTTTGCTACGAAACTG
GAAGTACAGGTTYTCNGCCACNNNNNNCCTCGCCTTGATTAATCAC
AAATTCATTTTTATCGC 
 
oMSB2601 ACATCTGACGCCTGGCTAATGGCCGCCTTCGCACTTGCAACCAGTT
CTGCGAGATGAACTCCAGTGACAAGTTCTTCTCCTTTGCTACGAAAC
TGGAAGTACAGGTTYTCNGACATNNNNNNCCTCATTGTGTCAGTGG
TGACACTGGTTCGTTGGAC 
 
oMSB2651 TGGGATGCGTGGTAAAACGTCCTCGTTGCGCAAGCTTTAGCGCCCG
CGCCATGTAATACTCGTCAACTCCAGTGACAAGTTCTTCTCCTTTGC
TACGAAACTGGAAGTACAGGTTYTCYTGCACNNNNNNGTCCTCCAG
GCGCGCGATCTCTTCGCCAAATTC 
 
oMSB2602 CCCCCTAAGAACGTCGGAGCGTTCCGTGAGTTCCTGAATGCGATTA
TTTACCGGATTAATTTCAACTCCAGTGACAAGTTCTTCTCCTTTGCTA
CGAAACTGGAAGTACAGGTTYTCRAACATNNNNNNATTTCTTTTATT
GAGCTAGTCAAAATGCGGT 
 
oMSB2603 CGTCTGACCGTTTCTAAGTAATAAAGCTAACNNNNNNGTGGTNGAR
AACCTGTACTTCCAGTTTCGTAGCAAAGGAGAAGAACTTGTCACTGG
AGTTAAGCTCGCATTTCCAAGGGAGTTACGCTTGTTAACTCCAAGTC
AATTCACATTCGTCTTCCAGCAGCCA 
 
oMSB2604 ATTACGCGCGGTAGTTTTGCCTGCGCCTTCAAGCCCCTCAATGACG
ATATACTTACTAACTCCAGTGACAAGTTCTTCTCCTTTGCTACGAAAC
TGGAAGTACAGGTTYTCNCGCATNNNNNNCCTTAAGCACTTTCAGAT
AATCCTGCACAGA 
oMSB2757 GGGCGATCACCGCTTCGATGCGAGCGATCTCAACAATATCCGTGCC
TAAACCTAATATAACTCCAGTGACAAGTTCTTCTCCTTTGCTACGAAA
CTGGAAGTACAGGTTYTCNGCCATNNNNNNCGCGCTTCCAGCATCA
GACGCTTCATTTCTGCC 
 
oMSB2752 
 
AGCGCGGTCTACCCCGGCACAAAAACCACGCGGGTTTGCCAACAG
GATAACTCCAGTGACAAGTTCTTCTCCTTTGCTACGAAACTGGAAGT
ACAGGTTYTCYTGCATNNNNNNCCTCCAGTGCCGGATCGATTTCCA
GCACTTCAA 
 
oMSB2753 TTTAGCGCCGGAAATTGTGACTTCGCCCTGTAGCTTCGTTGGCCCC
TGAACACGAAATTTAACTCCAGTGACAAGTTCTTCTCCTTTGCTACG
AAACTGGAAGTACAGGTTYTCRTCCATNNNNNNTGTTCTCAGTTAAC
AATTCATATCCGCTACCGGC 
 
oMSB2756 GATTCCAGTTATCAGCAATTTTTCCATGAGGTGNNNNNNATGTCNGA
RAACCTGTACTTCCAGTTTCGTAGCAAAGGAGAAGAACTTGTCACTG
GAGTTTGTCCGGTTATTGAGCTGACACAACAGCTTATTCGCCG 
 
oMSB2754 GACTTTCTTGCCGGTATGTAAACCGACACCAGTCGCCTGAACGATA
CGTTTAAGTGTCCTTTGTTTAACTCCAGTGACAAGTTCTTCTCCTTTG
CTACGAAACTGGAAGTACAGGTTYTCRATCATNNNNNNATCTCGCC
AAATTACCTATCCAACCGAAGTGTA 
 
oMSB2755 CGCGATGGTGATGGCGACGCGAGCGTCCGGTGTAGCAACGTTAGC
TTCAATAATAACTCCAGTGACAAGTTCTTCTCCTTTGCTACGAAACTG
GAAGTACAGGTTYTCRTTCATNNNNNNCCTTCGGGTTCGAGTATGG
CCCCGCAGGGGGGCG 
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oMSB2662 CCACGCATCGGGAACCCTGTTTCCGGCAAATTCAGTGTTGATTTATA
GTCAACTCCAGTGACAAGTTCTTCTCCTTTGCTACGAAACTGGAAGT
ACAGGTTTTCACTCATCAGATTCTCGGTTCCGTATTTCGGTTTGATTA
CATAACAGGCTTA 
 
oMSB2663 CGCGAAGGTGCGTCTGGCACCCACGGAGCAAGAAGATCGCGCAAA
TTACGATCAACTCCAGTGACAAGTTCTTCTCCTTTGCTACGAAACTG
GAAGTACAGGTTTTCTGCCACCTGTCCCCTCGCCTTGATTAATCACA
AATTCATTTTTATCGC 
 
oMSB2664 ACATCTGACGCCTGGCTAATGGCCGCCTTCGCACTTGCAACCAGTT
CTGCGAGATGAACTCCAGTGACAAGTTCTTCTCCTTTGCTACGAAAC
TGGAAGTACAGGTTTTCTGACATGGTTTTCCTCATTGTGTCAGTGGT
GACACTGGTTCGTTGGAC 
 
oMSB2665 TGGGATGCGTGGTAAAACGTCCTCGTTGCGCAAGCTTTAGCGCCCG
CGCCATGTAATACTCGTCAACTCCAGTGACAAGTTCTTCTCCTTTGC
TACGAAACTGGAAGTACAGGTTTTCCTGCACGGCTTAGTCCTCCAG
GCGCGCGATCTCTTCGCCAAATTC 
 
oMSB2666 CGTCTGACCGTTTCTAAGTAATAAAGCTAACCCCTGAGTGGTTGAAA
ACCTGTACTTCCAGTTTCGTAGCAAAGGAGAAGAACTTGTCACTGGA
GTTAAGCTCGCATTTCCAAGGGAGTTACGCTTGTTAACTCCAAGTCA
ATTCACATTCGTCTTCCAGCAGCCA 
 
oMSB2565 GAGCACAGGAATGCTCGCCTTGCGGGGTTTTAGAGCTAGAAAT 
 
oMSB2566 CTAAAACCCCGCAAGGCGAGCATTCCTGTGCTCAGTATCTCT 
 
oMSB2591 GAGCACCAATTGCGCGGCCAATTCCGGTTTTAGAGCTAGAAAT 
 
oMSB2592 CTAAAACCGGAATTGGCCGCGCAATTGGTGCTCAGTATCTCT 
 
oMSB2569 GAGCACGACTTTAATCACCGCGTCATGTTTTAGAGCTAGAAAT 
 
oMSB2570 CTAAAACATGACGCGGTGATTAAAGTCGTGCTCAGTATCTCT 
 
oMSB2571 GAGCACGACGACGTAAACCTTCAAGAGTTTTAGAGCTAGAAAT 
 
oMSB2572 CTAAAACTCTTGAAGGTTTACGTCGTCGTGCTCAGTATCTCT 
 
oMSB2573 GAGCACCCCTGTTTCCGGCAAATTCAGTTTTAGAGCTAGAAAT 
 
oMSB2574 CTAAAACTGAATTTGCCGGAAACAGGGGTGCTCAGTATCTCT 
 
oMSB2575 GAGCACCTGGCACCCACGGAGCAAGAGTTTTAGAGCTAGAAAT 
 
oMSB2576 CTAAAACTCTTGCTCCGTGGGTGCCAGGTGCTCAGTATCTCT 
 
oMSB2577 GAGCACGCTAATGGCCGCCTTCGCACGTTTTAGAGCTAGAAAT 
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oMSB2578 CTAAAACGTGCGAAGGCGGCCATTAGCGTGCTCAGTATCTCT 
 
oMSB2593 GAGCACCATGGCGCGGGCGCTAAAGCGTTTTAGAGCTAGAAAT 
 
oMSB2594 CTAAAACGCTTTAGCGCCCGCGCCATGGTGCTCAGTATCTCT 
 
oMSB2579 GAGCACGAACGTCGGAGCGTTCCGTGGTTTTAGAGCTAGAAAT 
 
oMSB2580 CTAAAACCACGGAACGCTCCGACGTTCGTGCTCAGTATCTCT 
 
oMSB2583 GAGCACGAAGACGAATGTGAATTGACGTTTTAGAGCTAGAAAT 
 
oMSB2584 CTAAAACGTCAATTCACATTCGTCTTCGTGCTCAGTATCTCT 
 
oMSB2585 GAGCACGTATATCGTCATTGAGGGGCGTTTTAGAGCTAGAAAT 
 
oMSB2586 CTAAAACGCCCCTCAATGACGATATACGTGCTCAGTATCTCT 
 
oMSB2750 GAGCACAGGTTTAGGCACGGATATTGGTTTTAGAGCTAGAAAT 
 
oMSB2751 CTAAAACCAATATCCGTGCCTAAACCTGTGCTCAGTATCTCT 
 
oMSB2740 GAGCACGGCACAAAAACCACGCGGGTGTTTTAGAGCTAGAAAT 
 
oMSB2741 CTAAAACACCCGCGTGGTTTTTGTGCCGTGCTCAGTATCTCT 
 
oMSB2742 GAGCACCGGAAATTGTGACTTCGCCCGTTTTAGAGCTAGAAAT 
 
oMSB2743 CTAAAACGGGCGAAGTCACAATTTCCGGTGCTCAGTATCTCT 
 
oMSB2748 GAGCACGTTGTGTCAGCTCAATAACCGTTTTAGAGCTAGAAAT 
 
oMSB2749 CTAAAACGGTTATTGAGCTGACACAACGTGCTCAGTATCTCT 
 
oMSB2744 GAGCACTAAACGTATCGTTCAGGCGAGTTTTAGAGCTAGAAAT 
 
oMSB2745 CTAAAACTCGCCTGAACGATACGTTTAGTGCTCAGTATCTCT 
 
oMSB2746 GAGCACGATGGCGACGCGAGCGTCCGGTTTTAGAGCTAGAAAT 
 
oMSB2747 CTAAAACCGGACGCTCGCGTCGCCATCGTGCTCAGTATCTCT 
 
oSONG145 CTTCTCCTTTGCTACGAAACGTTTTAGAGCTAGAAATAGCAAGTTAA
AATAAGGC 
oSONG146 GTTTCGTAGCAAAGGAGAAGACTAGTCTTTTCTCTATCACTGATAGG
GA 
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Table S3 
 
Table S3. Essential genes investigated in this study 
Essential 
gene tagged 
with PROTi 
tag 
Tagged 
by 
Cameron 
et al.   
Number 
of tagged 
clones  
Variants used for 
droptest 
Variants used for growth 
profile (Biolector) 
glmS No 8 
glmS-rt1, rt2, rt3, 
rt4 None (sick phenotype) 
ileS No 12 
ileS-rt1, rt2, rt3, rt4, 
rt5, rt6, rt7 ileS-rt1, ileS-rt2 
murE No 15 
murE-rt1, rt2, rt3, 
rt4, rt5, rt6, rt7 murE-rt1, murE-rt2 
pheS No 18 
pheS-rt1, rt2, rt3, 
rt4, rt5, rt6, rt7 pheS-rt1, pheS-rt2 
rnpA No 3 rnpA-rt1, rt2, rt3 rpnA-rt1, rnpA-rt2 
ribD No 7 
ribD-rt1, rt2, rt3, rt4, 
rt5, rt6 ribD-rt1, ribD-rt2 
tmk No 1 tmk-rt tmk-rt 
accD No 0 
  fabG No 0 
  prfB No 0 
  ftsZ yes 0 
  acpS yes 1 acpS-rt acpS-rt 
ispH yes 0 
  murA yes 0 
  dapE yes 1 dapE-rt dapE-rt 
lpxC yes 4 lpxC-rt1, rt2, rt3, rt4  lpxC-rt1, lpxC-rt2 
ribE Yes 0   
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Nucleotide sequences of pPROTi, pCRiPi and pgRNA-CRiPi in Genbank 
format 
 
pPROTi 
 
LOCUS       Exported                5622 bp ds-DNA     circular 
SYN 27-JUN-2017 
DEFINITION  synthetic circular DNA 
ACCESSION   . 
VERSION     . 
KEYWORDS     
SOURCE      synthetic DNA construct 
  ORGANISM  synthetic DNA construct 
REFERENCE   1  (bases 1 to 5622) 
  AUTHORS   towo 
  TITLE     Direct Submission 
  JOURNAL   Exported Thursday, Jul 6, 2017 from SnapGene 3.3.4 
            http://www.snapgene.com 
FEATURES             Location/Qualifiers 
     source          1..5622 
                     /organism="synthetic DNA construct" 
                     /mol_type="other DNA" 
     terminator      2..96 
                     /label=lambda t0 terminator 
                     /note="transcription terminator from phage 
lambda" 
     promoter        144..246 
                     /label=cat promoter 
                     /note="promoter of the E. coli cat gene" 
     CDS             247..906 
                     /codon_start=1 
                     /gene="cat" 
                     /product="chloramphenicol acetyltransferase" 
                     /label=CmR 
                     /note="confers resistance to 
chloramphenicol" 
                     
/translation="MEKKITGYTTVDISQWHRKEHFEAFQSVAQCTYNQTVQLDITAFL 
                     
KTVKKNKHKFYPAFIHILARLMNAHPEFRMAMKDGELVIWDSVHPCYTVFHEQTETFSS 
                     
LWSEYHDDFRQFLHIYSQDVACYGENLAYFPKGFIENMFFVSANPWVSFTSFDLNVANM 
                     
DNFFAPVFTMGKYYTQGDKVLMPLAIQVHHAVCDGFHVGRMLNELQQYCDEWQGGA" 
     oriT            1055..1163 
                     /note="incP origin of transfer" 
     CDS             complement(1174..1836) 
                     /codon_start=1 
                     /product="replication protein for the broad-
host-range  
                     plasmid pBBR1 from Bordetella 
bronchiseptica" 
                     /label=pBBR1 Rep 
                     
/translation="MATQSREIGIQAKNKPGHWVQTERKAHEAWAGLIARKPTAAMLLH 
                     
HLVAQMGHQNAVVVSQKTLSKLIGRSLRTVQYAVKDLVAERWISVVKLNGPGTVSAYVV 
                     
NDRVAWGQPRDQLRLSVFSAAVVVDHDDQDESLLGHGDLRRIPTLYPGEQQLPTGPGEE 
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PPSQPGIPGMEPDLPALTETEEWERRGQQRLPMPDEPCFLDDGEPLEPPTRVTLPRR" 
     rep_origin      1837..2608 
                     /label=pBBR1 oriV 
                     /note="replication origin of the broad-host-
range plasmid  
                     pBBR1 from Bordetella bronchiseptica; 
requires the pBBR1  
                     Rep protein for replication" 
     terminator      2723..2809 
                     /gene="Escherichia coli rrnB" 
                     /label=rrnB T1 terminator 
                     /note="transcription terminator T1 from the 
E. coli rrnB  
                     gene" 
     misc_feature    complement(2857..3792) 
                     /label=rhaR 
     CDS             complement(3779..4612) 
                     /codon_start=1 
                     /label=rhaS 
                     
/translation="MTVLHSVDFFPSGNASVAIEPRLPQADFPEHHHDFHEIVIVEHGT 
                     
GIHVFNGQPYTITGGTVCFVRDHDRHLYEHTDNLCLTNVLYRSPDRFQFLAGLNQLLPQ 
                     
ELDGQYPSHWRVNHSVLQQVRQLVAQMEQQEGENDLPSTASREILFMQLLLLLRKSSLQ 
                     
ENLENSASRLNLLLAWLEDHFADEVNWDAVADQFSLSLRTLHRQLKQQTGLTPQRYLNR 
                     
LRLMKARHLLRHSEASVTDIAYRCGFSDSNHFSTLFRREFNWSPRDIRQGRDGFLQ" 
     misc_feature    4816..4891 
                     /label=PrhaBAD 
     misc_feature    4886..4892 
                     /label=SDS 
     CDS             4900..5613 
                     /codon_start=1 
                     /label=TEV protease S219D 
                     
/translation="MGESLFKGPRDYNPISSTICHLTNESDGHTTSLYGIGFGPFIITN 
                     
KHLFRRNNGTLLVQSLHGVFKVKNTTTLQQHLIDGRDMIIIRMPKDFPPFPQKLKFREP 
                     
QREERICLVTTNFQTKSMSSMVSDTSCTFPSSDGIFWKHWIQTKDGQCGSPLVSTRDGF 
                     
IVGIHSASNFTNTNNYFTSVPKNFMELLTNQEAQQWVSGWRLNADSVLWGGHKVFMDKP 
                     EEPFQPVKEATQLMN" 
ORIGIN 
        1 ggactcctgt tgatagatcc agtaatgacc tcagaactcc atctggattt 
gttcagaacg 
       61 ctcggttgcc gccgggcgtt ttttattggt gagaatccag gggtccccaa 
taattacgat 
      121 ttaaattggc gaaaatgaga cgttgatcgg cacgtaagag gttccaactt 
tcaccataat 
      181 gaaataagat cactaccggg cgtatttttt gagttatcga gattttcagg 
agctaaggaa 
      241 gctaaaatgg agaaaaaaat cactggatat accaccgttg atatatccca 
atggcatcgt 
      301 aaagaacatt ttgaggcatt tcagtcagtt gctcaatgta cctataacca 
gaccgttcag 
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      361 ctggatatta cggccttttt aaagaccgta aagaaaaata agcacaagtt 
ttatccggcc 
      421 tttattcaca ttcttgcccg cctgatgaat gctcatccgg aatttcgtat 
ggcaatgaaa 
      481 gacggtgagc tggtgatatg ggatagtgtt cacccttgtt acaccgtttt 
ccatgagcaa 
      541 actgaaacgt tttcatcgct ctggagtgaa taccacgacg atttccggca 
gtttctacac 
      601 atatattcgc aagatgtggc gtgttacggt gaaaacctgg cctatttccc 
taaagggttt 
      661 attgagaata tgtttttcgt ctcagccaat ccctgggtga gtttcaccag 
ttttgattta 
      721 aacgtggcca atatggacaa cttcttcgcc cccgttttca ccatgggcaa 
atattatacg 
      781 caaggcgaca aggtgctgat gccgctggcg attcaggttc atcatgccgt 
ttgtgatggc 
      841 ttccatgtcg gcagaatgct taatgaatta caacagtact gcgatgagtg 
gcagggcggg 
      901 gcgtaatttg acttttgtcc ttttccgctg cataaccctg cttcggggtc 
attatagcga 
      961 ttttttcggt atatccatcc tttttcgcac gatatacagg attttgccaa 
agggttcgtg 
     1021 tagactttcc ttggtgtatc caacggcgtc agccgggcag gataggtgaa 
gtaggcccac 
     1081 ccgcgagcgg gtgttccttc ttcactgtcc cttattcgca cctggcggtg 
ctcaacggga 
     1141 atcctgctct gcgaggctgg ccgtaggccg gccctaccgg cgcggcagcg 
ttacccgtgt 
     1201 cggcggctcc aacggctcgc catcgtccag aaaacacggc tcatcgggca 
tcggcaggcg 
     1261 ctgctgcccg cgccgttccc attcctccgt ttcggtcaag gctggcaggt 
ctggttccat 
     1321 gcccggaatg ccgggctggc tgggcggctc ctcgccgggg ccggtcggta 
gttgctgctc 
     1381 gcccggatac agggtcggga tgcggcgcag gtcgccatgc cccaacagcg 
attcgtcctg 
     1441 gtcgtcgtga tcaaccacca cggcggcact gaacaccgac aggcgcaact 
ggtcgcgggg 
     1501 ctggccccac gccacgcggt cattgaccac gtaggccgac acggtgccgg 
ggccgttgag 
     1561 cttcacgacg gagatccagc gctcggccac caagtccttg actgcgtatt 
ggaccgtccg 
     1621 caaagaacgt ccgatgagct tggaaagtgt cttctggctg accaccacgg 
cgttctggtg 
     1681 gcccatctgc gccacgaggt gatgcagcag cattgccgcc gtgggtttcc 
tcgcaataag 
     1741 cccggcccac gcctcatgcg ctttgcgttc cgtttgcacc cagtgaccgg 
gcttgttctt 
     1801 ggcttgaatg ccgatttctc tggactgcgt ggccatgctt atctccatgc 
ggtaggggtg 
     1861 ccgcacggtt gcggcaccat gcgcaatcag ctgcaacttt tcggcagcgc 
gacaacaatt 
     1921 atgcgttgcg taaaagtggc agtcaattac agattttctt taacctacgc 
aatgagctat 
     1981 tgcggggggt gccgcaatga gctgttgcgt accccccttt tttaagttgt 
tgatttttaa 
     2041 gtctttcgca tttcgcccta tatctagttc tttggtgccc aaagaagggc 
acccctgcgg 
     2101 ggttccccca cgccttcggc gcggctcccc ctccggcaaa aagtggcccc 
tccggggctt 
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     2161 gttgatcgac tgcgcggcct tcggccttgc ccaaggtggc gctgccccct 
tggaaccccc 
     2221 gcactcgccg ccgtgaggct cggggggcag gcgggcgggc ttcgcccttc 
gactgccccc 
     2281 actcgcatag gcttgggtcg ttccaggcgc gtcaaggcca agccgctgcg 
cggtcgctgc 
     2341 gcgagccttg acccgccttc cacttggtgt ccaaccggca agcgaagcgc 
gcaggccgca 
     2401 ggccggaggc ttttccccag agaaaattaa aaaaattgat ggggcaaggc 
cgcaggccgc 
     2461 gcagttggag ccggtgggta tgtggtcgaa ggctgggtag ccggtgggca 
atccctgtgg 
     2521 tcaagctcgt gggcaggcgc agcctgtcca tcagcttgtc cagcagggtt 
gtccacgggc 
     2581 cgagcgaagc gagccagccg gtggccgctc gcggccatcg tccacatatc 
cacgggctgg 
     2641 caagggagcg cagcgaccgc gcagggcgaa gcccggagag caagcccgta 
gggggggcgc 
     2701 gcccagctgt ctagggcggc ggatttgtcc tactcaggag agcgttcacc 
gacaaacaac 
     2761 agataaaacg aaaggcccag tctttcgact gagcctttcg ttttatttga 
tgcctttaat 
     2821 taataaaaat aggcgtatca cgaggccctt tcgtctatct ttctgcgaat 
tgagatgacg 
     2881 ccactggctg ggcgtcatcc cggtttcccg ggtaaacacc accgaaaaat 
agttactatc 
     2941 ttcaaagcca cattcggtcg aaatatcact gattaacagg cggctatgct 
ggagaagata 
     3001 ttgcgcatga cacactctga cctgtcgcag atattgattg atggtcattc 
cagtctgctg 
     3061 gcgaaattgc tgacgcaaaa cgcgctcact gcacgatgcc tcatcacaaa 
atttatccag 
     3121 cgcaaaggga cttttcaggc tagccgccag ccgggtaatc agcttatcca 
gcaacgtttc 
     3181 gctggatgtt ggcggcaacg aatcactggt gtaacgatgg cgattcagca 
acatcaccaa 
     3241 ctgcccgaac agcaactcag ccatttcgtt agcaaacggc acatgctgac 
tactttcatg 
     3301 ctcaagctga ccaataacct gccgcgcctg cgccatcccc atgctaccta 
agcgccagtg 
     3361 tggttgccct gcgctggcgt taaatcccgg aatcgccccc tgccagtcaa 
gattcagctt 
     3421 cagacgctcc gggcaataaa taatattctg caaaaccaga tcgttaacgg 
aagcgtagga 
     3481 gtgtttatca tcagcatgaa tgtaaaagag atcgccacgg gtaatgcgat 
aagggcgatc 
     3541 gttgagtaca tgcaggccat taccgcgcca gacaatcacc agctcacaaa 
aatcatgtgt 
     3601 atgttcagca aagacatctt gcggataacg gtcagccaca gcgactgcct 
gctggtcgct 
     3661 ggcaaaaaaa tcatctttga gaagttttaa ctgatgcgcc accgtggcta 
cctcggccag 
     3721 agaacgaagt tgattattcg caatatggcg tacaaatacg ttgagaagat 
tcgcgttatt 
     3781 gcagaaagcc atcccgtccc tggcgaatat cacgcggtga ccagttaaac 
tctcggcgaa 
     3841 aaagcgtcga aaagtggtta ctgtcgctga atccacagcg ataggcgatg 
tcagtaacgc 
     3901 tggcctcgct gtggcgtagc agatgtcggg ctttcatcag tcgcaggcgg 
ttcaggtatc 
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     3961 gctgaggcgt cagtcccgtt tgctgcttaa gctgccgatg tagcgtacgc 
agtgaaagag 
     4021 aaaattgatc cgccacggca tcccaattca cctcatcggc aaaatggtcc 
tccagccagg 
     4081 ccagaagcaa gttgagacgt gatgcgctgt tttccaggtt ctcctgcaaa 
ctgcttttac 
     4141 gcagcaagag cagtaattgc ataaacaaga tctcgcgact ggcggtcgag 
ggtaaatcat 
     4201 tttccccttc ctgctgttcc atctgtgcaa ccagctgtcg cacctgctgc 
aatacgctgt 
     4261 ggttaacgcg ccagtgagac ggatactgcc catccagctc ttgtggcagc 
aactgattca 
     4321 gcccggcgag aaactgaaat cgatccggcg agcgatacag cacattggtc 
agacacagat 
     4381 tatcggtatg ttcatacaga tgccgatcat gatcgcgtac gaaacagacc 
gtgccaccgg 
     4441 tgatggtata gggctgccca ttaaacacat gaatacccgt gccatgttcg 
acaatcacaa 
     4501 tttcatgaaa atcatgatga tgttcaggaa aatccgcctg cgggagccgg 
ggttctatcg 
     4561 ccacggacgc gttaccagac ggaaaaaaat ccacactatg taatacggtc 
atactggcct 
     4621 cctgatgtcg tcaacacggc gaaatagtaa tcacgaggtc aggttcttac 
cttaaatttt 
     4681 cgacggaaaa ccacgtaaaa aacgtcgatt tttcaagata cagcgtgaat 
tttcaggaaa 
     4741 tgcggtgagc atcacatcac cacaattcag caaattgtga acatcatcac 
gttcatcttt 
     4801 ccctggttgc caatggccca ttttcttgtc agtaacgaga aggtcgcgaa 
tccaggcgct 
     4861 ttttagactg gtcgtaatga aattcaggag gaatatacca tgggagaaag 
cttgtttaag 
     4921 gggccgcgtg attacaaccc gatatcgagc accatttgtc atttgacgaa 
tgaatctgat 
     4981 gggcacacaa catcgttgta tggtattgga tttgggccct tcatcattac 
aaacaagcac 
     5041 ttgtttagaa gaaataatgg aacactgttg gtccaatcac tacatggtgt 
attcaaggtc 
     5101 aagaacacca cgactttgca acaacacctc atcgatgggc gggacatgat 
cattattcga 
     5161 atgcctaagg atttcccacc atttcctcaa aagctgaaat ttcgcgagcc 
acaacgggaa 
     5221 gagcgcattt gtcttgtgac aaccaacttc caaactaaga gcatgtctag 
catggtgtca 
     5281 gacactagtt gcacattccc ttcatctgat ggcatattct ggaagcattg 
gattcaaacc 
     5341 aaggatgggc agtgtggcag tccattagta tcaactcgag atgggttcat 
tgttggtata 
     5401 cactcagcat cgaatttcac caacacaaac aattatttca caagcgtgcc 
gaaaaacttc 
     5461 atggaattgt tgacaaatca ggaggcgcag cagtgggtta gtggttggcg 
attaaatgct 
     5521 gactcagtat tgtggggggg ccataaagtt ttcatggaca aacctgaaga 
gccttttcag 
     5581 ccagttaagg aagcgactca actcatgaat taaactagtc tt 
// 	  
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FEATURES             Location/Qualifiers 
     source          1..8726 
                     /organism="recombinant plasmid" 
                     /mol_type="other DNA" 
     misc_feature    complement(7..633) 
                     /label=TetR 
     misc_feature    634..706 
                     /label=tet promoter region 
     misc_feature    685..703 
                     /label=Tetracycline Response Element (TRE) 
     RBS             722..733 
                     /label=RBS (strong) 
     misc_feature    743..4843 
                     /label=Streptococcus pyogenes dCas9 
     misc_feature    3257..3258 
                     /label=CA in Cas9 wt (His) 
     terminator      4862..4990 
                     /label=dblTerm 
     misc_feature    5057..5132 
                     /label=PrhaBAD 
     misc_feature    5127..5133 
                     /label=SDS 
     CDS             5141..5854 
                     /codon_start=1 
                     /label=TEV protease S219D 
                     
/translation="MGESLFKGPRDYNPISSTICHLTNESDGHTTSLYGIGFGPFIITN 
                     
KHLFRRNNGTLLVQSLHGVFKVKNTTTLQQHLIDGRDMIIIRMPKDFPPFPQKLKFREP 
                     
QREERICLVTTNFQTKSMSSMVSDTSCTFPSSDGIFWKHWIQTKDGQCGSPLVSTRDGF 
                     
IVGIHSASNFTNTNNYFTSVPKNFMELLTNQEAQQWVSGWRLNADSVLWGGHKVFMDKP 
                     EEPFQPVKEATQLMN" 
     terminator      5865..5959 
                     /label=lambda t0 terminator 
                     /note="transcription terminator from phage 
lambda" 
     promoter        6007..6109 
                     /label=cat promoter 
                     /note="promoter of the E. coli cat gene" 
     CDS             6110..6769 
                     /codon_start=1 
                     /gene="cat" 
                     /product="chloramphenicol acetyltransferase" 
	 17	
                     /label=CmR 
                     /note="confers resistance to 
chloramphenicol" 
                     
/translation="MEKKITGYTTVDISQWHRKEHFEAFQSVAQCTYNQTVQLDITAFL 
                     
KTVKKNKHKFYPAFIHILARLMNAHPEFRMAMKDGELVIWDSVHPCYTVFHEQTETFSS 
                     
LWSEYHDDFRQFLHIYSQDVACYGENLAYFPKGFIENMFFVSANPWVSFTSFDLNVANM 
                     
DNFFAPVFTMGKYYTQGDKVLMPLAIQVHHAVCDGFHVGRMLNELQQYCDEWQGGA" 
     oriT            6918..7026 
                     /note="incP origin of transfer" 
     CDS             complement(7037..7699) 
                     /codon_start=1 
                     /product="replication protein for the broad-
host-range  
                     plasmid pBBR1 from Bordetella 
bronchiseptica" 
                     /label=pBBR1 Rep 
                     
/translation="MATQSREIGIQAKNKPGHWVQTERKAHEAWAGLIARKPTAAMLLH 
                     
HLVAQMGHQNAVVVSQKTLSKLIGRSLRTVQYAVKDLVAERWISVVKLNGPGTVSAYVV 
                     
NDRVAWGQPRDQLRLSVFSAAVVVDHDDQDESLLGHGDLRRIPTLYPGEQQLPTGPGEE 
                     
PPSQPGIPGMEPDLPALTETEEWERRGQQRLPMPDEPCFLDDGEPLEPPTRVTLPRR" 
     rep_origin      7700..8471 
                     /label=pBBR1 oriV 
                     /note="replication origin of the broad-host-
range plasmid  
                     pBBR1 from Bordetella bronchiseptica; 
requires the pBBR1  
                     Rep protein for replication" 
     terminator      8586..8672 
                     /gene="Escherichia coli rrnB" 
                     /label=rrnB T1 terminator 
                     /note="transcription terminator T1 from the 
E. coli rrnB  
                     gene" 
ORIGIN 
        1 gacgtcttaa gacccacttt cacatttaag ttgtttttct aatccgcata 
tgatcaattc 
       61 aaggccgaat aagaaggctg gctctgcacc ttggtgatca aataattcga 
tagcttgtcg 
      121 taataatggc ggcatactat cagtagtagg tgtttccctt tcttctttag 
cgacttgatg 
      181 ctcttgatct tccaatacgc aacctaaagt aaaatgcccc acagcgctga 
gtgcatataa 
      241 tgcattctct agtgaaaaac cttgttggca taaaaaggct aattgatttt 
cgagagtttc 
      301 atactgtttt tctgtaggcc gtgtacctaa atgtactttt gctccatcgc 
gatgacttag 
      361 taaagcacat ctaaaacttt tagcgttatt acgtaaaaaa tcttgccagc 
tttccccttc 
      421 taaagggcaa aagtgagtat ggtgcctatc taacatctca atggctaagg 
cgtcgagcaa 
      481 agcccgctta ttttttacat gccaatacaa tgtaggctgc tctacaccta 
gcttctgggc 
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      541 gagtttacgg gttgttaaac cttcgattcc gacctcatta agcagctcta 
atgcgctgtt 
      601 aatcacttta cttttatcta atctagacat cattaattcc taatttttgt 
tgacactcta 
      661 tcgttgatag agttatttta ccactcccta tcagtgatag agaaaagaat 
tcaaaagatc 
      721 taaagaggag aaaggatcta tggataagaa atactcaata ggcttagcta 
tcggcacaaa 
      781 tagcgtcgga tgggcggtga tcactgatga atataaggtt ccgtctaaaa 
agttcaaggt 
      841 tctgggaaat acagaccgcc acagtatcaa aaaaaatctt ataggggctc 
ttttatttga 
      901 cagtggagag acagcggaag cgactcgtct caaacggaca gctcgtagaa 
ggtatacacg 
      961 tcggaagaat cgtatttgtt atctacagga gattttttca aatgagatgg 
cgaaagtaga 
     1021 tgatagtttc tttcatcgac ttgaagagtc ttttttggtg gaagaagaca 
agaagcatga 
     1081 acgtcatcct atttttggaa atatagtaga tgaagttgct tatcatgaga 
aatatccaac 
     1141 tatctatcat ctgcgaaaaa aattggtaga ttctactgat aaagcggatt 
tgcgcttaat 
     1201 ctatttggcc ttagcgcata tgattaagtt tcgtggtcat tttttgattg 
agggagattt 
     1261 aaatcctgat aatagtgatg tggacaaact atttatccag ttggtacaaa 
cctacaatca 
     1321 attatttgaa gaaaacccta ttaacgcaag tggagtagat gctaaagcga 
ttctttctgc 
     1381 acgattgagt aaatcaagac gattagaaaa tctcattgct cagctccccg 
gtgagaagaa 
     1441 aaatggctta tttgggaatc tcattgcttt gtcattgggt ttgaccccta 
attttaaatc 
     1501 aaattttgat ttggcagaag atgctaaatt acagctttca aaagatactt 
acgatgatga 
     1561 tttagataat ttattggcgc aaattggaga tcaatatgct gatttgtttt 
tggcagctaa 
     1621 gaatttatca gatgctattt tactttcaga tatcctaaga gtaaatactg 
aaataactaa 
     1681 ggctccccta tcagcttcaa tgattaaacg ctacgatgaa catcatcaag 
acttgactct 
     1741 tttaaaagct ttagttcgac aacaacttcc agaaaagtat aaagaaatct 
tttttgatca 
     1801 atcaaaaaac ggatatgcag gttatattga tgggggagct agccaagaag 
aattttataa 
     1861 atttatcaaa ccaattttag aaaaaatgga tggtactgag gaattattgg 
tgaaactaaa 
     1921 tcgtgaagat ttgctgcgca agcaacggac ctttgacaac ggctctattc 
cccatcaaat 
     1981 tcacttgggt gagctgcatg ctattttgag aagacaagaa gacttttatc 
catttttaaa 
     2041 agacaatcgt gagaagattg aaaaaatctt gacttttcga attccttatt 
atgttggtcc 
     2101 attggcgcgt ggcaatagtc gttttgcatg gatgactcgg aagtctgaag 
aaacaattac 
     2161 cccatggaat tttgaagaag ttgtcgataa aggtgcttca gctcaatcat 
ttattgaacg 
     2221 catgacaaac tttgataaaa atcttccaaa tgaaaaagta ctaccaaaac 
atagtttgct 
     2281 ttatgagtat tttacggttt ataacgaatt gacaaaggtc aaatatgtta 
ctgaaggaat 
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     2341 gcgaaaacca gcatttcttt caggtgaaca gaagaaagcc attgttgatt 
tactcttcaa 
     2401 aacaaatcga aaagtaaccg ttaagcaatt aaaagaagat tatttcaaaa 
aaatagaatg 
     2461 ttttgatagt gttgaaattt caggagttga agatagattt aatgcttcat 
taggtaccta 
     2521 ccatgatttg ctaaaaatta ttaaagataa agattttttg gataatgaag 
aaaatgaaga 
     2581 tatcttagag gatattgttt taacattgac cttatttgaa gatagggaga 
tgattgagga 
     2641 aagacttaaa acatatgctc acctctttga tgataaggtg atgaaacagc 
ttaaacgtcg 
     2701 ccgttatact ggttggggac gtttgtctcg aaaattgatt aatggtatta 
gggataagca 
     2761 atctggcaaa acaatattag attttttgaa atcagatggt tttgccaatc 
gcaattttat 
     2821 gcagctgatc catgatgata gtttgacatt taaagaagac attcaaaaag 
cacaagtgtc 
     2881 tggacaaggc gatagtttac atgaacatat tgcaaattta gctggtagcc 
ctgctattaa 
     2941 aaaaggtatt ttacagactg taaaagttgt tgatgaattg gtcaaagtaa 
tggggcggca 
     3001 taagccagaa aatatcgtta ttgaaatggc acgtgaaaat cagacaactc 
aaaagggcca 
     3061 gaaaaattcg cgagagcgta tgaaacgaat cgaagaaggt atcaaagaat 
taggaagtca 
     3121 gattcttaaa gagcatcctg ttgaaaatac tcaattgcaa aatgaaaagc 
tctatctcta 
     3181 ttatctccaa aatggaagag acatgtatgt ggaccaagaa ttagatatta 
atcgtttaag 
     3241 tgattatgat gtcgatgcca ttgttccaca aagtttcctt aaagacgatt 
caatagacaa 
     3301 taaggtctta acgcgttctg ataaaaatcg tggtaaatcg gataacgttc 
caagtgaaga 
     3361 agtagtcaaa aagatgaaaa actattggag acaacttcta aacgccaagt 
taatcactca 
     3421 acgtaagttt gataatttaa cgaaagctga acgtggaggt ttgagtgaac 
ttgataaagc 
     3481 tggttttatc aaacgccaat tggttgaaac tcgccaaatc actaagcatg 
tggcacaaat 
     3541 tttggatagt cgcatgaata ctaaatacga tgaaaatgat aaacttattc 
gagaggttaa 
     3601 agtgattacc ttaaaatcta aattagtttc tgacttccga aaagatttcc 
aattctataa 
     3661 agtacgtgag attaacaatt accatcatgc ccatgatgcg tatctaaatg 
ccgtcgttgg 
     3721 aactgctttg attaagaaat atccaaaact tgaatcggag tttgtctatg 
gtgattataa 
     3781 agtttatgat gttcgtaaaa tgattgctaa gtctgagcaa gaaataggca 
aagcaaccgc 
     3841 aaaatatttc ttttactcta atatcatgaa cttcttcaaa acagaaatta 
cacttgcaaa 
     3901 tggagagatt cgcaaacgcc ctctaatcga aactaatggg gaaactggag 
aaattgtctg 
     3961 ggataaaggg cgagattttg ccacagtgcg caaagtattg tccatgcccc 
aagtcaatat 
     4021 tgtcaagaaa acagaagtac agacaggcgg attctccaag gagtcaattt 
taccaaaaag 
     4081 aaattcggac aagcttattg ctcgtaaaaa agactgggat ccaaaaaaat 
atggtggttt 
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     4141 tgatagtcca acggtagctt attcagtcct agtggttgct aaggtggaaa 
aagggaaatc 
     4201 gaagaagtta aaatccgtta aagagttact agggatcaca attatggaaa 
gaagttcctt 
     4261 tgaaaaaaat ccgattgact ttttagaagc taaaggatat aaggaagtta 
aaaaagactt 
     4321 aatcattaaa ctacctaaat atagtctttt tgagttagaa aacggtcgta 
aacggatgct 
     4381 ggctagtgcc ggagaattac aaaaaggaaa tgagctggct ctgccaagca 
aatatgtgaa 
     4441 ttttttatat ttagctagtc attatgaaaa gttgaagggt agtccagaag 
ataacgaaca 
     4501 aaaacaattg tttgtggagc agcataagca ttatttagat gagattattg 
agcaaatcag 
     4561 tgaattttct aagcgtgtta ttttagcaga tgccaattta gataaagttc 
ttagtgcata 
     4621 taacaaacat agagacaaac caatacgtga acaagcagaa aatattattc 
atttatttac 
     4681 gttgacgaat cttggagctc ccgctgcttt taaatatttt gatacaacaa 
ttgatcgtaa 
     4741 acgatatacg tctacaaaag aagttttaga tgccactctt atccatcaat 
ccatcactgg 
     4801 tctttatgaa acacgcattg atttgagtca gctaggaggt gactaactcg 
agtaaggatc 
     4861 tccaggcatc aaataaaacg aaaggctcag tcgaaagact gggcctttcg 
ttttatctgt 
     4921 tgtttgtcgg tgaacgctct ctactagagt cacactggct caccttcggg 
tgggcctttc 
     4981 tgcgtttata aagaaattca ccacaattca gcaaattgtg aacatcatca 
cgttcatctt 
     5041 tccctggttg ccaatggccc attttcttgt cagtaacgag aaggtcgcga 
atccaggcgc 
     5101 tttttagact ggtcgtaatg aaattcagga ggaatatacc atgggagaaa 
gcttgtttaa 
     5161 ggggccgcgt gattacaacc cgatatcgag caccatttgt catttgacga 
atgaatctga 
     5221 tgggcacaca acatcgttgt atggtattgg atttgggccc ttcatcatta 
caaacaagca 
     5281 cttgtttaga agaaataatg gaacactgtt ggtccaatca ctacatggtg 
tattcaaggt 
     5341 caagaacacc acgactttgc aacaacacct catcgatggg cgggacatga 
tcattattcg 
     5401 aatgcctaag gatttcccac catttcctca aaagctgaaa tttcgcgagc 
cacaacggga 
     5461 agagcgcatt tgtcttgtga caaccaactt ccaaactaag agcatgtcta 
gcatggtgtc 
     5521 agacactagt tgcacattcc cttcatctga tggcatattc tggaagcatt 
ggattcaaac 
     5581 caaggatggg cagtgtggca gtccattagt atcaactcga gatgggttca 
ttgttggtat 
     5641 acactcagca tcgaatttca ccaacacaaa caattatttc acaagcgtgc 
cgaaaaactt 
     5701 catggaattg ttgacaaatc aggaggcgca gcagtgggtt agtggttggc 
gattaaatgc 
     5761 tgactcagta ttgtgggggg gccataaagt tttcatggac aaacctgaag 
agccttttca 
     5821 gccagttaag gaagcgactc aactcatgaa ttaaactagt cttggactcc 
tgttgataga 
     5881 tccagtaatg acctcagaac tccatctgga tttgttcaga acgctcggtt 
gccgccgggc 
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     5941 gttttttatt ggtgagaatc caggggtccc caataattac gatttaaatt 
ggcgaaaatg 
     6001 agacgttgat cggcacgtaa gaggttccaa ctttcaccat aatgaaataa 
gatcactacc 
     6061 gggcgtattt tttgagttat cgagattttc aggagctaag gaagctaaaa 
tggagaaaaa 
     6121 aatcactgga tataccaccg ttgatatatc ccaatggcat cgtaaagaac 
attttgaggc 
     6181 atttcagtca gttgctcaat gtacctataa ccagaccgtt cagctggata 
ttacggcctt 
     6241 tttaaagacc gtaaagaaaa ataagcacaa gttttatccg gcctttattc 
acattcttgc 
     6301 ccgcctgatg aatgctcatc cggaatttcg tatggcaatg aaagacggtg 
agctggtgat 
     6361 atgggatagt gttcaccctt gttacaccgt tttccatgag caaactgaaa 
cgttttcatc 
     6421 gctctggagt gaataccacg acgatttccg gcagtttcta cacatatatt 
cgcaagatgt 
     6481 ggcgtgttac ggtgaaaacc tggcctattt ccctaaaggg tttattgaga 
atatgttttt 
     6541 cgtctcagcc aatccctggg tgagtttcac cagttttgat ttaaacgtgg 
ccaatatgga 
     6601 caacttcttc gcccccgttt tcaccatggg caaatattat acgcaaggcg 
acaaggtgct 
     6661 gatgccgctg gcgattcagg ttcatcatgc cgtttgtgat ggcttccatg 
tcggcagaat 
     6721 gcttaatgaa ttacaacagt actgcgatga gtggcagggc ggggcgtaat 
ttgacttttg 
     6781 tccttttccg ctgcataacc ctgcttcggg gtcattatag cgattttttc 
ggtatatcca 
     6841 tcctttttcg cacgatatac aggattttgc caaagggttc gtgtagactt 
tccttggtgt 
     6901 atccaacggc gtcagccggg caggataggt gaagtaggcc cacccgcgag 
cgggtgttcc 
     6961 ttcttcactg tcccttattc gcacctggcg gtgctcaacg ggaatcctgc 
tctgcgaggc 
     7021 tggccgtagg ccggccctac cggcgcggca gcgttacccg tgtcggcggc 
tccaacggct 
     7081 cgccatcgtc cagaaaacac ggctcatcgg gcatcggcag gcgctgctgc 
ccgcgccgtt 
     7141 cccattcctc cgtttcggtc aaggctggca ggtctggttc catgcccgga 
atgccgggct 
     7201 ggctgggcgg ctcctcgccg gggccggtcg gtagttgctg ctcgcccgga 
tacagggtcg 
     7261 ggatgcggcg caggtcgcca tgccccaaca gcgattcgtc ctggtcgtcg 
tgatcaacca 
     7321 ccacggcggc actgaacacc gacaggcgca actggtcgcg gggctggccc 
cacgccacgc 
     7381 ggtcattgac cacgtaggcc gacacggtgc cggggccgtt gagcttcacg 
acggagatcc 
     7441 agcgctcggc caccaagtcc ttgactgcgt attggaccgt ccgcaaagaa 
cgtccgatga 
     7501 gcttggaaag tgtcttctgg ctgaccacca cggcgttctg gtggcccatc 
tgcgccacga 
     7561 ggtgatgcag cagcattgcc gccgtgggtt tcctcgcaat aagcccggcc 
cacgcctcat 
     7621 gcgctttgcg ttccgtttgc acccagtgac cgggcttgtt cttggcttga 
atgccgattt 
     7681 ctctggactg cgtggccatg cttatctcca tgcggtaggg gtgccgcacg 
gttgcggcac 
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     7741 catgcgcaat cagctgcaac ttttcggcag cgcgacaaca attatgcgtt 
gcgtaaaagt 
     7801 ggcagtcaat tacagatttt ctttaaccta cgcaatgagc tattgcgggg 
ggtgccgcaa 
     7861 tgagctgttg cgtacccccc ttttttaagt tgttgatttt taagtctttc 
gcatttcgcc 
     7921 ctatatctag ttctttggtg cccaaagaag ggcacccctg cggggttccc 
ccacgccttc 
     7981 ggcgcggctc cccctccggc aaaaagtggc ccctccgggg cttgttgatc 
gactgcgcgg 
     8041 ccttcggcct tgcccaaggt ggcgctgccc ccttggaacc cccgcactcg 
ccgccgtgag 
     8101 gctcgggggg caggcgggcg ggcttcgccc ttcgactgcc cccactcgca 
taggcttggg 
     8161 tcgttccagg cgcgtcaagg ccaagccgct gcgcggtcgc tgcgcgagcc 
ttgacccgcc 
     8221 ttccacttgg tgtccaaccg gcaagcgaag cgcgcaggcc gcaggccgga 
ggcttttccc 
     8281 cagagaaaat taaaaaaatt gatggggcaa ggccgcaggc cgcgcagttg 
gagccggtgg 
     8341 gtatgtggtc gaaggctggg tagccggtgg gcaatccctg tggtcaagct 
cgtgggcagg 
     8401 cgcagcctgt ccatcagctt gtccagcagg gttgtccacg ggccgagcga 
agcgagccag 
     8461 ccggtggccg ctcgcggcca tcgtccacat atccacgggc tggcaaggga 
gcgcagcgac 
     8521 cgcgcagggc gaagcccgga gagcaagccc gtaggggggg cgcgcccagc 
tgtctagggc 
     8581 ggcggatttg tcctactcag gagagcgttc accgacaaac aacagataaa 
acgaaaggcc 
     8641 cagtctttcg actgagcctt tcgttttatt tgatgccttt aattaataaa 
aataggcgta 
     8701 tcaacgtctc attttcgcca gatatc 
// 
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pgRNA-CRiPi 
 
LOCUS       Exported                3177 bp ds-DNA     circular 
SYN 05-JAN-2017 
DEFINITION  synthetic circular DNA 
ACCESSION   . 
VERSION     . 
KEYWORDS    pgRNA-CRiPi : pSLQ1236-Tev for CRiPi - aTc inducible 
SOURCE      synthetic DNA construct 
  ORGANISM  synthetic DNA construct 
REFERENCE   1  (bases 1 to 3177) 
  AUTHORS   . 
  TITLE     Direct Submission 
  JOURNAL   Exported Thursday, Jul 6, 2017 from SnapGene 3.3.4 
            http://www.snapgene.com 
FEATURES             Location/Qualifiers 
     source          1..3177 
                     /organism="synthetic DNA construct" 
                     /mol_type="other DNA" 
     misc_feature    17..643 
                     /label=TetR 
     misc_feature    258..263 
                     /label=XbaI-SpeI scar(1) 
     misc_feature    644..716 
                     /label=tet promoter region 
     misc_feature    665..682 
                     /label=Q1, Q2 promoter (tetR) 
     misc_feature    695..713 
                     /label=TetO2 site 
     misc_feature    724..743 
                     /label=TEV gRNA 
     misc_feature    744..785 
                     /label=JAD designed chimera RNA 3'UTR 
     misc_feature    752..757 
                     /label=NheI-XbaI scar 
     misc_feature    777..782 
                     /label=NheI-SpeI scar 
     misc_feature    790..826 
                     /label=Streptococcus pyogenes tracrRNA 
terminator 
     terminator      827..1194 
                     /label=TrrnB 
     misc_feature    complement(863..868) 
                     /label=BglII-BamHI scar(3) 
     misc_feature    863..868 
                     /label=BamHI-BglII scar 
     misc_feature    914..919 
                     /label=BsaI site 
     misc_feature    1092..1097 
                     /label=BsaI site(1) 
     terminator      1120..1187 
                     /label=sglTerm 
     rep_origin      complement(1380..2062) 
                     /direction=LEFT 
                     /label=ColE1 origin 
     misc_feature    complement(1831..1836) 
                     /label=XbaI-SpeI scar 
     misc_feature    complement(1978..1983) 
                     /label=BglII-BamHI scar(4) 
     misc_feature    1978..1983 
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                     /label=BamHI-BglII scar(1) 
     misc_feature    1989..1994 
                     /label=BglII-BamHI scar 
     misc_feature    complement(1989..1994) 
                     /label=BamHI-BglII scar(4) 
     misc_feature    complement(2075..2080) 
                     /label=BglII-BamHI scar(5) 
     misc_feature    2075..2080 
                     /label=BamHI-BglII scar(2) 
     misc_feature    2087..2092 
                     /label=BglII-BamHI scar(1) 
     misc_feature    complement(2087..2092) 
                     /label=BamHI-BglII scar(5) 
     CDS             complement(2160..2819) 
                     /label=AmpR 
     misc_feature    complement(2297..2302) 
                     /label=BsaI site(2) 
     misc_feature    2419..2424 
                     /label=NheI-XbaI scar(1) 
     misc_feature    complement(2855..2860) 
                     /label=BglII-BamHI scar(6) 
     misc_feature    2855..2860 
                     /label=BamHI-BglII scar(3) 
     misc_feature    2872..2877 
                     /label=BglII-BamHI scar(2) 
     misc_feature    complement(2872..2877) 
                     /label=BamHI-BglII scar(6) 
     misc_feature    complement(3059..3087) 
                     /label=AmpR promoter 
ORIGIN 
        1 gaattcttca agatctttaa gacccacttt cacatttaag ttgtttttct 
aatccgcata 
       61 tgatcaattc aaggccgaat aagaaggctg gctctgcacc ttggtgatca 
aataattcga 
      121 tagcttgtcg taataatggc ggcatactat cagtagtagg tgtttccctt 
tcttctttag 
      181 cgacttgatg ctcttgatct tccaatacgc aacctaaagt aaaatgcccc 
acagcgctga 
      241 gtgcatataa tgcattctct agtgaaaaac cttgttggca taaaaaggct 
aattgatttt 
      301 cgagagtttc atactgtttt tctgtaggcc gtgtacctaa atgtactttt 
gctccatcgc 
      361 gatgacttag taaagcacat ctaaaacttt tagcgttatt acgtaaaaaa 
tcttgccagc 
      421 tttccccttc taaagggcaa aagtgagtat ggtgcctatc taacatctca 
atggctaagg 
      481 cgtcgagcaa agcccgctta ttttttacat gccaatacaa tgtaggctgc 
tctacaccta 
      541 gcttctgggc gagtttacgg gttgttaaac cttcgattcc gacctcatta 
agcagctcta 
      601 atgcgctgtt aatcacttta cttttatcta atctagacat cattaattcc 
taatttttgt 
      661 tgacactcta tcgttgatag agttatttta ccactcccta tcagtgatag 
agaaaagact 
      721 agtcttctcc tttgctacga aacgttttag agctagaaat agcaagttaa 
aataaggcta 
      781 gtccgttatc aacttgaaaa agtggcaccg agtcggtgct ttttttgaag 
cttgggcccg 
      841 aacaaaaact catctcagaa gaggatctga atagcgccgt cgaccatcat 
catcatcatc 
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      901 attgagttta aacggtctcc agcttggctg ttttggcgga tgagagaaga 
ttttcagcct 
      961 gatacagatt aaatcagaac gcagaagcgg tctgataaaa cagaatttgc 
ctggcggcag 
     1021 tagcgcggtg gtcccacctg accccatgcc gaactcagaa gtgaaacgcc 
gtagcgccga 
     1081 tggtagtgtg gggtctcccc atgcgagagt agggaactgc caggcatcaa 
ataaaacgaa 
     1141 aggctcagtc gaaagactgg gcctttcgtt ttatctgttg tttgtcggtg 
aactggatcc 
     1201 ttactcgagt ctagactgca ggcttcctcg ctcactgact cgctgcgctc 
ggtcgttcgg 
     1261 ctgcggcgag cggtatcagc tcactcaaag gcggtaatac ggttatccac 
agaatcaggg 
     1321 gataacgcag gaaagaacat gtgagcaaaa ggccagcaaa aggccaggaa 
ccgtaaaaag 
     1381 gccgcgttgc tggcgttttt ccataggctc cgcccccctg acgagcatca 
caaaaatcga 
     1441 cgctcaagtc agaggtggcg aaacccgaca ggactataaa gataccaggc 
gtttccccct 
     1501 ggaagctccc tcgtgcgctc tcctgttccg accctgccgc ttaccggata 
cctgtccgcc 
     1561 tttctccctt cgggaagcgt ggcgctttct catagctcac gctgtaggta 
tctcagttcg 
     1621 gtgtaggtcg ttcgctccaa gctgggctgt gtgcacgaac cccccgttca 
gcccgaccgc 
     1681 tgcgccttat ccggtaacta tcgtcttgag tccaacccgg taagacacga 
cttatcgcca 
     1741 ctggcagcag ccactggtaa caggattagc agagcgaggt atgtaggcgg 
tgctacagag 
     1801 ttcttgaagt ggtggcctaa ctacggctac actagaagga cagtatttgg 
tatctgcgct 
     1861 ctgctgaagc cagttacctt cggaaaaaga gttggtagct cttgatccgg 
caaacaaacc 
     1921 accgctggta gcggtggttt ttttgtttgc aagcagcaga ttacgcgcag 
aaaaaaagga 
     1981 tctcaagaag atcctttgat cttttctacg gggtctgacg ctcagtggaa 
cgaaaactca 
     2041 cgttaaggga ttttggtcat gagattatca aaaaggatct tcacctagat 
ccttttaaat 
     2101 taaaaatgaa gttttaaatc aatctaaagt atatatgagt aaacttggtc 
tgacagttac 
     2161 caatgcttaa tcagtgaggc acctatctca gcgatctgtc tatttcgttc 
atccatagtt 
     2221 gcctgactcc ccgtcgtgta gataactacg atacgggagg gcttaccatc 
tggccccagt 
     2281 gctgcaatga taccgcgaga cccacgctca ccggctccag atttatcagc 
aataaaccag 
     2341 ccagccggaa gggccgagcg cagaagtggt cctgcaactt tatccgcctc 
catccagtct 
     2401 attaattgtt gccgggaagc tagagtaagt agttcgccag ttaatagttt 
gcgcaacgtt 
     2461 gttgccattg ctacaggcat cgtggtgtca cgctcgtcgt ttggtatggc 
ttcattcagc 
     2521 tccggttccc aacgatcaag gcgagttaca tgatccccca tgttgtgcaa 
aaaagcggtt 
     2581 agctccttcg gtcctccgat cgttgtcaga agtaagttgg ccgcagtgtt 
atcactcatg 
     2641 gttatggcag cactgcataa ttctcttact gtcatgccat ccgtaagatg 
cttttctgtg 
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     2701 actggtgagt actcaaccaa gtcattctga gaatagtgta tgcggcgacc 
gagttgctct 
     2761 tgcccggcgt caatacggga taataccgcg ccacatagca gaactttaaa 
agtgctcatc 
     2821 attggaaaac gttcttcggg gcgaaaactc tcaaggatct taccgctgtt 
gagatccagt 
     2881 tcgatgtaac ccactcgtgc acccaactga tcttcagcat cttttacttt 
caccagcgtt 
     2941 tctgggtgag caaaaacagg aaggcaaaat gccgcaaaaa agggaataag 
ggcgacacgg 
     3001 aaatgttgaa tactcatact cttccttttt caatattatt gaagcattta 
tcagggttat 
     3061 tgtctcatga gcggatacat atttgaatgt atttagaaaa ataaacaaat 
aggggttccg 
     3121 cgcacatttc cccgaaaagt gccacctgac gtctaagaaa ccattattat 
catgaca 
// 
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